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Abstract
Effects of a demand-led evidence briefing service on the
uptake and use of research evidence by commissioners
of health services: a controlled before-and-after study
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Duncan Chambers,5 Mark Lambert,6 Carl Thompson,2
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1Alliance Manchester Business School, University of Manchester, Manchester, UK
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6Public Heath England North East Centre, Newcastle upon Tyne, UK
7School of Psychology, Queen’s University Belfast, Belfast, UK
8Department of Health Sciences, University of York, York, UK
*Corresponding author paul.wilson@manchester.ac.uk
Background: The Health and Social Care Act 2012 (Great Britain. Health and Social Care Act 2012.
London: The Stationery Office; 2012) has mandated research use as a core consideration of health service
commissioning arrangements. We evaluated whether or not access to a demand-led evidence briefing
service improved the use of research evidence by commissioners, compared with less intensive and less
targeted alternatives.
Design: Controlled before-and-after study.
Setting: Clinical Commissioning Groups (CCGs) in the north of England.
Main outcome measures: Change at 12 months from baseline of a CCG’s ability to acquire, assess,
adapt and apply research evidence to support decision-making. Secondary outcomes measured individual
clinical leads’ and managers’ intentions to use research evidence in decision-making.
Methods: Nine CCGs received one of three interventions: (1) access to an evidence briefing service;
(2) contact plus an unsolicited push of non-tailored evidence; or (3) an unsolicited push of non-tailored
evidence. Data for the primary outcome measure were collected at baseline and 12 months post
intervention, using a survey instrument devised to assess an organisation’s ability to acquire, assess, adapt
and apply research evidence to support decision-making. In addition, documentary and observational
evidence of the use of the outputs of the service was sought and interviews with CCG participants
were undertaken.
Results: Most of the requests were conceptual; they were not directly linked to discrete decisions or
actions but were intended to provide knowledge about possible options for future actions. Symbolic use to
justify existing decisions and actions were less frequent and included a decision to close a walk-in centre
and to lend weight to a major initiative to promote self-care already under way. The opportunity to impact
directly on decision-making processes was limited to work to establish disinvestment policies. In terms of
impact overall, the evidence briefing service was not associated with increases in CCGs’ capacity to
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acquire, assess, adapt and apply research evidence to support decision-making, individual intentions to use
research findings or perceptions of CCGs’ relationships with researchers. Regardless of the intervention
received, at baseline participating CCGs indicated that they felt that they were inconsistent in their
research-seeking behaviours and their capacity to acquire research remained so at follow-up. The informal
nature of decision-making processes meant that there was little or no traceability of the use of evidence.
Limitations: Low baseline and follow-up response rates (of 68% and 44%, respectively) and missing data
limit the reliability of these findings.
Conclusions: Access to a demand-led evidence briefing service did not improve the uptake and use of
research evidence by NHS commissioners compared with less intensive and less targeted alternatives.
Commissioners appear to be well intentioned but ad hoc users of research.
Future work: Further research is required on the effects of interventions and strategies to build individual
and organisational capacity to use research. Resource-intensive approaches to providing evidence may best
be employed to support instrumental decision-making. Comparative evaluation of the impact of less
intensive but targeted strategies on the uptake and use of research by commissioners is warranted.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Plain English summary
In the NHS, Clinical Commissioning Groups (CCGs) are the bodies responsible for the planning andcommissioning of health-care services in a defined local area. In 2012 it became a duty for CCGs to use
evidence obtained from research in their decision-making. The aim was to help ensure that effective
health-care interventions and ways of working are adopted and that procedures and practices of low or no
clinical benefit were no longer used.
We know that acquiring, assessing, adapting and applying research evidence in health-service decision-making
can be problematic. This study involved staff from nine CCGs and assessed different ways of delivering
evidence obtained from research to support decision-making. Two of the CCGs had access to a responsive
(i.e. demand-led) evidence briefing service provided by researchers at the University of York. Over the
course of the study, the service addressed 24 topics raised by the two CCGs. The majority of requests dealt
with options for delivering and reorganising services and the evidence provided raised awareness about
possible options for future actions.
Over the course of 1 year, we measured whether or not having access to the service had improved uptake
and use of research evidence by commissioners compared with the alternative interventions. We found
that the evidence briefing service was not associated with increases in CCG capacity to acquire, assess,
adapt and apply evidence obtained from research in their decision-making. Low response rates and
missing data limit the reliability of these findings.
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Scientific summary
Background
The Health and Social Care Act 2012 (Great Britain. Health and Social Care Act 2012. London: The Stationery
Office; 2012) has mandated research use as a core consideration in health-service commissioning arrangements.
NHS commissioners are expected to use research to inform commissioning and decommissioning of services
and there is a substantive evidence base on which they can draw. Building on development work undertaken
as part of the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health
Research and Care (CLAHRC) for Leeds, York and Bradford and under the auspices of the then Centre for
Reviews and Dissemination (CRD) core contract with NIHR, we sought to establish if having access to a
responsive (demand-led) evidence briefing service would improve uptake and use of research evidence by NHS
commissioners compared with less intensive and less targeted alternatives.
Objectives
Does access to a demand-led evidence briefing service improve uptake and use of research evidence by
NHS commissioners compared with less intensive and less targeted alternatives?
Do evidence briefings tailored to specific local contexts inform decision-making in other Clinical
Commissioning Groups (CCGs)?
Does contact between researchers and NHS commissioners increase use of research evidence?
Design
Controlled before-and-after study.
Setting
Clinical Commissioning Groups in the north of England.
Methods
Twelve CCGs were invited to participate in the study; two declined to participate and one was excluded
after failing to provide staff contact details for the baseline assessment. The nine participating CCGs
received one of three interventions to support the use of research evidence in their decision-making.
1. Contact plus responsive push of tailored evidence – CCGs in this arm received on-demand access to an
evidence briefing service provided by the CRD.
2. Contact plus an unsolicited push of non-tailored evidence – CCGs allocated to this arm received
on-demand access to advice and support but the CRD did not produce evidence briefings in response
to questions and issues raised, but instead distributed evidence briefings generated in intervention A.
3. ‘Standard service’ unsolicited push of non-tailored evidence – the third intervention constituted a
control arm. In this, the CRD used its normal processes to disseminate the evidence briefings generated
in intervention A.
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The evidence briefing service was provided by team members at the CRD, University of York. In response
to CCG requests, the team followed an established methodology to produce summaries of the available
evidence together with the implications for practice within an agreed time frame.
The intervention phase ran from the end of April 2014 to the beginning of May 2015. As this study was
evaluating uptake of a demand-led service, the extent to which the CCGs engaged with the interventions
on offer was determined by the CCGs itself.
Data for the primary outcome measure were collected at baseline and at 12-month follow-up, using a
survey instrument devised to assess an organisations’ ability to acquire, assess, adapt and apply research
evidence to support decision-making. Individuals from each CCG completed the survey and scores of all
responses were aggregated to represent each participating CCG.
To guard against maturation effect/bias, and to test the generalisability of findings, we administered the
survey instrument to all English CCGs to assess the organisational ability of each to acquire, assess, adapt
and apply research evidence to support decision-making. The most senior manager (chief operating officer
or chief clinical officer) of each CCG was contacted and asked to complete the instrument on behalf of
their organisation.
Baseline and follow-up assessments and the qualitative aspects of the research were undertaken by a
separate evaluation team. The CRD evidence briefing team members were blinded from both baseline and
follow-up assessments until after data collection was complete. Participating CCGs were also blinded from
baseline and follow-up assessments and analysis.
A process evaluation combining interview, observation and documentary analysis was undertaken to
explore evidence-informed decision-making processes in participating CCGs and to explore the nature and
success of the interactions between those receiving and those delivering the evidence briefing service.
Findings
Over the course of the study the evidence briefing service addressed 24 topics raised by participating CCGs
(see Chapter 3). Because we employed a degree of flexibility in delivery (employing a combination of full
evidence briefings and shorter more exploratory evidence notes in response to questions raised) we were
able to deliver a number of outputs beyond the estimate made in our original protocol. Requests for
evidence briefings served different purposes. The majority of requests were focused on options for the
delivery and organisation of a range of services and possible interventions to support self-management of
long-term conditions. Most of the requests could be categorised as conceptual; they were not directly
linked to discrete decisions or actions, but instead provided knowledge and awareness of possible options
for future actions. Symbolic use of research (i.e. to justify or support pre-existing intentions or actions) was
less frequent and included a pre-existing decision to close a walk-in centre and to lend weight to a major
initiative to promote self-care already under way. Instrumental use (i.e. explicit use of research evidence to
inform discrete decisions) was limited to work to establish disinvestment policies for interventions of low or
no clinical value.
In terms of the primary outcome measure (see Chapter 4), baseline and follow-up response rates among
participating CCGs were 68% and 44%, respectively. Response rates for the survey used to collect
benchmarking data from other national CCGs were much lower at 39% and 15%, respectively. Overall,
the evidence briefing service was not associated with increases in CCG capacity to acquire, assess, adapt
and apply research evidence to support decision-making. The secondary outcomes were also not associated
with positive changes in relation to individual intentions to use research findings or perceptions of CCG
relationships with researchers.
SCIENTIFIC SUMMARY
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Regardless of the intervention received, at baseline participating CCGs indicated that they lacked a
consistent approach to their research-seeking behaviours, and capacity to acquire research remained the
same at follow-up. At baseline, CCGs were non-committal (neither agreeing nor disagreeing) about
whether on not they had the capacity to assess the quality, reliability and applicability of research for use in
decision-making. This perception remained unchanged at follow-up. There was also no change between
baseline and follow-up on perceptions of CCGs’ capacity to adapt and summarise research results for use
in decision-making with responding staff neither agreeing nor disagreeing that their CCG had the capacity
to do so. Finally, individual’s perceptions that their CCG did not have systems and processes in place to
apply research routinely remained unchanged.
Exposure to the evidence briefing service did not appear to have any impact on individuals’ intentions to
use research evidence in decision-making or their perceptions of a shift in collective CCG norms towards
the use of research for decision-making. Regardless of intervention received, these measures were
positively orientated at baseline and were sustained at follow-up.
Most discussions between contacts in CCGs and the evidence briefing team were informal and rarely
involved minuted meetings or formal gatherings of CCG staff. Analysis of records supporting the more
formal executive and governing body meetings provided little information about sources used or the
decision-making process itself. The ‘unseen and informal spaces’ of decision-making processes, the small
numbers of staff involved and the reality that no audit trail existed for sources used meant that there was
little or no ‘traceability’ of use of evidence briefings at an organisational level.
Limitations
The respective baseline and follow-up response rates of 68% and 44% are not unreasonable given the
number of competing requests for information with which CCGs are routinely faced. However, we
acknowledge that we experienced considerable attrition between baseline and follow-up. Survey length
may have contributed to the lack of completeness in the data collected. Taken together, these limitations
mean that we have been suitably cautious in our interpretation of the findings.
Conclusions
This study has provided further insight into how and where services packaging evidence derived from
systematic reviews may be most efficiently deployed to inform decision-making processes in a commissioning
context. Overall, access to a demand-led evidence briefing service as constituted in this study did not improve
the uptake and use of research evidence by NHS commissioners compared with less intensive and less
targeted alternatives.
Given the large resource requirement and the particularity of process and unpredictable timing of
decision-making in individual commissioning organisations, resource intensive approaches to providing
evidence may best be employed to support instrumental decision-making at the meso (regional) level.
Otherwise, it may be better to invest far more in identifying commissioning priorities and uncertainties
from key informants with local credibility. In the cases examined in this study, this would include members
of local public health teams. Identified priorities could then be more efficiently serviced by less intensive
approaches that optimally package research messages and target not only commissioners but
intermediaries with local credibility and influence.
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Recommendations for research
This study suggests that commissioners are well intentioned but that they work in a setting lacking in the
necessary skills and infrastructure to make use of research evidence routinely. Further research is required
on the effects of interventions and strategies to build individual and organisational capacity to use research.
Resource-intensive approaches to providing evidence may best be employed to support instrumental
decision-making. Otherwise, less intensive but targeted strategies to deliver optimally packaged research
messages should be pursued. The comparative evaluation of such strategies is warranted.
Disinvestment decisions relating to interventions of no or low clinical value remain high on the
commissioning agenda. No established process appears to be in place for assessing research evidence to
inform the generation of local policies. Rather than have local settings developing their own distinct
approaches, it would seem sensible if a country-wide approach was taken to identify and then summarise
the evidence for interventions of no or low clinical value. Methodological research is therefore required to
establish an optimal, transparent and standardised approach that identifies and contextualises research
evidence that can then be used to inform local decision-making processes.
Funding
Funding for this study was provided by the NIHR Health Services and Delivery Research programme.
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Chapter 1 Context
The NHS is facing severe funding constraints both now and in the medium term. A funding gap of upto £30B has been forecast by 2020–1.1 In challenging times, innovation is increasingly advocated as
crucial to the long-term sustainability of health services, and the greatest potential for savings may be
found by increasing efficiency and reducing variations in clinical practices.1,2 However, it is important that
the NHS takes steps to ensure that only the most effective, best-value health-care interventions and service
improvements are adopted and that procedures and practices that have been shown to be ineffective are
no longer used.
To do this well, commissioners need to be fully aware of the strength of the underlying evidence for
interventions and new ways of working that promise to deliver more value from the finite resources
available. The Health and Social Care Act 20123 has now embedded research use as a core function of the
commissioning arrangements of the health service. The Secretary of State for NHS England (previously the
NHS Commissioning Board) and each Clinical Commissioning Group (CCG) must now, in the exercise of its
functions, promote (1) research on matters relevant to the health service and (2) the use in the health
service of evidence obtained from research.
NHS commissioners therefore have a key role in improving uptake and use of knowledge to inform
commissioning and decommissioning of services, and there is a substantive evidence base on which they
can draw. In the UK there has been significant and continued investment in the production of research
evidence on the effectiveness and cost-effectiveness of interventions to inform health-care decisions and
choices. However, uptake of this knowledge to increase efficiency, reduce practice variations and to ensure
best use of finite resources within the NHS is not always realised. This is in part through system failings
to fully implement interventions and procedures of known effectiveness.4,5 There has also been rapid,
sometimes policy-driven, deployment of unproven interventions despite known uncertainties relating to
costs, impacts on service utilisation and clinical outcomes, patient experience and sustainability;6 the NHS
has also been slow to identify and disinvest in those interventions known to be of low or no clinical value.7
Despite advances in the conduct and reporting of systematic reviews and recognition of their importance in
health-care decision-making,8,9 their potential impact on processes is not yet realised. Although it is widely
acknowledged that different sources of knowledge combine in evidence-informed decision-making10
and that the process itself is highly contingent and context dependent,11 a number of challenges have
undermined the usefulness of systematic reviews in decision-making contexts.8,12–17 These barriers include
difficulties in locating and appraising relevant reviews; the review reports’ lack of timeliness or user-
friendliness; and the real or perceived failure of reviews to address relevant questions, contextualise the
findings, or make actionable policy recommendations.
One way in which these barriers can be overcome is through the provision of resources that adapt and
present the findings of systematic reviews in a more directly useful form. Three types of review-derived
products (summaries of systematic reviews, overviews of systematic reviews and policy briefs) aimed at
policy-makers and other stakeholders have been postulated.18 Summaries encapsulate take-home messages
and add value by, for example, assessing the findings’ local applicability. Overviews of systematic reviews
identify, select, appraise, and synthesise all known systematic reviews in a given topic area. Policy briefs
identify, select, appraise and synthesise systematic reviews, other research studies, and context-specific data
to address all aspects of a policy question. Alongside presentational issues, it has also been proposed that
efforts should focus on the environment within which decision-makers work.14 It is recognised that structural
supports and facilitated strategies are required to ensure the capacity to acquire, assess, adapt and apply
evidence obtained from research in decision-making. However, the best way to deliver this may be context
specific, and evidence of effectiveness of interventions and strategies is lacking.
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Public health specialists have traditionally supported and facilitated the use of research evidence in a
commissioning context.19,20 Those trained in public health and working in commissioning were more likely
to report using empirical evidence than other senior commissioners, who were more likely to use colloquial
evidence generated locally.20 With the relocation of the specialty to local authorities, public health input
now has a more limited role in commissioning processes. CCGs will need access to a variety of different
evidence sources and expert involvement to ensure that evidence obtained from research continues to be
incorporated into decisions made for their populations.20 However, who is responsible for ensuring the
absorptive capacity for research use,21,22 and that CCGs recognise and understand valuable research-based
knowledge, is less clear. Although the Health and Social Care Act 20123 outlines research use as a statutory
duty, operational guidance to commissioners also appears to significantly underplay the potential of
research, and there are no explicit requirements relating to the use of evidence obtained from research.23
An initiative aiming to enhance the uptake of evidence obtained from research in decision-making was
developed as an adjunct to the implementation theme of the National Institute for Health Research (NIHR)
Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leeds, York and Bradford.24
The Centre for Reviews and Dissemination (CRD) developed a demand-led knowledge translation service
aimed at NHS commissioners and senior managers in provider trusts. The service attempted to address
known barriers to systematic review uptake and use and aimed to make best use of existing sources of
synthesised research evidence to inform local decision-making. Rapid evidence briefings were produced in
response to requests from local NHS decision-makers who required an independent assessment of evidence
to inform a specific ‘real world’ decision or problem. The rationale for this demand-led service was that
addressing real decisions or problems in collaboration with those directly affected should mean that research
evidence is more likely to be used and have an impact on decision-making.
Development of the service was informed by a scoping review of existing resources,25 previous CRD
experience in producing and disseminating the internationally renowned Effective Health Care and
Effectiveness Matters series of bulletins and initial iterative interactions with decision-makers on a range of
mental health topics. We sought to address a number of known content, format and communication
barriers to research use.8,12,13,15–17 We targeted answering policy-relevant questions, ensuring timeliness of
response, and delivering non-technical summaries with key messages, tailored to the relevant audience.
As interactions between researchers and decision-makers might be expected to facilitate the ongoing use
of research knowledge in decision-making we also instigated a process of ‘linkage and exchange’.26
Although evidence was lacking on how best to do this13 and the time and resource costs required for
both sides was unclear, the benefit of interactions between managers and researchers was theoretically
grounded. Specifically, ongoing positive intergroup contact27 can be effective at generating positive
relations between members of two parties when there is institutional support, equal status between
those involved, and co-operation in order to achieve a common goal.28 Contact has most benefit if those
involved identify both with their own group and the overarching organisation to which they both belong.29
The evidence briefing service adopted an approach that was both consultative and responsive and involved
building relations and having regular contact (face to face and e-mail) with a range of NHS commissioners
and managers. This enabled the team to discuss issues and, for those that required a more considered
response, formulate questions from which contextualised briefings could be produced and their implications
discussed. In doing so, we utilised a framework designed to clarify the problem and frame the question to
be addressed.30 Each evidence briefing produced would summarise the quality and the strength of identified
systematic reviews and economic evaluations, but go beyond effectiveness and cost-effectiveness to consider
local applicability, implications relating to service delivery, resource use, implementation and equity.
The evidence briefing service had some early impacts, notably including work to inform service
reconfiguration for adolescent eating disorders and enabling commissioners to invest in more services on a
more cost-effective outpatient basis.31 Later work that assessed the effects of telehealth technologies (use
of communication and information technologies that aim to provide health care at a distance) for patients
with long-term conditions informed a decision to disinvest from a costly and much criticised technology
CONTEXT
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deployment. Full details of the early briefings produced under the auspices of the NIHR CLAHRC for Leeds,
York and Bradford can be found at www.york.ac.uk/crd/publications/evidence-briefings/.
Although feedback from users was consistently positive, the evidence briefing service had been
developmental and no formal evaluation had been conducted. The service as constituted was also a
resource-intensive endeavour and made use of the considerable review capacity and infrastructure
available at the CRD. As such, we needed to establish how much value was added over alternative or
more basic approaches. This was especially important as passive dissemination of systematic review
evidence can have impact particularly when there is a single clear message and there is awareness by
recipients that a change in practice is required.15
As part of our developmental work we conducted a systematic review of products and services aimed at
making the results of systematic reviews more accessible to health-care decision-makers.25 This highlighted
a lack of formal evaluation in the field. Indeed, most identified evaluations focused on perceived usefulness
of products and services and not on actual impact. This study therefore aimed to address a clear knowledge
gap and to help clarify which elements of the service were of value in promoting the use of research
evidence and may be worth pursuing further.
This research was also timely because of the current and future need to use research evidence effectively
to ensure optimum use of resources by the NHS, both in accelerating innovation and in stopping the use
of less effective practices and models of service delivery. It therefore addressed a problem that faces a wide
variety of health-care organisations, namely how to best build the infrastructure it needs to acquire, assess,
adapt and apply research evidence to support its decision-making. For CCGs, this includes fulfilling its
statutory duties under the Health and Social Care Act 2012.3
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Chapter 2 Methods
Primary research question
Does access to a demand-led evidence briefing service improve uptake and use of research evidence by
NHS commissioners compared with less intensive and less targeted alternatives?
Secondary research questions
Do evidence briefings tailored to specific local contexts inform decision-making in other CCGs?
Does contact between researchers and NHS commissioners increase use of research evidence?
This was a controlled before-and-after study involving CCGs in the North of England. The original protocol
is available online (see www.nets.nihr.ac.uk/projects/hsdr/12500218) and has also been published in the
journal Implementation Science.32 There were three phases:
1. phase 1 – pre intervention: recruitment and collection of baseline outcome data (survey)
2. phase 2 – intervention: delivery of study interventions
3. phase 3 – post intervention: collection of outcome measures (survey) and qualitative process evaluation
data (interviews, observations and documentary analyses).
Setting, participants and recruitment
Nine CCGs from one geographical area in the north of England were the original focus of this study.
The recruitment process is presented as a flow diagram in Figure 1.
When designing the study, we had anticipated that we would invite nine or ten CCGs from the geographical
area based on the 2012/13 primary care trust (PCT) cluster arrangements. By the start of the study, some
consolidation in the proposed commissioning arrangements had occurred in the transition from PCTs to CCGs
and so the Accountable Officers of the resulting seven CCGs were contacted, told the nature of the study and
invited to participate. Of these, six agreed to participate. One CCG declined, intimating that it could not
participate in any intervention. No CCG asked for financial reimbursement for taking part in the study.
Clinical Commissioning Groups that agreed to participate were asked to provide details of all governing
body and executive members, clinical leads and any other individuals deemed as being involved in
commissioning decision-making processes. These individuals were then contacted by the evaluation team
and informed of the study aims.
We had originally intended to randomly allocate CCGs to interventions. However, a combination of
expressed preferences (one CCG indicated that it would like to be a ‘control’) and the prospect of further
consolidation in commissioning arrangements meant that this was not feasible. Taking these factors into
account, two CCGs were allocated to receive on-demand access to the evidence briefing service, three
coterminous CCGs (who were likely to merge) received on-demand access to advice and support from the
CRD team and one to a ‘standard service’ control arm.
After the initial allocation, we were approached by a research lead from a CCG in a neighbouring
geographical area who had heard about the study and indicated that he and colleagues in other CCGs
were also keen to participate.
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The research team then had discussions with representatives of five CCGs at two research collaborative
meetings. At these meetings, we explained that any CCGs willing to participate would be recruited as
‘standard service’ controls, but would be offered the opportunity to receive on-demand access to the CRD
evidence briefing service after the follow-up phase was complete. Three CCGs agreed to participate.
A fourth CCG initially agreed to participate but failed to provide contact details for any personnel involved
in commissioning processes, despite repeated requests from the research team to do so. As we would
therefore be unable to collect baseline data, rather than delay the start of the intervention phase, the team
informed the CCG that it would have to be excluded from the study.
Characteristics of participating Clinical Commissioning Groups
In total, nine CCGs agreed to participate and were able to provide contact details for personnel involved in
commissioning processes.
CCGs invited
(n = 7)
Non-random allocation
Intervention B
Contact with CRD
(3 CCGs)
Phase 1 recruitment
Intervention C
Control
(1 CCG)
Intervention A
Evidence briefing service
(2 CCGs)
CCGs invited to
participate as controls
(n = 5)
Declined to participate
(n = 1)
Excluded (unable to
provide contact details)
(n = 1)
Phase 2 recruitment
(5 CCGs ask to 
participate)
Final allocation
Intervention B
Contact with CRD
(3 CCGs)
Intervention C
Control
(4 CCGs)
Intervention A
Evidence briefing service
(2 CCGs)
Declined to participate
(n = 1)
FIGURE 1 Flow diagram of CCG recruitment.
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A1
The CCG covers a population of around 150,000 with 27 member practices. The CCG is strongly aligned
to the local authority, with which it is coterminous, and also works closely with a range of other
organisations such as NHS England, local NHS providers and neighbouring CCGs.
It is in one of the 20% most deprived local authorities in the country with considerable inequality between
the most and least affluent areas within the borough; deprivation is, therefore, higher than the England
average. Average life expectancy is also lower than the England average. Around 23% of children and
26% of adults are classified as obese. Rates of recorded diabetes, alcohol-related hospital stays, smoking-
related deaths, early cardiovascular deaths and early cancer deaths are higher than the England average.
The CCG is the lead commissioner for the local NHS trust, which provides general hospital services and
hosts many community services for a wide geographic area. Many specialist hospital services are provided
by general and teaching hospitals outside the district. The CCG is small, as it has delegated most of
its commissioning functions to the local Commissioning Support Unit (CSU). The CCG nonetheless
demonstrates an interest in extending its commissioning reach, as it has taken on joint commissioning
responsibility for primary medical care with NHS England from 2015/16. This is intended to give greater
commissioning power to the CCG and will help to drive the development of new integrated models of
care, such as multispecialty community providers and primary and acute care systems. The CCG is also a
pioneer site for developing integrated care.
The CCG has worked in partnership with the local authority and third-sector providers to complete the
Better Care Fund plan, which identifies four key transformation schemes. It has received over £12M in
Better Care funding for 2015/16 to assist in delivering greater integration of services.
A2
The CCG covers a population of around 300,000, and has 45 member practices. Deprivation is lower than
the England average and average life expectancy is lower than the England average. Around 17% of
children and 26% of adults are classified as obese. Rates of recorded diabetes, alcohol-related hospital
stays, smoking-related deaths and early cancer deaths are higher than the England average. Early
cardiovascular deaths are slightly lower than the England average.
The CCG is coterminous and works closely with the local authority, as demonstrated by a partnership
agreement for the management of continuing health-care patients. This reflects a stated aim about the
need to join up patient care not just in health, but also in social care. CCG plans are also closely aligned
with the priority areas of the Health and Wellbeing Board, and a Joint Health and Wellbeing Strategy has
been developed with partners. The CCG has been involved in overseeing commissioning of a Specialist
Emergency Care Hospital, the first purpose-built emergency care hospital in England, which opened in
June 2015.
In 2015, the CCG began to cocommission primary medical care through a joint commissioning
arrangement with NHS England. In addition, the CCG is part of a NHS vanguard site that is testing the
new integrated primary and acute care systems. The CCG also received £22M in Better Care funding in
2015/16 to support the integration of health and social care.
B1–B3
During the course of the study, three participating CCGs merged to form a single statutory body with
> 60 member practices. The new CCG covers a population of around 500,000. Deprivation is higher
than the England average and average life expectancy is lower than the England average across these
populations. In part of the locality, 23% of children and 22% of adults are classified as obese; rates of
alcohol-related hospital stays, smoking-related deaths, early cardiovascular deaths and early cancer deaths
are higher than the England average. Rates of recorded diabetes are lower than the England average. In a
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second locality, 22% of children and 23% of adults are classified as obese; rates of recorded diabetes,
alcohol-related hospital stays, smoking-related deaths, early cardiovascular deaths and early cancer deaths
are higher than the England average.
The strategic aim of the CCG is to improve the health and well-being of the population through a range of
measures underpinned by the key principles of prevention. These include early intervention, integrated and
co-ordinated primary, community, secondary and social care services, and timely access to secondary care
services for those requiring hospital admissions. The CCG is the host commissioner for a large teaching
hospital trust, which provides general hospital services, prescribed specialised hospital services and
community-based services. The CCG is also host commissioner for a second hospital trust, which principally
provides hospital services.
The original constituent CCGs received a combined £35M in Better Care funding in 2015/16: one CCG
(B1) also received £2M in the second wave of funding from the Prime Minister’s Challenge Fund for
improving access to general practice. The CCG now shares joint commissioning responsibility for primary
medical care with NHS England.
C1
The CCG covers a population of > 250,000 and is made up of 51 member practices which cover five
localities. The CCG faces challenges including a growing ageing population with escalating health needs,
poor health compared to the rest of the England and excess deaths, particularly from heart disease, cancer
and respiratory problems. The local community is affected by lifestyle factors such as obesity, smoking and
alcohol abuse which pose a major risk to health and well-being.
Deprivation is higher than the England average and average life expectancy is lower than the England
average. Twenty-one per cent of children and 27% of adults are classified as obese. Rates of recorded
diabetes, alcohol-related hospital stays, smoking-related deaths, early cardiovascular deaths and early
cancer deaths are higher than the England average.
The CCG works closely with the coterminous local authority and aims to tackle jointly identified local
needs by working closely with the local community and engaging with a wide range of local partners to
ensure the very best health and social care. To this end, the CCG also sits on the local Health and
Wellbeing Board.
The CCG is one of the largest for its population size, having chosen to discharge the bulk of its
commissioning responsibilities in-house, with a minority being undertaken by the CSU. The CCG is host
commissioner for a large district general hospital, and a specialist eye hospital, which between them also
provide many prescribed specialised services that are commissioned by NHS England. The vast majority of
the CCG’s expenditure on hospital services is within the local health-care system.
The CCG received £22M in Better Care funding to support the integration of health and social care. Under
cocommissioning arrangements, the CCG has assumed full responsibility for commissioning general
practice services.
C2
The CCG covers a population of > 250,000 made up of 40 member practices. The CCG covers a large and
diverse geographical area, which includes some of the most deprived communities in England and some of
the most rural areas of the country.
In one locality within the CCG, the average life expectancy for both men and women is lower than
the England average. A large proportion of the population is aged ≥ 50 years and this is set to rise.
Meanwhile, rates of coronary heart disease, hypertension and depression are higher than the England
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average. There is a similar picture in another locality with regard to ageing and life expectancy, although
there are higher rates of coronary heart disease, hypertension and obesity. This is also mirrored in a third
locality, which also has greater deprivation, as 74% of lower super output areas are in the 30% most
deprived nationally and 30% are in the 10% most deprived.
Under cocommissioning arrangements, the CCG has assumed full responsibility for commissioning general
practice services and therefore has delegated responsibility for commissioning. A key element of the CCG’s
2-year operational and 5-year strategic plan is the Better Care Fund, which sees a single pooled budget
across the CCG and other key stakeholders, including the local authority. The CCG received £21M in
Better Care funding in 2015/16.
C3
The CCG covers a population of around 300,000 with 40 member practices. The CCG is coterminous with
two local authorities. Deprivation is higher than the England average and average life expectancy is lower
than the England average. Twenty-one per cent of children and 31% of adults are classified as obese;
rates of alcohol-related hospital stays, smoking-related deaths, early cardiovascular deaths and early cancer
deaths are higher than the England average; rates of recorded diabetes are equivalent to the England
average. In one locality, 21% of children and 26% of adults are classified as obese; rates of alcohol-related
hospital stays, smoking-related deaths, early cardiovascular deaths and early cancer deaths are higher than
the England average; rates of recorded diabetes are lower than the England average.
Under cocommissioning arrangements, the CCG jointly commissions general practice services with NHS
England. The CCG also draws on the CSU to provide a wide range of functions to enable delivery on
priorities. The CCG works as part of the Health and Wellbeing Board for each local authority. The CCG
recognises the importance of collaboration as highlighted by local action plans for single pooled budgets
for health and social care services as part of the Better Care Fund, funding for which amounted to £19M
in 2015/16.
C4
The CCG covers a population of around 300,000 with 46 member practices. The CCG is coterminous with
two local authorities. Deprivation is higher than the England average and average life expectancy is lower
than the England average. In one locality 23% of children and 24% of adults are classified as obese and in
a second locality, 23% of children and 28% of adults are classified as obese. Rates of recorded diabetes,
alcohol-related hospital stays, smoking-related deaths, early cardiovascular deaths and early cancer deaths
are higher than the England average.
The CCG aims to tackle health inequalities and ensure that everyone has the right access to care at the
right time, regardless of where they live in the area. There is recognition that this requires collaborative
working and relationships are being developed with local partners including member practices, local
authorities, Healthwatch and local third-sector providers. A key priority has been the development of a
joint vision to improve services for the vulnerable and elderly.
The CCG received £20M in Better Care funding in 2015/16. The CCG jointly commissions general practice
services with NHS England.
Baseline and follow-up assessment
We collected data for our two primary outcome measures (perceived organisational capacity to use
research evidence and reported research use) at baseline (phase 1) and again 12 months after the
intervention period was completed (phase 3).
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Main study Clinical Commissioning Groups
The survey instrument (see Appendix 1) was the means by which we collected these data. It was designed
to collect four sets of information that assess the organisations’ ability to acquire, assess, adapt and apply
research evidence to support decision-making. Section 1 was based on a tool originally devised by the
Canadian Health Services Research Foundation33,34 and then modified by the SUPPORT (SUPporting Policy
relevant Reviews and Trials) Collaboration.35 The SUPPORT Collaboration included additional domains
designed to assess the extent to which the general organisational environment supported the linking of
research to action;36 specifically the production of research, efforts to communicate research findings
(‘push’), and efforts to facilitate the use of research findings (‘user pull’).
Section 2 was based on a modified version of a tool designed to be administered as part of a planned trial
evaluating the effects of an evidence service specifically designed to support health system policy-makers in
finding and using research evidence.37,38 This Canadian tool was itself based on the theory of planned
behaviour, a widely used theoretical framework for understanding and predicting behaviours.39 We used
this to assess the intentions of individual CCG staff to use research evidence in their decision-making. The
theory of planned behaviour is useful for examining intentions and behaviours of CCG decision-makers as
it provides a (validated) model of how the social action involved in using research is shaped by three key
variables: attitudes (i.e. beliefs and judgments), subjective norms (i.e. normative beliefs and judgments
about those beliefs) and perceived behavioural control (i.e. the perceived ability to enact the behaviour).
These three variables drive intentions to behave, which in turn shape future behaviour.40–42 Lavis et al.37
and Wilson et al.38 highlight a compelling rationale for the utility of the theory of planned behaviour as an
explanatory framework for at least some of the variability (in the influence on intentions and behaviour)
in health care professionals and – in theory – policy-makers:
l About 39% of the variance in intention and about 27% of the variance in behaviour can be explained
by theory of planned behaviour constructs.
l Producing valid and reliable measures of key theory of planned behaviour constructs for use with
health-care professionals is feasible.
l The proportion of the variance in health-care professionals’ behaviour explained by their intentions was
similar in magnitude to that found in the broader literature.
l The agency relationship – between health-care professionals and patients – is not dissimilar to the
agency relationship between policy-makers and others.
It was clear from preliminary discussions and our previous contact with CCG decision-makers that they
were aware of the desirability of using research and often expressed an intention to use research (indeed,
this was one of the principal drivers for our research), but that other mediating factors impacted on their
ability to enact these intentions. Using the theory of planned behaviour allowed us to model an important
proportion of at least some of the drivers for any eventual behaviour reported or observed.
Section 3 was designed to evaluate the changes to the nature of the (proposed) interactions, both within the
participating sites and between commissioners and researchers. Participants are asked how much contact they
have had with researchers in their job (quantity), and how successful the interaction (quality) had been, using
an existing modified measure.43 This section included questions regarding the extent to which the interactions
were perceived as friendly and co-operative, and as helping to achieve the goals of both managers and
researchers. The extent to which those involved in the interaction are perceived as being on an equal footing,
without either group dominating, and the extent to which the contact is perceived as being supported by the
CCGs, and the NHS more generally, was examined. Participants were also asked to indicate the extent to
which their status as a NHS manager/lead is important to them (in-group identification) and to what extent
they see themselves and researchers as part of one overarching group committed to achieving the same
things (superordinate identification). In addition, we included measures of perceptions of researchers in
general using a generalised intergroup attitude scale.44
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Section 4 captured information on individual respondent characteristics, which was collected to help
understand any variation in responses.
The language used in all sections was adapted to match the NHS commissioning context and readability
was first piloted with the study advisory group. The sections were ordered by importance beginning with
the primary outcome measure, the organisational use of evidence. The instrument was then piloted to
assess ease of completion, time to complete, appropriateness of language and face validity with a small
group of commissioning staff from outside the study setting. Feedback suggested that the questionnaire
was comprehensive but feasible, especially as its administration would be solicited rather than unsolicited.
As a result of the feedback and in anticipation of some fall in responses as a result of fatigue, we
deliberately chose to prioritise the primary outcome measure as the first section on the questionnaire.
National survey of Clinical Commissioning Groups
A second survey instrument that included only the questions from Section 1 in the main case site survey
was used to collect data from other CCGs across England. This was delivered at baseline and then again
post intervention.
Survey administration: main sites
Each participating CCG supplied a list of names and e-mail addresses for potential respondents. These
were checked by a member of the evaluation team and where inaccurate or missing details were
identified, these were sourced and corrected. Survey instruments were sent by personalised e-mail to
identified participants via an embedded URL. The online questionnaire was hosted by the Survey Monkey
website (www.surveymonkey.com). Reminder e-mails were sent out to non-respondents at 2, 3 and
4 weeks. A paper version of the questionnaire was also posted out and telephone call reminders were
made by the research team. In addition, the named contact in each CCG sent an e-mail to all their
colleagues, encouraging completion.
Survey administration: national Clinical Commissioning Groups
As CCGs were new and evolving entities at the time of the study, we needed to be able to determine if
any changes viewed from baseline were linked to the intervention(s) and were not just a consequence of
the development of the CCG(s) over the course of the study. To guard against this maturation effect/bias,
and to test the generalisability of findings, we administered the instrument to all English CCGs to assess
their organisational ability to acquire, assess, adapt and apply research evidence to support decision-making.
The most senior manager (chief operating officer or chief clinical officer) of each CCG was contacted and
asked to complete the instrument on behalf of their organisation. For the national survey we used publicly
available information (NHS England and CCG websites) supplemented by telephone calls to CCG
headquarters to construct our sampling frame consisting of every CCG in England.
Interventions
Participating CCGs received one of three interventions aimed at supporting the use of research evidence in
their decision-making.
1. Intervention A: contact plus responsive push of tailored evidence.
2. Intervention B: contact plus an unsolicited push of non-tailored evidence.
3. Intervention C: unsolicited push of non-tailored evidence (‘standard service’).
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Intervention A: contact plus responsive push of tailored evidence
Clinical Commissioning Groups in this arm received on-demand access to an evidence briefing service
provided by research team members at the CRD. In response to questions and issues raised by a CCG,
the CRD team synthesised existing evidence together with relevant contextual data to produce tailored
evidence briefings to a specified time scale agreed with the CCG. Full details of the evidence briefing
production process are presented in Chapter 3. Based on developmental work undertaken as part of the
NIHR CLAHRC for Leeds, York and Bradford, the project was resourced so that the team could respond to
six to eight substantive issues during the intervention phase.
The CRD intervention team was formulated to provide regular advice and support on how to seek
solutions from existing evidence resources, commissioning question framing and prioritisation. Advice and
support was to be delivered via telephone or e-mail or face to face. As this was planned as a demand-led
service CCGs in this arm could contact the intervention team at any time to request their services. Contact
initiated by the CRD intervention team was made on a monthly basis and was expected to include
discussion of progress on ongoing topics, identification of further evidence needs and discussion of any
issues around use of evidence. The team also flagged any new systematic reviews and other synthesised
evidence relevant to CCG priorities.
The evidence briefing team also offered to provide training on how to acquire, assess, adapt and apply
synthesised existing evidence. Training (which was dependent on demand/uptake) would depend on the
needs of the CCG but it was anticipated that this could cover question framing, priority setting, identifying
and appraising systematic review evidence, assessing uncertainty and generalisability.
Intervention B: contact plus an unsolicited push of non-tailored evidence
Clinical Commissioning Groups allocated to this arm received on-demand access to advice and support
from the CRD as those allocated to receive on-demand access to the evidence briefing service. However,
the CRD intervention team did not produce evidence briefings in response to questions and issues raised
but instead disseminated the evidence briefings generated in the responsive push intervention.
Intervention C: ‘standard service’ unsolicited push of non-tailored evidence
The third intervention constituted a ‘standard service’ control arm; thus, an unsolicited push of non-tailored
evidence. In this, the CRD intervention team used their normal push-and-pull processes to disseminate the
evidence briefings generated in intervention A and any other non-tailored briefings produced by the CRD
over the intervention period.
The intervention phase ran from the end of April 2014 to the beginning of May 2015. As this study was
evaluating uptake of a demand-led service, the extent to which the CCGs engaged with the interventions
was determined by the CCGs themselves.
Quantitative analysis
The primary analysis measured the impact of study interventions on two main outcomes (perceived
organisational capacity to use research evidence and reported research use) at two time points: baseline
(pre intervention) and 1 year later (post intervention). The key dependent variable was CCG-perceived
organisational capacity to use research evidence in their decision-making as measured by Section 1 of the
survey instrument (see Appendix 1). We also measured the impact of interventions on our second main
outcome of perceived research use (see Appendix 1, Section 3) and CCG members’ intentions to use
research (see Appendix 1, Section 2). These were treated as continuous variables and for each we
calculated the overall mean score, any subscale means, related standard deviations and 95% confidence
intervals (CIs) at two time points pre and post intervention.
METHODS
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Secondary analysis assessed any relationships between the model of evidence briefing service (intervention)
received and three further continuous independent variables measuring individual demographic
characteristics (e.g. job role, clinical or other qualifications) and the quality and frequency of contact with
researchers on the two outcome measures.
In our original protocol we (rather optimistically) held out the possibility that the data might allow for a more
complex multivariate analysis, which would take into account clustering effects associated with CCGs or NHS
Regions. There were insufficient data of sufficient quality to allow for such an analysis. When measures were
non-normal, we transformed the data (logarithmically) where necessary and possible. Analysis was undertaken
using IBM Statistical Product and Service Solutions (SPSS) Statistics, version 22.0 (IBM Corporation, Armonk,
NY, USA) and Stata statistical software version 14 (StataCorp LP, College Station, TX, USA).
We undertook a number of statistical comparisons:
Chi-squared tests of independence were performed to examine the relation between the model of
evidence briefing service received and the biographical characteristics of respondents.
To examine the hypothesis that CCGs would differ in their capacity to acquire, assess, adapt and apply
research evidence to support decision-making as a result of receiving one of the interventions, we
undertook a factorial analysis of variance [(ANOVA) SPSS, version 22.0, general linear model procedure],
comparing the main effect of a single independent variable (CCG status) on a dependent variable (capacity
to acquire, assess, adapt and apply research evidence to support decision-making) ignoring all other
independent variables (i.e. the effect ignoring the potential for confounding from other independent
factors). Thus, we assessed the main effects of time and intervention received and the interaction effect
(effects of all independent variables on a dependent variable) of both time elapsed and of the intervention
on domain scores. Thus, we had one independent variable (the type of intervention) and one repeated
measures variable [the total score and domain subscore(s) at baseline and 1 year later].
To examine the hypothesis that the intervention would impact on CCG’s collective intention to use
research evidence for decision-making, a factorial ANOVA using the SPSS (version 22.0) general linear
model repeated measures procedure was conducted to compare the main effects of time and evidence
briefing service received and the interaction effect of time and evidence briefing on intention to use
research evidence (using a measure derived from the theory of planned behaviour – see the ‘intention’
component of the study questionnaire, Qs 41–43). As the theory of planned behaviour (in the context of
this study) predicts that intention to use research evidence for decision-making will be positively correlated
with attitude, group norms and perceived behavioural control in the CCGs according to the intervention it
received, we also examined the main effects of time and evidence briefing service received and the
interaction effect of time and evidence briefing on these variables.
To examine the effects of (1) perceived contact and (2) the amount of perceived contact with the evidence
briefing service, (3) institutional support for research, (4) a sense of being equal partners during contact,
(5) common in-group identity, (6) achievement of goals and (7) perceptions of researchers generally, we
undertook a mixed 3 (intervention: A vs. B vs. C) × 2 (time: baseline vs. outcome) ANOVA using SPSS
(version 22.0), with the intervention as a between-subjects independent variable, and repeated measures
on the second factor, time.
Missing data
Missing data and attrition between baseline and 1-year follow-up were issues. Although only ≈16–20% of
questionnaires had missing data at baseline, at follow-up more than half the responses were missing or
incomplete. As analysing only the data for which we had complete responses would have led to potentially
biased results,45 and as anticipated at bid and protocol stages, the use of multiple imputation techniques
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was required.46 SPSS multiple imputation processes were used. We assumed that data were missing at
random (visual comparison of original versus imputed data and significance testing of response and
non-response data impact on outcome variables – see Chapter 4). Five imputed data sets were created
and the data imputed were the dependent variables of the capacity score derived from Section 1 of the
survey instrument, theory of planned behaviour variables and the measures of perceived quality and
quantity of contact with researchers.
We used guidance on interpreting effect sizes in before-and-after studies to examine the clinical/policy
significance of any changes.47
Blinding
Baseline and follow-up assessments and the qualitative aspects of the research were undertaken by a
separate evaluation team. The CRD evidence briefing team members were blinded from both baseline and
follow-up assessments until after all the data collection was complete. The CRD evidence briefing team
were made aware of baseline and follow-up response rates. Participating CCGs were also blinded from
baseline and follow-up assessments and analysis.
Qualitative evaluation
To internally (within the context of the local health economy) validate the self-reported data collected in
phases 1 and 3 and to explore the decision-making processes within each case site, we collected
qualitative data. This was also an opportunity to explore CCGs’ experiences of working with the CRD
intervention team and to feed back directly on the service it received. The qualitative data collected via
observations and interviews were used to address the following questions:
1. What do commissioners consider to be ‘evidence’?
2. How is research evidence used in the commissioning decision-making processes in CCGs?
3. What is the perceived impact of a demand-led evidence briefing service on organisational use of
research evidence?
4. What were commissioners’ experiences of the evidence briefing service?
5. How could the evidence briefing service be improved?
Change to protocol
Part of our original plan (outlined in the study protocol) was to collect and analyse documentary evidence
of the use of evidence in decision-making using executive and governing body meeting agendas, minutes
and associated documents. This component aimed to capture reported actual use of research evidence in
decision-making, whereas our primary outcome measures focused on intention to do so. This was to be
supplemented with interviews to explore perceived use of evidence and any unanticipated consequences.
Early in the intervention phase, it became apparent that this approach may not be feasible. With a few
exceptions, we found a lack of recorded evidence of research use (a finding in itself), as executive and
governing body meetings were mainly used to ratify recommendations and so would not tell us anything
about sources or processes. With research use and decisions occurring elsewhere and often involving
informal processes, we decided to undertake four case studies to explore use of research evidence
in decision-making in the intervention sites. The case studies were three case site CCGs and one
commissioning topic involving all CCGs across the region (low-value interventions). The Project Advisory
Group approved this change in October 2014. Within the case studies, three types of data were collected:
documents, observations and interviews.
METHODS
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Documents
Documentation was obtained from participating CCGs on request and through searches of publicly
accessible documents on CCG websites. For the case studies, 55 policy documents, governing body papers
and evidence documents supporting decision-making were sourced from CCGs. To understand how
participants engaged with and used evidence in their decision-making, we utilised themes emerging from
previous NIHR Health Services and Delivery Research (HSDR)-funded research examining ‘evidence’ use in
commissioning processes.48
Observations
In the absence of documentary evidence of decision-making, the aim of the observations was to
capture the role and use of evidence in decision-making discussions and to identify topics to inform the
subsequent interviews. One evaluation team researcher (KF) attended meetings at different stages of the
decision-making process for one commissioning topic (low-value interventions) that cut across all CCGs.
Relevant meetings were identified by key contacts within each organisation and included only formal
decision-making contexts. Observation notes were taken during each meeting and non-participant
observations were conducted with full knowledge and permission of attendees.
Interviews
To add richness and depth, in-depth qualitative interviews were undertaken with named contacts and key
informants in participating CCGs. Interviews aimed to explore perceptions of the use of research evidence
locally and experiences of interacting with the evidence briefing service, as well as any unanticipated
consequences of the work. A topic guide was devised to explore engagement with the CRD intervention
team and to capture aspects of influencing theories. This guide was piloted with general practitioner (GP)
commissioners in a different CCG for feedback on language and operability of the guide. Feedback was
positive and indicated that the guide was suitable for the purposes of the study. Interviews took place at the
end of the intervention phase. The purposive sampling criteria included commissioners (board or executive
team members and commissioning managers) who had had contact with the evidence briefing service.
Interview participants were invited to interview initially via e-mail and they received a participant
information sheet electronically. In the case of non-response, e-mails were followed by telephone calls to
the participant or via their personal assistant (where appropriate). A second e-mail was sent to those who
could not be contacted by telephone. Participants were given the opportunity to ask questions about the
research before agreeing to participate. Two evaluation team researchers (KF and CT) conducted the
interviews face to face. All interviews were digitally recorded and transcribed by an external transcription
company. Interviews were scheduled to last 1 hour.
Informed consent was obtained at the start of interviews. Participants were offered the opportunity to
ask any questions about the process (but the researcher did not answer any questions relating to the
evidence briefing service itself in order to avoid bias) prior to giving consent. Interviewees were given the
opportunity to view direct quotations (and their immediate context) prior to publication.
In total, 39 participants were contacted and invited to participate. Of these, 21 agreed to participate,
one delegated participation to a colleague and four agreed to discuss participation but despite repeated
attempts were unable to schedule a time to do so. Seven participants declined (one no longer worked at
the CCG, two declined because of time commitments and lack of knowledge of the evidence briefing
service, one because of a job change and four gave no reason). The remaining six participants did not
respond to repeated invitations.
Analysis and data integration
This was a mixed-methods study using a sequential explanatory strategy. Initial integration was of the three
forms of qualitative data. Data from interview, observation and documentary analysis were uploaded into
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analysis software and combined to generate a descriptive account of the use of evidence in decision-making
within each case. The primary point of data integration was the analysis stage in which themes generated by
qualitative analysis were used to help us to understand variation in quantitative outcomes.
Qualitative analysis
Analysis was by constant comparison and used the qualitative data analysis software package NVivo,
version 10 (QSR International Pty Ltd, Melbourne, VIC, Australia) to organise and manage the data. Our
analytical approach was both deductive (developing themes from the research questions and survey
instruments employed) and inductive (new themes emerging from the accounts of key informants). This
process was iterative, the researcher returned to the original data several times, reviewing codes and
revising each case-study narrative. During this process, data were integrated in three ways. First, interviews
were categorised according to the intervention received and differences in the themes generated by each
interview were compared and contrasted across each case. Once all data had been collected, one researcher
(KF) developed a coding framework based on initial readings of the interview data without grouping by case.
Cases were coded systematically with categories emerging from the data itself as well as from the research
questions and theories and research literature relating to evidence-informed decision-making. These categories
were reviewed by members of the research team (CT, ML, PW and KF) in order to focus the next iteration of
coding. KF then reviewed and recoded all transcripts grouped as case studies. At the same time KF conducted
text searches of all documentation and observation notes (text searches and manual review of observation
notes) to understand the role of evidence obtained from research in decision-making. Identified terms were
examined individually to understand the textual context of its use. Finally, themes generated by interviews were
compared with those arising from documentary evidence to identify any conflict or consistency between local
perceptions of the use of evidence and recorded use of evidence. Analysis of each type of data was integrated
into case summaries for each of the three CCG case studies. For example, evidence of the use of research in
documentation was used to explore support or refute descriptions given in interviews. Transcripts were
randomly selected for review by CT to identify additional themes and to challenge conclusions made by KF.
Summaries describing the characteristics of each case and the local health economy were developed by
two researchers (ML and LB). These were used to set the context of the case study and to inform
discussion. Some themes were identified in advance from the research questions and theories and research
literature relating to evidence-informed decision-making, others emerged from the data during analysis.
The researcher was also alerted to concepts and themes while observing meetings during the intervention
period. These were explored or reignited during the interview analysis period. The researcher sought
confirmation or deviation from these concepts in transcripts and by revisiting notes from observations.
Case summaries were developed that drew on data from all sources. Once these had been created, KF
returned to the original data to identify any deviation from the narratives created. The second point of
data integration was the analysis stage in which themes generated by qualitative analysis were used to
help us to understand variation in quantitative outcomes.
Ethics and governance
This study was granted research ethics permission by the Department of Health Sciences, University of York
Research Ethics Board. Appropriate research governance approval was also obtained.
Organisation-level consent granting permission to contact staff was obtained from each participating CCG.
Individual participants had the opportunity to discuss any aspect of the study and their involvement in it
with the research team at any stage of the study. Completion of questionnaires was anonymised and
CCGs were informed of response rates but not of individuals’ participation. Interview participants and
those present at observed meetings gave informed consent to their participation. None of the interventions
involved any direct risks or burdens to the CCGs involved.
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Patient and public involvement
The primary focus of this study was interventions targeted at NHS staff undertaking core roles within
CCGs, so the active involvement of the public or service users in the design of this project was not sought.
Patient and public involvement was provided through lay representation on the Project Advisory Group and
through the development of the Plain English summary. We also committed to produce a summary of our
findings in plain English and to ensure that these are shared with lay members of governing bodies in all
of the participating CCGs.
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Chapter 3 The evidence briefing service
The evidence briefing service was provided by team members at the CRD, University of York. In responseto CCG requests, the team followed a well-established methodology to produce summaries of the
available evidence together with the implications for practice within an agreed time frame. This chapter
describes the introduction of the service to the intervention arm of the study, production of the briefings
and the topics covered, including detailed examples.
Introducing the service
For the five participating CCGs allocated to receive contact via interventions A and B, we offered to come
and explain the nature of the evidence briefing service and the aims of the study at the next available
executive team meeting. Three of the five CCGs accepted the offer. Face-to-face meetings were arranged
with representatives of the remaining two CCGs (who were also two of the three CCGs likely to merge).
At each meeting, we outlined the aims of the study and highlighted the free advice and support for
evidence-informed commissioning being made available from the CRD. Specifically, we offered help on
clarifying issues, formulating questions and advice on how to make best use of the research evidence
relevant to the commissioning challenges it faced. Recent work on telehealth undertaken for a CCG
outside the study setting was used to illustrate how the evidence briefing process worked and what the
CCG could expect in terms of a response to any questions it raised. At the meetings, we emphasised that
participation in the study would help the CCG to fulfil its statutory duties under the Health and Social
Care Act 2012,3 but also stressed that as this was a demand-led service; the extent to which the CCG
engaged with the service was entirely at its own discretion.
After each meeting, a personalised e-mail was sent to all Executive Team members, clinical leads and
commissioning managers within the CCG restating the aims of the study and the nature of the offer from
the CRD.
For co-ordination purposes we suggested that each CCG nominate a senior person who we could liaise
with and could act as the conduit for all CCG requests. Once named contacts were identified, they were
invited to discuss areas of interest with their colleagues and get in touch and discuss their needs with the
evidence briefing team. Each named contact was then met individually face to face to discuss the evidence
briefing process, the nature of support being offered and to identify any initial CCG priorities.
Producing the evidence briefings
The process for producing evidence briefings followed that developed as part of the TRiP-LaB (Translating
Research into Practice in Leeds and Bradford) theme of the NIHR CLAHRC for Leeds, York and Bradford
and by the CRD as part of its core contract under the NIHR Systematic Reviews Programme.30
On receipt of each request, an attempt was made to define the research question to be addressed in terms
of population, intervention, comparator and outcome.49 This was done via discussion with the named
contact and/or the individual(s) making the request. Discussions rarely involved more than three named
individuals as decision-making processes were found to be largely informal and rarely involved minuted
meetings or gatherings of CCG staff. Most interactions around priority topics and questions were either
telephone or e-mail based (> 500 e-mails relating to the formulation of questions and the production and
dissemination of briefings were received or sent over the course of the study). Relevant contextual
information, and, in particular, the background to the request being made, were also sought from the
individuals making the request.
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In some instances, interest in a topic was identified but a specific research question could not be framed
initially. In such cases, we produced evidence notes, which aimed to provide a quick scope of the available
evidence in the area. This then helped to frame the question(s) to be explored by subsequent, more
focused, evidence briefings.
Identifying the content
As with our earlier developmental work,30 the evidence briefings were based on existing sources of
synthesised, quality-assessed evidence and applied to the local context. Searches for relevant systematic
reviews and economic evaluations were performed by the researchers responsible for each briefing.
The core sources searched for evidence were:
l Database of Abstracts of Reviews of Effects (DARE)
l NHS Economic Evaluation Database (NHS EED)
l Health Technology Assessment (HTA) database
l International Prospective Register of Systematic Reviews (PROSPERO)
l Cochrane Database of Systematic Reviews (CDSR).
During the course of the study, NIHR funding for the production of two databases, DARE and NHS EED,
ceased. The CRD continued to conduct weekly searches, systematic reviews and economic evaluations until
the end of December 2015. From January 2015 onwards, when searching for systematic reviews, the
briefing researchers undertook additional searches of PubMed using the ‘Review’ filter and NHS Evidence
using the ‘Systematic review’ filter.
For topics that were likely to be impacted by national guidance, we searched the National Institute for
Health and Care Excellence (NICE) website. Additional sources were also searched for relevant policy
reports and for other grey literature. These included the websites of The King’s Fund, Nuffield Trust, Health
Foundation, Nesta, NHS England and the NIHR Journals Library. If systematic review evidence was limited,
recent primary studies (published from 2010 onwards) were identified by searches of PubMed.
Data extraction and quality assessment
We stored the literature search results in a reference management database [EndNote (Thomson Reuters,
CA, USA)]. One researcher screened all titles and abstracts obtained through the searches for potentially
relevant content. Two researchers then independently made decisions on content most relevant to the
questions to be addressed. Once selected, data were extracted into summary tables by one researcher and
checked by another. Throughout this process discrepancies were resolved by consensus or where necessary
by recourse to a third researcher.
Systematic reviews and economic evaluations included in DARE and NHS EED meet basic criteria for quality
and a significant number have been critically appraised in a structured abstract. Where a critical abstract
was not available, or was identified through other sources, we applied the well-established CRD critical
appraisal processes for DARE and NHS EED (see www.crd.york.ac.uk/crdweb/HomePage.asp). For
systematic reviews, the specific aspects assessed were the adequacy of the search; assessment of risk
of bias of included studies; whether or not study quality was taken into account in the analysis and
differences between studies accounted for; any investigation of statistical heterogeneity; whether or not
the review conclusions were justified. When systematic review evidence was limited and primary research
was identified, quality was assessed using the appropriate Critical Appraisal Skills Programme tool for the
study design.50 We included only evidence from primary studies that were judged to be well conducted.
Quality assessments were performed by one researcher and checked by a second; discrepancies were
resolved by consensus or recourse to a third researcher where necessary.
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Presentation and dissemination
The presentational format for evidence briefings was based on our previous experience producing the
renowned Effective Health Care and Effectiveness Matters series of bulletins (www.york.ac.uk/crd/
publications/archive/)51,52 and from CRD guidance on disseminating the findings of systematic reviews.49
With the exception of the independent appraisal of the evidence underpinning the proposed policies for
musculoskeletal (MSK) procedures, evidence briefings took the following format:
l front page bullet point summary of key actionable messages
l background section describing the topic and the local context
l evidence of effectiveness: a summary of systematic review findings (or primary studies if necessary);
critical appraisal of the strength of the evidence; assessment of generalisability
l evidence of cost-effectiveness: summary of economic evaluations and their findings; critical appraisal
l implementation considerations based on the evidence, for example, implications for service delivery,
patient and process outcomes, and health equity
l references.
Evidence briefings were formatted using InDesign (Adobe, San Jose, CA, USA) desktop publishing software
and were reviewed and edited by a second researcher and the principal investigator before being approved
for circulation. Once approved, evidence briefings (and evidence notes) were e-mailed as an attachment to
the named contact and to the individual(s) who made the initial request. The e-mail included the headline
messages from the briefing, a request to circulate and an offer both to discuss the findings further (either
by telephone or face to face) and to respond to any questions or clarifications that readers may have.
Each evidence briefing was also e-mailed to the named contacts at other CCGs using the same format.
Each evidence briefing was published (with metadata) on the CRD website, and a record added to the
HTA database. HTA database records contain full bibliographic details, hyperlinks and contact information
for the organisation publishing the report. Indexing on the HTA database increased the likelihood that
anyone searching for related terms on linked platforms such as The Cochrane Library, NHS Evidence,
TRiP (Turning Research into Practice) Database and The Knowledge Network of NHS Scotland would
identify any relevant evidence briefing as part of their search.
Questions addressed by the evidence briefing service
Over the course of the study we addressed 24 questions raised by the participating CCGs, 17 of which
were addressed during the intervention phase (see Table 1). The majority of requests were focused on
options for the delivery and organisation of a range of services and way of working rather than on the
effects of individual interventions. Vignettes for each topic addressed are presented in Appendix 3.
The evidence briefings are available at www.york.ac.uk/crd/publications/evidence-briefings/ (accessed
9 June 2016).
Types of evidence use
Requests for evidence briefings from the CCGs served different purposes. Four broad categories of
research use have been proposed.8,53,54 Conceptual use is when new ideas or understanding are provided
and, although not acted on in direct and immediate ways, these influence thinking towards options for
change. Instrumental use is when evidence directly informs a discrete yes/no, should we invest/disinvest
decision-making process. Symbolic (or tactical) use refers to those instances in which research evidence is
used to justify or lend weight to pre-existing intentions and actions. The final category is imposed when
there are organisational, legislative or funding requirements that research be used.
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For each evidence briefing and note produced, we employed these categories to classify the underlying
purpose driving the type of research use. Although our interpretation is subjective, the classification
presented in Table 1 is derived from a consensus-based approach. Most of the requests we received were
categorised as conceptual. These were not directly linked to discrete decisions or actions but were
requested to provide new understanding about possible options for future actions. Symbolic drivers for
evidence requests included a pre-existing decision to close a walk-in centre, a successful challenge fund bid
to implement self-care and decisions to implement GP telephone consultations. Questions categorised as
instrumental related to explicit disinvestment or investment decisions. There were no instances that we
considered to represent an imposed use of research.
In addition to the evidence briefings and notes, we also circulated other CRD-generated content known to
be of relevance and interest to participating CCGs. Effectiveness Matters is a short, four-page summary of
research evidence about the effects of important interventions for practitioners and decision-makers in
the NHS.
During the study period, a number of these bulletins were produced by the CRD in collaboration with the
Improvement Academy of the Yorkshire and Humber Academic Health Science Network [www.york.ac.uk/
crd/publications/effectiveness-matters (accessed 9 June 2016)]. When topics aligned with the stated areas
of interest of the intervention CCGs, relevant issues of Effectiveness Matters were circulated to the named
contacts for onward dissemination within the CCG. The issues of Effectiveness Matters that were
circulated were as follows:
l Dementia carers: evidence about ways of providing information, support and services to meet the
needs of carers for people with dementia (May 2014)
l Preventing pressure ulcers in hospital and community care settings (October 2014)
l Preventing falls in hospital and community care settings (October 2014)
l Recognising and managing frailty in primary care (January 2015)
l Acute kidney injury: introducing the 5 ‘R’s approach (December 2015).
TABLE 1 Questions addressed by the evidence briefing service
Source Topic Question Date asked Output produced
Way in
which the
research
was used
A1 Urgent care services Evidence for implementing
an ‘urgent care hub’,
consolidating out-of-hours
provision on a single site
adjacent to an A&E
department, with front-door
triage assessing patients for
both facilities
November 2013 Evidence briefing Symbolic
A1 Supporting
self-management:
helping people
manage long-term
conditions
Rapid summary of the
evidence relating to self-care
January 2014 Evidence note Symbolic
All Urgent care services Evidence to inform urgent
and emergency care systems
March 2014 Evidence briefing Conceptual
A1 Loneliness and social
isolation
Interventions to reduce
loneliness and social
isolation, particularly in
elderly people
April 2014 Evidence briefing Conceptual
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TABLE 1 Questions addressed by the evidence briefing service (continued )
Source Topic Question Date asked Output produced
Way in
which the
research
was used
A1 Supporting
self-management:
helping people
manage long-term
conditions
Self-care support for people
with COPD
April 2014 Evidence briefing Conceptual
All Low-value
interventions
Identify relevant
recommendations from the
NICE Do Not Do database
May 2014 Evidence note Conceptual
A2, All Low-value
interventions
l Independent appraisal of
evidence underpinning
l 14 proposed VBCPs for
MSK procedures
July 2014 Evidence briefing Instrumental
A1 Community
pharmacy minor
ailments service
Identify evidence to inform a
review of the community
pharmacy minor ailments
service
July 2014 Evidence note Conceptual
A1 Integrated
community teams
Evidence for effects of
integrated community teams
including any examples of
best practice
August 2014 Evidence note Conceptual
A2 Psychiatric liaison Models of psychiatric liaison
implemented in general
hospital settings
July 2014 Evidence note Instrumental
A1 ‘One-stop shop’
screening model for
diabetes
Does implementing a
comprehensive one-stop
shop annual review and
screening model for diabetes
have an adverse impact on
either the quality or uptake?
September 2014 Evidence note Symbolic
A2 Frailty What evidence/validated
tools are there for frailty risk
profiling in an A&E context?
October 2014 Short e-mail note
sufficient to address
question. Later
followed up with a
related issue of
Effectiveness
Matters on
recognising and
managing frailty in
primary care
Conceptual
A2 Unplanned
admissions from
care homes
What is the evidence for
effects of interventions to
reduce inappropriate
admissions and deaths in
hospital of patients from
care homes
October 2014 Evidence briefing Conceptual
A2 Social prescribing What is the effectiveness
and cost-effectiveness
evidence of social
prescribing programmes in
primary care?
October 2015 Evidence note and
then later updated
into evidence
briefing
Conceptual
continued
DOI: 10.3310/hsdr05050 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 5
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
23
TABLE 1 Questions addressed by the evidence briefing service (continued )
Source Topic Question Date asked Output produced
Way in
which the
research
was used
A1 Supporting
self-management:
helping people
manage long-term
conditions
What is the evidence for the
effects of mobile telephone
apps to help people to
manage their own care?
November 2015 Evidence note Instrumental
A1 Supporting
self-management:
helping people
manage long-term
conditions
What is the evidence for
the effects of interventions
to promote shared
decision-making?
November 2015 Evidence note Conceptual
A1 Supporting
self-management:
helping people
manage long-term
conditions
What is the evidence for
interventions to support
promoting patient-centred
care-planning consultations?
November 2015 Evidence briefing Conceptual
A1 Supporting
self-management:
helping people
manage long-term
conditions
Evidence for lay-led self-care
education programmes
generally as part of creating
an environment and culture
that supports self-care
November 2015 Evidence briefing Conceptual
A1 Supporting
self-management:
helping people
manage long-term
conditions
An evidence-based steer in
how to give patients the
confidence and skills to
effectively self-manage their
long-term conditions
November 2015 Evidence briefing Conceptual
A2 Accountable care
organisations
What is the evidence
for accountable care
organisations?
April 2015 Evidence note Conceptual
A2 Enhancing access in
primary care
What is the evidence for
extended hours, telephone
consultation/triage, and role
substitution in enhancing
access to primary care?
June 2015 Evidence briefing Conceptual
A2 Telehealth for COPD What lessons can be learned
from previous evaluations
of the implementation of
telehealth for COPD?
July 2015 Evidence note Instrumental
A1 Participatory
democracy
What is the evidence for
different methods of patient/
public engagement in
decision-making
August 2015 Evidence note Conceptual
All Low-value
interventions:
existing hernia and
hysterectomy
policies
Independent review of
evidence for existing hernia
and hysterectomy policies
August 2015 Instrumental
A&E, accident and emergency; app, application; COPD, chronic obstructive pulmonary disease; VBCP, value-based
commissioning policy.
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Other questions raised but not addressed
Other topics of interest were raised by CCGs around the beginning of the intervention period but were not
addressed as individual evidence briefings or notes. Some were not pursued, as CCGs deemed other topics
to be of higher priority, whereas others were constituent parts of other published or planned briefings.
Details of questions raised are presented in Table 2.
TABLE 2 Topics raised but not addressed
Source Topic Covered by other outputs?
Urgent and emergency care
A2 Triaging minor ailments out of A&E Covered by urgent care services briefing
Elderly care
A2 Risk stratification for frail elderly Covered by short e-mail note on validated tools
for frailty risk profiling in an A&E context and
Effectiveness Matters: Recognising and Managing
Frailty in Primary Care (Spring 2015)
B1–3 Seamless falls service Covered by Effectiveness Matters: Preventing Falls in
Hospital and Community Care Settings (Autumn 2014)
A1 Falls pathway review Covered by Effectiveness Matters: Preventing Falls in
Hospital and Community Care Settings (Autumn 2014)
A1 Do regular reviews including an agreed care plan
of management reduce unnecessary admissions
and attendances and improve patient preferences
for end-of-life care?
Circulated earlier CRD evidence briefing on
advanced care planning
Community-based care
B1–3 Multidisciplinary preventative community care
including supported discharge, virtual wards and
GP-led case management
Some aspects covered by unplanned admissions
from care homes briefing
Mental health
A2 Evidence to inform the delivery of new community-
based care pathways for adult mental health
services
Circulated earlier CRD evidence briefing on
integrated pathways in mental health
A2 Child and adolescent mental health service early
intervention and prevention
Not addressed
A1 Substance misuse liaison in urgent/emergency care Not addressed
Neurology
A1 For patients with a neurological diagnosis, does
access to a local multidisciplinary hub help improve
well-being and reduce unnecessary health-care
attendances and long-stay admissions?
Not addressed
Prescribing
A2 Reducing prescribing spend and waste Not addressed
A1 Medicines management in care homes Not addressed
A&E, accident and emergency.
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Training
The evidence briefing team offered to provide training on how to acquire, assess, adapt and apply
synthesised evidence to those CCGs receiving interventions A and B. The formal offer was made at
baseline to named contacts and separately to all staff. Separate informal offers were made to named
contacts throughout the course of the intervention. Two CCGs (A2 and B3) did express interest in
receiving training on identifying and using research evidence but were then unable to respond to requests
to suggest dates and times for the training to take place. As such, the team instead opted to devise and
circulate a two-page guide for commissioners on using evidence to support decision-making, based on the
process for developing evidence briefings (see Appendix 5). The guide was circulated in April 2015 and
made available on the CRD website at www.york.ac.uk/media/crd/Process%20flowchart_expanded%
20FINAL.pdf (accessed 9 June 2016).
What follows are three exemplars of the types of conceptual, instrumental and symbolic research use
experienced during the study.
Conceptual use of research evidence: social prescribing
In October 2014 we were approached by the A2 CCG and asked if we could provide evidence on the
effectiveness of social-prescribing schemes. The CCG provided a short briefing report, which outlined that
it was considering introducing a pilot scheme in one locality to improve the health and well-being of
people with long-term conditions. It was envisaged that people would be referred to community-based
services that would complement traditional medical interventions and that these would help people to
manage their conditions better by learning new skills in self-management and avoid costly interventions in
specialist care in the longer term. The CCG recognised that partnership with the voluntary sector could
provide increased choice and value for money and that services could be more closely tailored to the needs
of the community.
The CCG was particularly interested in any evidence that social prescribing reduced primary, secondary
and community care workloads and service utilisation and in any evidence of cost-effectiveness (a specific
request for cost per quality-adjusted life-year gained). After visiting a few high-profile schemes, it was
concerned that its plans to introduce small-scale social prescribing on a ‘shoestring’ might not be effective
and/or sustainable. It was hoped that a review of evidence would help to justify the small investment
needed to get the scheme off the ground and would help to ensure that this would be a service investment
that would pay back in the longer term.
A quick (10-day) response was requested, so we opted to compile a short evidence note rather than a
full briefing. We searched the DARE, NHS EED and CDSR databases for relevant systematic reviews and
economic evaluations. These initial searches revealed little relevant evidence, so we also conducted quick
searches of MEDLINE, Applied Social Sciences Index and Abstracts (ASSIA), Social Policy and Practice, NICE,
Social Care Institute for Excellence (SCIE) and NHS Evidence to locate details of any relevant guidance,
case studies or service evaluations.
Overall, we found little supporting evidence to inform the commissioning of a social-prescribing
programme. The identified evidence was characterised by brief descriptions of small-scale projects and
failed to provide sufficient detail to judge either success or value for money. Rigorous evaluation of the
cost-effectiveness of social-prescribing schemes was also lacking.
On feeding back these findings to the CCG, it highlighted that it knew of the existence of an evaluation of
a scheme that it had visited but that was not included in the evidence note. The evaluation was of interest
as the scheme had showed areas of improvement and possible savings. We explained that, as we had
not yet searched for grey literature, the report had not been identified but that we would appraise it
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separately. Although detailed, the evaluation presented a number of significant limiting factors, which
were in line with the overall findings of the evidence note. Specifically, the uncontrolled before-and-after
evaluation failed to address the counterfactual potential confounders and the issue of regression to the
mean. The report also lacked detail about the type of patients included in the analysis – what conditions
they had, what interventions they received. The CCG indicated that it found the additional information
‘very helpful’ and noted the absence of evidence. The CCG opted to proceed with developing a pilot
social-prescribing programme in conjunction with the local authority.
Before circulating the findings more widely, we decided to convert the evidence note into an evidence
briefing. As we were aware that we had missed an evaluation, we conducted updates of our initial
searches and undertook systematic searches for individual studies and for grey literature. Plans to convert
this work into a systematic review were also registered with PROSPERO (CRD42015023501). The evidence
briefing was circulated to all participating CCGs in March 2015.
Once publicly available, the evidence briefing generated media interest with the briefings headline
message of a lack of evidence featuring in the Guardian newspaper. The team also received a number of
enquiries from CCGs and Health and Wellbeing Boards located elsewhere in England and Scotland. All
of the enquiries focused on evaluation and asked, given the absence of evidence, how should the effects
of social-prescribing schemes be evaluated in ways that would improve the existing evidence base?
In July 2015, we were contacted by members of the public health team in a local council in the
geographical area in which the study was based. They had been asked to summarise the latest evidence
related to social prescribing and indicated that this was an area that the council in conjunction with B1
CCG was keen to explore further. They had found the evidence briefing through a search of NHS Evidence
and were unaware that the briefing had previously been circulated to contacts within B1 CCG or of the
plans of A2 CCG to develop a pilot programme.
They asked if we had any plans to update and if we would be willing to present the evidence base around
social prescribing at a workshop being held for the Health and Wellbeing Board. The workshop took place
in November 2015 and brought together local councillors, NHS organisations, third-sector agencies and
representatives from social-prescribing schemes to explore if and how best to take social prescribing
forward in the area. Our contribution was to present on ways to improve the measurement and evaluation
of social-prescribing schemes. The Health and Wellbeing Board indicated that it intended to proceed with
developing plans for a pilot social-prescribing programme in 2016.
Instrumental use of research evidence: low-value interventions
In early discussions with the named contact for the B3 CCG about their priority areas, low-value
interventions were identified as a major area of interest for all CCGs in the region.
Low-value interventions are those treatments that are considered to be of no or low clinical benefit or that
are not cost-effective compared with treatment alternatives. A region-wide list of low-value procedures
was established in 2010. The aim of the value-based commissioning policy (VBCP) list was to provide local
GPs with clear criteria for funding and referral, and to ensure that policies were applied consistently across
all PCTs in the region. Each PCT had run its own individual funding request (IFR) process to handle any
requests (on exceptionality grounds) that fell outside the commissioning criteria. The regional VBCP list
included 39 procedures and was last reviewed and updated in 2012. This last update pre dated the
transition of commissioning arrangements from PCTs to CCGs.
The initial exchange of e-mails focused on the practical challenges in identifying and implementing
low-value policies, and a paper on the experiences from a NICE and Cochrane project was circulated.55
The named contact revealed that they were about to start heading up a project group representing a
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cluster of seven CCGs to try to look at procedures of limited clinical value being undertaken in secondary
care. The aim of the collective work was to consider the inclusion of a wider range of procedures on the
regional VBCP list. The group also planned to assess the usability of data monitoring reports and to look at
how IFR policies were being implemented with a view to developing strategies to ensure more effective
implementation of policies. The CRD intervention team was invited to attend the meetings.
As a first contribution, we offered to identify any further policies that might be considered going forward.
A systematic search of the NICE Do Not Do Database and Cochrane Quality and Productivity topic reports
was conducted and yielded a list of 36 potential topics for consideration. These were presented to the
Group in a summary form in July 2014.
At the September meeting of the VBCP Implementation Group, the Lead for the A2 CCG presented a
MSK resource pack they had compiled. They indicated that it had been developed as part of a cost-saving
exercise and were anticipating that its implementation would reduce the number of referrals as well as
ensure appropriateness of referrals from GPs. The resource pack included 16 policies, 14 of which were
not included in the regional VBCP list. The pack had been compiled from existing policies identified at
other CCGs across the country. It was also ‘sense checked’ by a consultant in public health who had been
involved in the compilation of the original regional VBCP list. Discussions had taken place with colleagues in
the local provider trust who, it was reported, had not expressed any concerns about the proposed polices.
The A2 CCG had already asked its member practices to implement the new MSK procedures in addition
to the existing 39 procedures. However, a regional web-based system to manage IFRs from GPs in all
CCGs had recently been introduced. This meant that any IFRs derived from this new list would have to
be processed separately. GPs making IFRs from the new list were being asked to complete a paper-based
checklist and incorporate this into the patient notes and referral request. The A2 CCG therefore hoped
that all the other local CCGs would adopt the MSK policies and that these would become incorporated
into the regional VBCP list and the web-based system. It asked if this could be taken forward for
consideration by individual CCGs and if an indicative stance could be provided at the next meeting.
There was some discussion about the provenance of the resource pack and the lack of involvement of
other CCGs in its development. To assist the deliberation process, the CRD intervention team offered to
undertake an independent and systematic appraisal of the evidence underpinning the proposed policies for
MSK procedures. It was agreed that a preliminary assessment would be presented at the next meeting.
As no established local process appeared to be in place for assessing the evidence for proposed policies,
the CRD team devised a simple process to appraise the 14 policies not included in the regional VBCP list.
Figure 2 illustrates the process. We searched DARE, HTA and CDSR for potentially relevant systematic
reviews and conducted web searches to identify relevant NICE or national specialty guidance. Taking each
policy in turn we asked the following questions:
l Is the proposed policy or change based on NICE or nationally recognised specialty guidance?
l Is the guidance up to date?
l Does the wording of the proposed policy or change match current evidence?
A one-page summary of the CRD preliminary assessments was presented to the VBCP Implementation
Group at their next meeting. For clarity, we used a traffic light system to indicate the extent to which each
proposed policy was supported by guidance and/or evidence from systematic reviews. Nine policies were
rated green. This rating indicated that these were supported by national guidance recommendations
and/or good-quality evidence from systematic reviews. Five policies were rated amber. An amber rating
indicated that there was no explicit national guideline recommendation but that proposed policy reflected
current evidence (low- or moderate-quality evidence). None of the proposed policies received a red rating.
A red rating would have been used for any proposed policy that contradicted national guidance and/or
was not supported by evidence from good-quality systematic reviews.
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The preliminary assessments were well received by the CCG and the ‘York review’ was deemed to have
provided reassurance. There appeared to be a consensus that moves to include these policies should be
part of the natural progression of the regional VBCP list. The CCG also felt that the inclusion of the
additional policies could potentially assist in waiting list management.
Individual CCGs would need to ratify the revised VBCP list. At the meeting there was recognition that the
project group represented only seven of the 14 CCGs that would need to ratify the revised list if it was
to be adopted. As a similar implementation group existed for the other seven CCGs, individual CCG
ratification would be sought via that panel. The proposed revisions would also be sent to a geographically
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FIGURE 2 Using evidence to support commissioning decisions.
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distant CCG that had been invited to join the group but could not attend. The team prepared a briefing
including the traffic light indications and process flow diagram for circulation with the revised VBCP list.
At this point, moves to merge the two project groups into one also began. This revised grouping met in
April 2015. The sign-off for the incorporation of the proposed policies into the regional VBCP list of
commissioning intentions for 2016 occurred at the October 2015 meeting.
Symbolic use of research evidence: self-care
In 2013, the National Collaboration for Integrated Care and Support committed to support a number of
local integration pioneers that would test new models of commissioning, organising and delivering
integrated care and support at scale and pace.56
Clinical Commissioning Group A1 was part of a successful pioneer bid that planned to implement a
comprehensive 5-year programme promoting self-care through all health, care and community services.
The local programme described as complex and transformational, aims to deliver self-care as the accepted
norm of practice across the whole system. The programme has three objectives: (1) to shift the culture
from helping the public to helping the public to help themselves, (2) to help staff to support local people’s
ability to better manage their long-term conditions and day-to-day lives and (3) to reduce over-reliance on
statutory services. Four key performance indicators were to provide a focus for measuring the impact of
the programme. These were:
1. proportion of people who use services who have control over their daily life
2. proportion of people feeling supported to manage their condition
3. proportion of pregnant woman smoking at time of delivery
4. unplanned hospitalisation for chronic ambulatory care sensitive conditions.
The programme was in its early stages when the intervention phase started and the A1 named contact
asked for help in ‘providing evidence to support or contradict some of the assumptions we are making’
and whether or not the team could provide a ‘quick and dirty’ appraisal of the evidence relating to the
following questions as ‘quickly and as briefly’ as possible?
l Does self-care improve well-being?
l Does self-care improve health outcomes?
l Does self-care reduce demand on unplanned health services?
l Does self-care reduce demand on unplanned social services?
l What are the strategies for encouraging self-care among staff and the public?
Answers to the first four questions were deemed to be most crucial to help build up a case for change and
to develop a vision. The CCG also highlighted a King’s Fund report that it felt would give an idea of what
it was trying to achieve by involving social care and the third-sector agencies as well.57
It also forwarded a Nesta report, ‘The Business Case for People Powered Health’,58 that it thought would
probably help the evidence appraisal.
An initial search of DARE, NHS EED, HTA and CDSR and the websites of the Health Foundation, The King’s
Fund and Nesta revealed a large number of potentially relevant reports, systematic reviews and economic
evaluations. As a quick (10-day) response was requested, we opted to compile a short evidence note based
on an appraisal of two overview reports, one from the Health Foundation and one from the Nesta report.
Our two-page summary highlighted that both reports made some attempt to systematically identify and
appraise relevant evidence, although neither adopted a very rigorous or reproducible approach. Overall,
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it seems that there is reasonable evidence that self-management support and related interventions can
produce improvements in outcomes for patients with long-term conditions (including most of the
outcomes specified by the CCG). However, there is a lot of uncertainty around the magnitude of benefits,
the cost of interventions, and which patient/population groups would benefit most. Detail about specific
self-management interventions, their delivery settings and what was actually implemented was also lacking.
We suggested that rather than adopting a whole-systems approach to self-care from the outset, it may be
more beneficial to focus on the groups and conditions that would benefit most. Priority should then be
given to identifying the self-care interventions most likely to be effective in these groups and to considering
ways of overcoming the documented barriers to implementation. The offer was made to discuss how best
to further interrogate the evidence base once the CCG and Operating Group had had an opportunity to
digest and discuss this initial sift.
Although the initial request can be viewed as using evidence symbolically to lend weight to an existing
course of action, much of what followed in terms of request was more conceptual in nature. The CCG
made a series of requests, which, although not directly linked to discrete decisions or actions, could be
seen to influence their understanding and thinking on how best to deliver self-care.
We were aware that self-care for chronic obstructive pulmonary disease (COPD) was an area of interest
for other participating CCGs (B1–3). Following on from this initial sift and further discussions with the A1
named contact about priorities, we offered to produce an evidence briefing focused on self-care support for
people with COPD (separate work on loneliness and social isolation also emerged from these discussions).
We suggested a scope that looked at multicomponent interventions (including elements such as education,
telephone support and action plans) and pulmonary rehabilitation. At a face-to-face meeting this scope
was agreed. The A1 named contact also asked that, rather than using our current briefing format, could
we instead consider a simpler summary format to aid group discussion. An infographic or pictorial
representation (i.e. smiley faces) was requested, but we offered instead to produce a clearer one-page
evidence summary as part of the briefing.
The evidence briefing was circulated to all participating CCGs in July 2014 with a headline message that
there was consistent evidence that multicomponent interventions reduce respiratory-related hospital
admissions and improve quality of life for people with COPD.
In November 2014, the A1 CCG named contact got in touch again to say that the Pioneer Programme had
been generating interest among staff and the public in self-management through a series of workshops titled
‘Changing the Conversation’. He stressed that the programme had a wider focus than the management
of long-term conditions and was aiming to encompass a spectrum of activities from promoting healthy
lifestyles, to expert patient/shared decision-making through to self-care interventions that could be stratified
according to population group. The named contact said that he was struggling to formulate a clear research
question and was not sure what to do next in terms of giving patients the confidence and skills to effectively
self-manage their physical, mental and social health issues. The CCG was aware of expert patient courses,
but said that it could really do with an evidence-based steer on what sorts of programmes or structures it
might commission to help people to manage their own care. The named contact stressed that the CCG
wanted to avoid investing badly, but was especially interested in anything that could be ‘community led’.
One topic, the effectiveness of mobile telephone applications (apps), was identified as urgent, as the
programme group were considering whether or not to commission an app and were meeting with
developers the following week. We produced an evidence note based on three systematic reviews and
one rapid scope of the literature. Our one-page summary highlighted that despite growing popularity
and availability, much of the available evidence is small scale and focuses on development, user testing
and feasibility, and that evidence is lacking on the effects of mobile telephone apps on health-related
outcomes. After the meeting with the developers, the A1 named contact indicated that they had decided
not to pursue mobile telephone apps as an intervention option.
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After an initial sift of the evidence base, we suggested that rather than producing one large briefing, we
would offer to scope the available evidence under the following broad themes:
l self-management support for long-term conditions
l provision of education and supportive (lay-led) interventions to increase patients’ skills and confidence
in managing their own health
l self-care interventions targeting frail elderly populations
l self-care interventions generally
l interventions that promote shared decision-making.
The A1 CCG named contact indicated that the staff were planning to have a brainstorming session to
consider all the interventions possible. He said that they had learned from our advice regarding mobile
telephone apps and were going to consider how to target certain interventions to certain populations or
parts of the system. He also mentioned that they had been running workshops to introduce the concept of
supported self-management to GP staff and then introduce some of the skills needed by staff to promote
it. They were considering using action learning sets of keen staff who wish to implement their learning and
need support in doing so and thus would be interested in the evidence for this approach (or for others)
that would help create an environment and culture that supports self-care.
The first briefing we produced in December 2014 focused on lay-led education programmes and was
based on two systematic reviews and a scoping review. We highlighted that the evidence suggests lay-led
self-care education leads to small, short-term improvements in self-efficacy, self-rated health, cognitive
symptom management and frequency of exercise, but that there was no evidence for improved
health-related quality of life, or reduced primary care and emergency department visits. On the last point
we were asked to clarify if this meant that no evidence of effect or an absence of evidence. We clarified
that it was the former, but with the caveat that participants were relatively healthy/well managed at the
outset, so it was possible that differences at 6–12 months would be less likely.
Supplementary comments were made in relation to the suggestion that men may want different things to
women and that the programme should consider this, or it may inadvertently widen health inequalities.
The public health consultant thought that it was really important to ensure that the programme does not
widen the inequality gap, although she did not think that it was targeting according to need currently.
The nature of the study participants was also considered. The public health consultant noted that the
underlying message appears to be one of careful targeting. The recruits to the studies were already
self-reporting as being in good health – and so she asked if those who reported less good health benefited
more or less. She was keen to ensure that they did not just end up recruiting the worried well. The limited
but potentially positive evidence in relation to health champions and similar roles was also noted and it
was mentioned that this was part of the Every Contact is a Health Improvement Contact work from
front-line staff and being evaluated as part of an AHSN bid and that there may be some potential to scale.
We mentioned that we have not been able to identify any relevant evidence on action learning sets but
have signposted a ‘how to’ toolkit from the Faculty of Public Health which may be helpful. The named
contact asked if we could revisit action learning sets when we looked at staff-orientated interventions.
The named contact also mentioned that they were likely to adopt some interventions when there was no
evidence one way or the other and could the group call on our help in evaluating them? We said that we
could provide advice on what to measure and we may want to have a separate meeting focused on that.
The next Evidence Note produced in January 2015 focused on interventions to promote shared
decision-making. Based on five systematic reviews and one overview of reviews, it suggested that, if
tailored, appropriately shared decision-making can have beneficial effects on patient-centred outcomes.
We offered to look at some of the more successful interventions in more depth if the group wished.
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We started work on an evidence briefing on interventions to support self-management in people with
long-term conditions, and were asked to present key messages at a forthcoming Programme Operating
Group development session. Two NIHR HSDR-funded reviews formed the basis of the briefing.59,60 The
Reducing Care Utilisation through Self-management Interventions (RECURSIVE) review focused on the
effect of self-management on health services utilisation and costs; the Practical systematic Review of
Self-Management Support for long-term conditions (PRISMS) review summarised the key components of
self-management and looked at issues around implementation. The named contact circulated the PRISMS
review to the group while the CRD team were preparing the briefing.
At the meeting, further clarification around who does and does not engage with self-management
programmes was requested as well as more detail on the barriers to and facilitators of patient participation.
Evidence relating to self-management in a social care context was also sought. The presentation with its
long-term conditions focus also generated quite a bit of discussion/concern within the wider programme
group around whether or not there was to be a reassessment of the scope of the Pioneer project. Was it
now going to focus solely on long-term conditions, or would the goal remain self-care across the full
spectrum of public experiences from those who have limited contact with services to those with regular and
increasing contact? It was emphasised that the project remained committed to the latter, while also
recognising that there is potential overlap with other (e.g. Change4Life)61 initiatives.
A marketing company also presented ideas for the Pioneer project at the meeting and the A1 named
contact asked about the effectiveness of public health mass media campaigns. Post event, the CRD
researcher responded via e-mail to say that much of the evidence relates to smoking cessation-type
interventions and, although there appears to be reasonable evidence for raising awareness, it was
decidedly mixed for changing individual behaviours. At this meeting the named contact again mentioned
how the CCG much preferred the shorter format for briefings.
Prior to a ‘shaping self-care’ event in March, the research team circulated the final self-care evidence
briefing on patient-centred consultations, which we were informed were being increasingly advocated
by NHS England. We highlighted that there is consistent evidence that most interventions promoting
patient-centred approaches lead to improvements in the patient-centeredness of consultations and that
investment in training and skills development for health professionals appears key.
After the intervention phase was complete, a local public health consultant informed the CRD team that
he had in September 2015 been asked to revisit and summarise all the self-care briefings produced for the
CCG. They did this in an informal presentation to around 20 colleagues from the CCG and Programme
Operating Group. The presentation highlighted the key messages from each briefing and included pictorial
representations for value for money, reduced admissions to emergency care, patient satisfaction, reduction
in inequalities and the quality of evidence. Four areas for future focus were also proposed, namely (1) the
staff culture, (2) patient choice, (3) collaborative action planning and (4) further exploration of COPD
self-care intervention options.
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Chapter 4 Clinical Commissioning Group capacity
and intentions to use research
In this chapter we have abridged the intervention types used in tables and reporting for the sake ofbrevity. Chapter 2 outlines the details of each intervention and in this chapter the following conventions
are used:
l intervention A = access to the evidence briefing service
l intervention B = contact plus an unsolicited push of non-tailored evidence
l intervention C = ’control’ unsolicited push of non-tailored evidence.
Individuals from each participating CCG were to complete baseline and follow-up surveys (see Appendix 1)
assessing the organisations’ ability to acquire, assess, adapt and apply research evidence to support
decision-making. Each CCG supplied a list of e-mail addresses for potential respondents. A total of
181 baseline (A = 45; B = 61; C = 75) and 168 follow-up (A = 43; B = 60; C = 65) e-mail addresses were
supplied by participating CCGs; none was undeliverable.
Any questionnaires not returned by 31 April 2014 (baseline) and 31 August 2015 (follow-up) were classed
as non-responses.
Response rates
In total, 123 questionnaires were returned at baseline (A = 37; B = 54; C = 32), giving a response rate of
68%. Of these, 101 were completed, 13 were deemed to be incomplete (one section or fewer completed)
and nine were from individuals declining to participate or indicating that they had departed the CCG.
At the 1-year follow-up, 76 questionnaires were returned (A = 23; B = 28; C = 25), giving a response rate of
44%. Of these, 71 were completed, two were deemed to be incomplete (one section or fewer completed)
and three were from individuals declining to participate or indicating that they had departed the CCG.
Characteristics of respondents
Survey respondents reported holding a range of roles within the CCGs (Table 3). Most respondents were
highly qualified, but only a minority reported having had prior experience in commissioning or undertaking
TABLE 3 Clinical Commissioning Group roles of survey respondents
Role Frequency Percentage
Executive team and/or directors 44 33.8
Clinical lead and/or non-executive GP 42 32.3
Commissioning manager 15 11.5
Lay member 5 3.8
Role not stated 24 18.5
Total 130 100.0
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research (Table 4). Sites with a lower response rate had a higher proportion of clinically qualified
respondents [× 2 (2, n = 53) = 6.15; p = 0.05], but except for this difference, there were no significant
differences in the characteristics of respondents receiving the three interventions.
Missing data
The proportions of missing data at baseline and follow-up for the variables measuring capacity to use
research in decision-making and intention to use behaviour are presented in Table 5. Individuals with
missing data did not differ significantly in scores from those for whom complete data existed.
Original and imputed means for the main variables used in the analysis of capacity for and intention to use
are presented in Table 6. As can be seen, the original and imputed means are similar. ANOVA of means in
the original and imputed datasets reveal no significant differences.
Benchmarking against the national picture
Section 1 of the survey instrument was used to collect benchmarking data from other CCGs across England
(see Chapter 2 and Appendix 1). The most senior manager (Chief Operating Officer or Chief Clinical Officer)
of each CCG was contacted and asked to consult with colleagues and complete the instrument on behalf
of their CCG. At baseline we received usable responses from 79 CCGs (a response rate of 39%) and 1 year
later at follow-up, we received usable responses from 31 CCGs (a response rate of 15%).
TABLE 4 Characteristics of survey respondents
Characteristic
Intervention received (n)
A B C
Formal responsibility for doing or managing research in CCG? Yes, doing and managing 5 2 2
Yes, managing 3 3 7
Yes, doing 1 2 0
Neither 28 35 17
Highest educational achievement? School level 2 0 0
Undergraduate 17 27 12
Master’s degree 14 13 8
Higher degree 3 2 6
Clinical qualifications? No 16 8 6
Yes 21 34 20
Worked as a researcher in an academic context No 34 42 24
Yes 5 11 13
Commissioned research No 29 47 32
Yes 10 6 5
Been a coapplicant or advisor on a research project No 30 44 30
Yes 9 9 7
Been employed as a researcher No 35 49 32
Yes 4 4 5
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Table 7 illustrates that mean total scores for CCGs were in the area of some capacity to make use of
research, but unlikely to be well equipped to do so or to do so often. The total score (overall capacity)
increased marginally but not significantly over the year. With the exception of the ability to ‘adapt’
research through summarising in a more user-friendly way [baseline Canadian Health Services Research
Foundation (CHSRF) M = 3.07, SD = 0.65; 1 year later M = 3.57, SD = 0.58; t(13) = –2.7; p = 0.02] no
other significant differences were observed. However, it is important to be cautious in interpreting this,62
as our 1-year follow-up rates were very low and a difference of this magnitude is unlikely to be
behaviourally significant.
Did the evidence briefing service improve Clinical Commissioning
Groups’ ability to acquire, assess, adapt and apply research evidence
to support decision-making?
We examined the hypothesis (Table 8) that CCGs would differ in their capacity to acquire, assess, adapt
and apply research evidence to support decision-making as a result of receiving one of the interventions.
TABLE 5 Complete and missing responses (and percentage missing) by survey variables
Variable (score) Complete data Missing data, n (%)
Acquire (staff) pre EBS 109 21 (16.15)
Acquire (sources) pre EBS 109 21 (16.15)
Assess evidence (staff) pre EBS 108 22 (16.92)
Assess evidence (external expertise) pre EBS 108 22 (16.92)
Adapt pre EBS 107 23 (17.69)
Apply (leadership) pre EBS 107 23 (17.69)
Apply (decision-making) pre EBS 106 24 (18.46)
Acquire (staff) post EBS 61 69 (53.08)
Acquire (sources) post EBS 61 69 (53.08)
Assess evidence (staff) post EBS 61 69 (53.08)
Assess evidence (external expertise) post EBS 61 69 (53.08)
Adapt post EBS 61 69 (53.08)
Apply (leadership) post EBS 62 68 (52.31)
Apply (decision-making) post EBS 62 68 (52.31)
Pre-EBS TPB intention 105 25 (19.23)
Pre-EBS TPB attitude 102 28 (21.54)
Pre-EBS TPB norms 105 25 (19.23)
Pre-EBS TPB PBC 105 25 (19.23)
Post-EBS TPB intention 62 68 (52.31)
Post-EBS TPB attitude 61 69 (53.08)
Post-EBS TPB norms 62 68 (52.31)
Post-EBS TPB PBC 62 68 (52.31)
EBS, evidence briefing service; PBC, perceived behavioural control; TPB, theory of planned behaviour.
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Overall capacity to acquire, assess, adapt and apply research
evidence to support decision-making
The total capacity to acquire, assess, adapt and apply research evidence to support decision-making
appeared to improve slightly over time, both among our national survey (see Table 8) and irrespective of
the presence of any intervention (see Table 9 and Figure 3). The main effect of time in the factorial
ANOVA yielded an F-ratio of F(1,127) = 4.49; p < 0.05, η2p 0.034, indicating a significant difference over
time in all three groups of CCGs’ total capacity to acquire, assess, adapt and apply research evidence to
support decision-making. The main effect of the evidence briefing service received yielded an F-ratio of
F(2,127) = 0.77; p > 0.5, η2p 0.012. The interaction of time and the intervention was also not significant
yielding an F-ratio of F(2,127) = 0.213; p > 0.05, η2p 0.003. Exposure to the intervention had no significant
effect on perceived CCG capacity.
TABLE 6 Original (missing data included) vs. imputed scores
Score variables
Original data Imputation data
Mean n SD Mean n SD
Acquire (staff) pre EBS 2.92 109 0.71 2.98 130 0.76
Acquire (sources) pre EBS 3.20 109 0.70 3.16 130 0.74
Assess evidence (staff) pre EBS 3.18 108 0.74 3.24 130 0.77
Assess evidence (external expertise) pre EBS 3.32 108 0.76 3.28 130 0.76
Adapt pre EBS 2.94 107 0.80 2.96 130 0.86
Apply (leadership) pre EBS 3.38 107 0.62 3.33 130 0.65
Apply (decision-making) pre EBS 3.45 106 0.61 3.47 130 0.62
Pre-CHSRF total score 3.20 110 0.56 3.20 130 0.53
Acquire (staff) post EBS 2.91 61 0.65 2.99 130 1.00
Acquire (sources) post EBS 3.36 61 0.68 3.35 130 0.73
Assess evidence (staff) post EBS 3.26 61 0.66 3.35 130 0.75
Assess evidence (external expertise) post EBS 3.51 61 0.69 3.49 130 0.70
Adapt post EBS 3.19 61 0.79 3.21 130 0.79
Apply (leadership) post EBS 3.37 62 0.71 3.34 130 1.22
Apply (decision-making) post EBS 3.49 62 0.66 3.52 130 0.97
Post-EBS CHSRF total score 3.29 62 0.56 3.35 130 0.61
Pre-EBS TPB intention 5.50 105 1.13 5.52 130 1.17
Pre-EBS TPB attitude 6.18 102 0.80 6.19 130 0.78
Pre-EBS TPB norms 5.13 105 0.97 5.18 130 1.04
Pre-EBS TPB PBC 4.49 105 0.82 4.53 130 0.87
Post-EBS TPB intention 5.51 62 0.97 5.47 130 1.20
Post-EBS TPB attitude 6.11 61 0.73 5.98 130 1.00
Post-EBS TPB norms 5.06 62 0.84 5.06 130 1.45
Post-EBS TPB PBC 4.41 62 0.68 4.44 130 0.85
CHSRF, Canadian Health Services Research Foundation; EBS, evidence briefing service; PBC, perceived behavioural control;
TPB, theory of planned behaviour.
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Impact of the evidence briefing service on Clinical Commissioning
Groups’ capacity to acquire, assess, adapt and apply research
evidence to support decision-making
Although there was no summary effect on capacity, we nonetheless hypothesised that the interventions
may have had differential effects on different aspects of capacity.
Acquiring: capacity to acquire research
Neither the main effects of time [F(1,127) = 0.01; p > 0.05, η2p 0.01], nor the evidence briefing service
received [F(2,127) = 1.07; p > 0.05, η2p 0.02] nor the interaction effect of time and the evidence briefing
service received [F(2,127) = 0.88; p > 0.05, η2p 0.01] were significant. CCGs’ perceived capacity to acquire
research therefore appeared unchanged.
Acquiring: capacity to look for research in the right places
Clinical Commissioning Groups’ perceived capacity to look for research in the right places appeared to
improve over time (Figure 4). The main effect of time yielded an F-ratio of F(1,127) = 4.76 (p < 0.05, η2p
0.036), indicating a statistically significant improvement over time irrespective of any intervention. The
main effect of the evidence briefing service received yielded an F-ratio of F(2,127) = 0.09 (p > 0.5, η2p 0.01).
The interaction of time and evidence briefing service was also not significant, yielding an F-ratio of
F(2,127) = 0.05 (p > 0.05, η2p 0.01), indicating no statistically significant benefit from the form of
intervention received.
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FIGURE 3 Total capacity to acquire, assess, adapt and apply research evidence to support decision-making.
CHSRF, Canadian Health Services Research Foundation.
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Assessing: capacity to tell if research is valid and high quality
None of the main effects of time [F(1,127) = 1.66; p > 0.05, η2p 0.01], or the evidence briefing service
received [F(2,127) = 0.91; p > 0.05, η2p 0.01] or the interaction effect of time and the evidence briefing
service received [F(2,127) = 1.48; p > 0.05, η2p 0.02] were statistically significant, suggesting that perceived
capacity to discern research quality in CCGs remained unchanged.
Assessing: capacity to tell if research is relevant and applicable
There was an apparent increase in the capacity to determine relevance of research across the intervention
groups (Figure 5). The main effect of time yielded an F-ratio of F(1,127) = 7.62 (p < 0.05, η2p 0.06),
indicating that all three groups of CCGs had a statistically significant improvement in their perceived ability
to acquire research evidence relevant to decision-making. The main effect of the evidence briefing service
received yielded an F-ratio of F(2,127) = 0.9 (p > 0.5, η2p 0.01). The interaction of time and the evidence
briefing service was also not significant, yielding an F-ratio of F(2,127) = 0.82 (p > 0.05, η2p 0.01), indicating
that the intervention had not contributed to CCGs’ perceived improvement in their ability to identify relevant
research.
Adapt: capacity for summarising results in a user-friendly way
There appeared to be a small increase in the capacity of CCGs to summarise research findings and
adapt them to decision-making (Figure 6). The main effect of time in ANOVA yielded an F-ratio of
F(1,127) = 5.46 (p < 0.05, η2p 0.04), indicating that this improvement was statistically significant. The main
effect of the evidence briefing service received yielded an F-ratio of F(2,127) = 2.62 (p > 0.5, η2p 0.04).
The interaction of time and the evidence briefing service was also not significant, yielding an F-ratio of
F(2,127) = 0.52 (p > 0.05, η2p 0.01), indicating that the evidence briefing service had not contributed to
CCGs’ perceived improvement in their ability to summarise and adapt research to their own decisions.
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FIGURE 4 ‘Acquire’: capacity to look for research in the right places to support decision-making. CHSRF, Canadian
Health Services Research Foundation.
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Apply: capacity for leading by example and valuing research use
Neither the main effects of time [F(1,127) = 0.02; p > 0.05, η2p 0.01], nor the evidence briefing service
received [F(2,127) = 2.09; p > 0.05, η2p 0.03] nor the interaction effect of time and evidence briefing service
received [F(2,127) = 0.92; p > 0.05, η2p 0.01] were significant, indicating that perceived capacity for leading
and valuing research use had remained unchanged and was unaffected by the interventions.
Apply: capacity of decision-making processes for research use
In all other aspects of applying research in decision-making neither the main effects of time [F(1,127) = 0.49;
p > 0.05, η2p 0.01], nor the evidence briefing service received [F(2,127) = 0.53; p > 0.05, η
2
p 0.01] nor the
interaction effect of time and the evidence briefing service received [F(2,127) = 1.2; p > 0.05, η2p 0.02]
were statistically significant, suggesting that CCGs’ systems and processes had not appreciably changed,
irrespective of the intervention.
Summary
Over a 1-year period, all CCGs – regardless of the intervention received – were associated with a
(statistically) significant increase in capacity to use research evidence for decision-making. However, this
apparent effect should be interpreted cautiously for two reasons. First, the overall capacity has changed
little and does not represent a meaningful shift in the overall score. Second, the increase in perceived
capacity observed in study CCGs was similar for all the CCGs in the national survey, which received no
interventions directly from the CRD. Overall, the evidence briefing service had no measurable impact on
the overall ability to acquire, assess, adapt or apply research.
4.0
3.0
2.0M
ea
n
1.0
0.0
A B
Intervention received
C
Pre-service CHSRF
Post-service CHSRF
FIGURE 5 ‘Assess’: capacity to tell if research is relevant and applicable to support decision-making.
CHSRF, Canadian Health Services Research Foundation.
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The increases in subdomains that were observed in perceived ability to look in the right places for research,
to tell if research is relevant and applicable and to summarise results in a user-friendly way also occurred
nationally. Again, although the changes are statistically significant, the magnitude of change is so small
that it is unlikely to represent meaningful observable changes in CCGs’ acquisition, assessment, adaptation
and application of research.
Did the evidence briefing service improve Clinical Commissioning Groups’
intentions to use research evidence to support decision-making?
As with the effect of the evidence briefing service on capacity to use research for decision-making, we also
wanted to examine the effect on CCG’s collective intention to use research evidence for decision-making.
Attitude towards use of research in decision-making was the strongest of these dimensions, and perceived
behavioural control the weakest (Table 9). All intervention groups had apparent small and non-statistically
significant declines in almost all of these theory of planned behaviour dimensions from baseline to follow-up.
Intention
Neither the main effects of time [F(1,127)= 0.3; p> 0.05, η2p 0.01], nor the evidence briefing service received
[F(2,127) = 1.09; p> 0.05, η2p 0.02] nor the interaction effect of time and the evidence briefing service
received [F(2,127) = 5.96; p> 0.05, η2p 0.01] were statistically significant. This suggests CCGs have not changed
in their intention to use research evidence in their decision-making, irrespective of any interventions applied.
4.0
3.0
2.0M
ea
n
1.0
0.0
A B
Intervention received
C
Pre-service CHSRF
Post-service CHSRF
FIGURE 6 ‘Adapt’: capacity for summarising results in a user-friendly way to support decision-making (means and
95% CIs, pre and post intervention). CHSRF, Canadian Health Services Research Foundation.
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Attitudes
All CCGS, regardless of intervention received, appeared slightly less positive towards using research in their
decision-making (Figure 7). The main effect of time yielded an F-ratio of F(1,127) = 4.28 (p < 0.05, η2p 0.01),
indicating a statistically significant difference over time in each of the three groups of CCGs’ attitudes
towards research evidence to support decision-making. The main effect of the evidence briefing service
received yielded an F-ratio of F(2,127) = 1.55 (p > 0.5, η2p 0.02). The interaction of time and the evidence
briefing service was also not significant, yielding an F-ratio of F(2,127) = 0.72 (p > 0.05, η2p 0.01). These
together confirm the initial impression of a decline in attitude towards use of research.
Group norms
Neither the main effects of time [F(1,127) = 0.69; p > 0.05, η2p 0.01] nor the evidence briefing service
received [F(2,127) = 2.01; p > 0.05, η2p 0.04] nor the interaction effect of time and the evidence briefing
service received [F(2,127) = 0.78; p > 0.05, η2p 0.01] were statistically significant. This suggests that
there was no effect on the perceived group norms surrounding the use of research evidence in CCG
decision-making from pre to post intervention.
Perceived behavioural control
Neither the main effects of time [F(1,127) = 1.27; p > 0.05, η2p 0.26] nor the evidence briefing service
received [F(2,127) = 1.08; p > 0.05, η2p 0.02] nor the interaction effect of time and the evidence briefing
service received [F(2,127) = 2.30; p > 0.05, η2p 0.04] were statistically significant. This suggests there was
no effect on the perceived behavioural control associated with the use of research evidence in CCG
decision-making from pre to post intervention.
Summary
The evidence briefing service did not appear to have any effect on individuals’ intentions to use research
evidence in decision-making, their perceptions of the CCG norms surrounding research evidence or their
sense of standard service around the use of research for decision-making. There was a (statistically)
significant decline in attitudes towards research use; specifically, all CCGs were less positive towards
research use for decision-making after 1 year. However, this difference is – in real terms – marginal; the
positions were representative of broadly similar positions before and after encountering the intervention.
How do the Clinical Commissioning Groups view their contact
with research and researchers?
At both baseline and follow-up, participants receiving all three interventions were asked questions that
assessed the quality and quantity of contact with researchers, specifically:
l perceptions of equal status between CCG members and the researchers they encounter
l Clinical Commissioning Group support for that contact (both important aspects of contact quality)
l Clinical Commissioning Groups and researchers seeing themselves as part of an overarching group with
common goals
l researchers in general
l whether or not contact with researchers is equally useful for both parties, more important for
researchers, or for CCGs.
These measures were used to assess whether or not the evidence briefing service improves contact
between CCGs and researchers and/or results in more positive perceptions of researchers in general.
Strength of identification as a CCG was also assessed, as a potential moderator of any impact of the
intervention, but the small sample size makes it difficult to analyse or interpret this measure as
a moderator.
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Did the evidence briefing service improve Clinical Commissioning Groups’
perceptions of intergroup contact?
Perceptions of contact appeared generally more positive from the start among respondents receiving
intervention A (see Table 10) than in the other intervention groups. Other than this, the amount of contact
stood out as having the most consistent negative rating across the intervention groups, and changed little
from baseline to 1-year follow-up.
There were increases in most other dimensions of contact from baseline to follow-up across the groups.
None of these appeared to reach statistical significance (Table 10). The magnitude of these gains appeared
a little lower in intervention A than in interventions B and C.
Amount of perceived contact
We examined the hypothesis that the evidence briefing service would increase the amount of perceived
contact between CCGs and researchers. Respondents reported low amounts of contact (see Table 10).
Neither intervention had a statistically significant effect on respondents’ perceptions of the amount of
contact (for a variety of formats: face to face or via e-mail, or telephone) with researchers.
Perceived quality of contact
We examined the hypothesis that the evidence briefing service would improve the quality of contact
between CCGs and researchers. No intervention had a statistically significant effect on the perceived
quality of contact with researchers that CCGs experienced.
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FIGURE 7 Theory of planned behaviour: CCGs’ attitudes towards research (means and 95% CIs, pre and post
intervention). TPB, theory of planned behaviour.
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Perceived institutional support for contact
We examined the hypothesis that the evidence briefing service would improve perceptions that CCGs and
the NHS more generally are supportive of NHS managers/leads and researchers working closely together.
Neither intervention had a statistically significant impact on the degree of support for collaborative
relationships between service staff and researchers.
Equal status during contact
We examined the hypothesis that the evidence briefing service would improve perceptions that researchers
and CCGs recognise one another’s expertise, and that the CCG participants are perceived as having equal
status in the contact. The interaction between intervention and time was not significant [F(1,57) = 1.61;
p = 0.208], suggesting that the interventions did not have a statistically significant effect on perceptions of
equal status.
Perceptions of a common in-group identity superordinate goals
We examined the hypothesis that the evidence briefing service would improve perceptions that NHS
managers/leads and researchers feel like part of one overarching team committed to achieving the same
goals, rather than two separate groups. The interaction between intervention and time was not significant
[F(1,57) = 2.24; p = 0.12], suggesting that there is no statistically significant impact on the development of
a common team identity.
Did the evidence briefing service increase the perception that communication
between Clinical Commissioning Groups and researchers achieve their goals?
The findings identified a slightly more positive perception of both individual common goals at baseline
among those receiving intervention A (evidence briefing service) than among the other two interventions
(B and C). There was a small improvement in these perceptions among those in intervention A, with a
slightly larger improvement in this perception among those receiving either of the other two interventions
(Table 11).
Clinical Commissioning Groups’ professional goals
We examined the hypothesis that the evidence briefing service would improve the perception that
communication with researchers helps CCGs to achieve their professional goals. The interaction between
intervention and time approached significance [F(1,47) = 2.99; p = 0.06].
Post hoc analyses demonstrate that communication with researchers is perceived as more valuable in achieving
CCG goals at outcome (M= 4.87) than at baseline (M= 2.40) in those receiving intervention C [F(1,14)= 12.08;
p= 0.48] [and intervention B follow-up:M= 5.05; baseline:M= 2.38; F(1,20)= 25.60; p= 0.0005].
In contrast, there was no change in attitude towards researchers between baseline (M= 4.29) and outcome
(M= 4.85) with those receiving the evidence briefing service (intervention A) [F(1,13)= 0.59; p= 0.48]. In
summary, the hypothesis was not upheld: intervention did not increase the perception that communication
with researchers helps CCGs to achieve their professional goals.
Researchers’ professional goals
We examined the hypothesis that the evidence briefing service would improve managers’ perception that
communication with CCGs helps researchers to achieve their professional goals. The interaction between
intervention and time was not significant [F(1,47) = 2.45; p = 0.10], indicating that the intervention had no
statistically significant impact on achieving their professional goals.
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Clinical Commissioning Group and researcher goals
We examined the hypothesis that the evidence briefing service would improve managers’ perception that
communication between the two parties helps both researchers and CCGs to achieve their professional
goals. The interaction between intervention and time was not significant [F(1,47) = 2.37; p = 0.11],
indicating that the intervention had no statistically significant impact on achieving common goals.
Did the evidence briefing service improve Clinical Commissioning Groups’
perceptions of researchers?
We examined the hypothesis that the evidence briefing service would improve perceptions of researchers
in general using a ‘feeling thermometer’ measure in which participants reported perceptions of researchers
on a scale of 0 (very negative) to 100 (very positive). Perceptions of researchers were positive among
respondents receiving intervention A, at baseline, almost at the level of the post-intervention responses
across the board (Table 12).
There was a significant interaction between intervention and time [F(2,57) = 3.29; p = 0.045]. Post hoc
analyses demonstrate that perceptions of researchers in general were significantly more positive at
follow-up (M = 77.20) than at baseline (M = 46.35) in intervention B [F(1,19) = 9.76; p = 0.006]. Similarly,
perceptions of researchers were also significantly more positive at outcome (M = 78.21) than at baseline
(M = 41.25) in ‘control’ intervention C [F(1,23) = 23.72; p = 0.0005]. In contrast, there was no change in
attitude towards researchers between baseline (M = 67.31) and outcome (M = 72.69) in intervention A
[F(1,15) = 0.36; p = 0.56]. In summary, the evidence briefing service did not change perceptions of
researchers (in general).
Summary
Exposure to the evidence briefing service did not increase perceptions that communication between CCGs
and researchers helped CCGs achieve professional goals (or indeed, researchers’ goals). Nor did it lead to
increases in what were already positive perceptions of researchers in general. Exposure to the evidence
briefing service did not increase perceptions of the quality or quantity of contact between CCGs
and researchers.
Table 13 presents a summary of the results of all the hypotheses tested in this chapter.
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TABLE 13 Summary of tested hypotheses
Hypothesis Supported
Capacity
Access to an evidence briefing service will improve overall capacity to use research in commissioning
decision-making
No
Access to an evidence briefing service will improve CCGs’ abilities in acquiring (capacity to acquire
research)
No
Access to an evidence briefing service will improve CCGs’ abilities in acquiring (capacity to look for
research in the right places)
No
Access to an evidence briefing service will improve CCGs’ abilities in assessing (capacity to tell if research
is valid and high quality)
No
Access to an evidence briefing service will improve CCGs’ abilities in assessing (capacity to tell if research
is relevant and applicable)
No
Access to an evidence briefing service will improve CCGs’ abilities in adapting (capacity to summarise
results in a user friendly way)
No
Access to an evidence briefing service will improve CCGs’ abilities in applying (capacity for leading by
example and valuing research use)
No
Access to an evidence briefing service will improve CCGs’ abilities in applying (capacity of decision making
processes for research use)
No
Intention to use research evidence
Access to an evidence briefing service will improve CCGs’ intentions to use research evidence in their
decision-making
No
Access to an evidence briefing service will improve CCGs’ attitudes to using research evidence in their
decision-making
No
Access to an evidence briefing service will improve CCGs’ group norms around using research evidence in
their decision-making
No
Access to an evidence briefing service will improve CCGs’ sense of self-efficacy with regard to using
research evidence in their decision-making
No
Intergroup contact
Access to an evidence briefing service will improve the reported amount of contact between CCGs and
researchers
No
Access to an evidence briefing service will improve the reported quality of contact between CCGs and
researchers
No
Access to an evidence briefing service will improve the reported institutional (CCGs’) support for contact
between CCGs and researchers
No
Perceptions of researchers and the research relationship
Access to an evidence briefing service will improve CCGs’ perceptions of having an equal status between
CCG members and the researchers they encounter
No
Access to an evidence briefing service will improve CCGs’ support for contact with researchers No
Access to an evidence briefing service will improve CCGs’ perceptions that it will see itself and researchers
as part of an overarching group with common goals
No
Access to an evidence briefing service will improve CCGs’ perceptions of researchers in general No
Access to an evidence briefing service will improve CCGs’ perceptions that contact with researchers is
useful for both parties
No
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Chapter 5 Case studies exploring uptake and use
of evidence in Clinical Commissioning Groups’
decision-making
This chapter explores the question: does access to a demand-led knowledge translation service improveuptake and use of research evidence by NHS commissioners compared with less intensive and less
targeted alternatives?
Four case studies are presented. These are the two CCGs receiving intervention A, one CCG receiving
intervention B and a regional cross-case analysis based on the topic of value-based commissioning. The
case studies are based on analysis of interviews, observations and documents. Interviews with two public
health consultants were also included to assist understanding of local ways of working and the
relationships within the local health economy.
Four themes are described and explored in the context of existing frameworks/what is known:
1. local decision-making processes (and the use of evidence)
2. the types of sources identified as ‘evidence’
3. the organisation’s absorptive capacity
4. the relationship between and exchange of knowledge between commissioners and researchers.
We also capture the complexity of commissioners’ relationships with research evidence. In particular,
the challenges involved in acquiring and applying research evidence under pressures of time constraints,
limited resources (organisational, intellectual and translational) and specific local contextual factors.
Exploring uptake and use of evidence in decision-making in the
A1 Clinical Commissioning Group
Decision-making processes
Interview data suggest that commissioners in the A1 CCG aspire to adopt a logical analytical approach by
developing evidence-based options papers capturing risks and benefits:
The traditional approach really would be to go away, do lots of research, understand what’s happened
in other areas, look at the evidence, see what works, write a specification, a service specification and
then you’d go out to the market and you’d go out to tender and say ‘Actually this is the service that
we want to deliver, who’s going to come forward and can deliver it for us?’.
P14
Evidence-informed decision-making is valued and built into the system by a requirement to confirm the use
of evidence via ticking a box on the front cover of all documents examined by the executive board:
All papers are signed off by directors, and the director . . . or if the director doesn’t do it the exec[utive]
should do it, should say, ‘Where’s the evidence behind this?’ and there is on the . . . again on that front
cover sheet it says, are the proposals within this paper evidence based and are they referenced within
the paper.
P18
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This is supported at board level as the board requests additional evidence or queries the evidence
presented to support options: ‘if the board don’t feel assured that that hasn’t been worked up adequately
prior to the paper coming then they won’t make a decision on it’ (P14). In an ideal decision-making
scenario, all questions regarding risk, cost and benefit would be answerable with evidence, however,
information may be best sourced from people with practical experience, such as palliative care experts
‘thinking about going forwards, does a different model of how we look after people in the community
and in care homes influence the number of specialist palliative care beds that you might need’ (P17).
There is consensus among CCG informants that there are different ways of decision-making. Two
participants (P18 and P14) suggested that policy decisions with significant impact (cost, mortality, etc.) are
more likely to include what is described as an ‘evidence cycle’ (P18) in which evidence for different options
is sought, acquired, assessed and adapted. The difference appears to relate to whether or not a decision
will result in significant ‘change’ or impact. One participant (P14) suggested that the applied use of
evidence was improving in the CCG but that it is not ‘necessarily the first port of call’. This structured
process of evidence seeking and evidence-informed business case development does take place in some
circumstances. For example, participant 18 described collecting advice from local experts on interventions,
placing these in a grid and refining them through an iterative process of challenging by members of the
team to develop an appropriate service. It is likely that decisions in which there are clearly specified and
measurable goals require the more formal ‘evidence cycle’ approach, whereas less clearly defined decisions
merit more informal approaches.63
Despite organisational intentions, research evidence is not always sought to support recommendations
presented in business cases. The emphasis on evidence is not always translated into practice even at the
strategic level of the organisation: ‘. . . I don’t think we’re good at pushing back things at exec[utive] level
that maybe don’t seem to have an evidence base which might have been a better thing to, do . . .’ (P14).
Aspirations to seek and appraise evidence to inform options appraisal may also be discarded unintentionally:
We forget to do that [look for the evidence], and we just think it’s . . . is a good idea and it’s based on
some case reviews, something we’ve read, or something we’ve heard about and we plod on, and then
don’t involve them [public health] to the degree that we could, and in an ideal world we wouldn’t
even ask them, they would be at the table hearing about the early discussions and they would say, ‘I’ll
go and do some research about that, I think I know what you need here, you need to know whether
this works or this works’.
P18
In other commissioning areas, commissioners may not always be able to apply processes that are intended
to ensure evidence use, perhaps owing to a lack of research-related skills. For example, the box ticking
process indicates the presence of any evidence rather than an assessment of the quality of that evidence
and the value of this process is dependent on the individual member’s ability to judge the quality
of evidence:
It’s about whether there’s any reference to evidence as opposed to what is quality and the quality of
the evidence, the volume of evidence and even whether the evidence is directly relevant and supports
what you’re saying, what you’re suggesting . . . So that [box on the front of documents] is meant to
be a prompt, but you can tick yes and then have very flimsy evidence. So the quality of the evidence
isn’t therefore systematically reviewed.
P18
In addition, what commissioners value as evidence varies; for example, those with a management
background may value certain types of journal but a clinical member would question trial conduct (P17).
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The organisation’s capacity to adopt a rational decision-making process is partially limited by the perceived
lack of availability of information about options. This is partly in recognition that high-quality research
evidence may not be available to support commissioning decisions:
Well, coming from this other medical background, it tends to be evidence-based medicine that’s the
sort of thing that pops up, which gets peer reviewed, randomised control trial evidence, there’s very,
very little of that in commissioning.
P17
Executive members are reported to ask ‘is it evidence based?’ but the answer is often ‘there isn’t the
evidence out there’.
Commissioners identified pressures that exert a greater influence than research evidence. One participant
stresses the importance of listening to people:
. . . from our perspective, we’re delivering a day job which is about making sure patients out there get
the best possible care and it seems lunacy to not say ‘Well why don’t you look at evidence in order to
do that’, but it’s almost like we’re being more reactive around listening to what their needs are and
trying to build services to meet those needs whereas the pro activity will come around that review of
evidence and using that evidence to full effect.
P14
The absence of research evidence can lead to decisions that are influenced by the values of CCG leadership
and acceptability to the local population rather than information on cost-effectiveness. For example, in the
context of the Vanguard projects, decisions are based on what models would ‘best fit’ the local health and
social care system and ‘which ones are likely to be palatable’. This appears to be influenced by the need
for local buy-in to ensure that implementation is effective. There is no formal process for integrating
organisational values into decision-making, it is an assumed process.
Table 14 compares the pressures on commissioners identified in the CCG with those documented by
Wye et al.48 The possibility that there may be limited time available for decision-making was, surprisingly,
not extensively discussed by participants from this CCG.
Developing alternative processes in response to challenges
The context of a perceived lack of research evidence to support decisions encouraged participants to
identify alternative sources of information as ‘evidence’ to inform their decision-making. Our observations
of decision-making meetings and analysis of documentary evidence suggest regular use of forms of
information other than research to inform decision-making.
Commissioners described seeking the experience of other CCGs that have already developed policies
or activities:
They would always want that sent to check about well what’s happening in other areas, it’s you
know, and what’s that learning? So rather than us having to learn for ourselves the experience of
implementing a service, well if someone else has done it, what have they learnt and why have they
either chosen to continue it or chosen to stop it?
P14
This experiential information is treated as evidence even though it is not research based and conflicts with
the recognition of a ‘gold standard’ for high-quality evidence:
One of the big pieces of work that the CCG has been involved with is around an urgent care redesign
and we looked around the country for other models and how they had been implemented and what
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their outcomes were, so a form of evidence, a low grade of evidence as a case review, but they’re
often referred to within business cases that come to the exec[utive].
P18
Obviously he’s come across, you know evidence of other places where they’ve written up the
outcomes of their services and so it’s almost like we’ve instructed the CSU to embark on a review of
our MSK services based on that and around how you can integrate pain services with MSK.
P14
Board members also request information about what other CCGs are doing; this is treated as evidence
even if effectiveness has not been robustly demonstrated.
Another driver of an innovative approach to policy-making in the absence of research is quality:
[we] have a responsibility of spending that money absolutely as wisely as we possibly can so even
though we’re good at coming up with ideas the back stop is if it’s going to save money but be a more
efficient way of delivering that service for the patient, bringing the services closer to the patient, then
ultimately that’s going to help, you know, be prioritised probably over something that maybe might
not save that money. But there is a strong quality thread through the work that we do as a CCG even
though we are quite cash strapped, we don’t have a lot of spare money I would say to do like masses
of innovation, I do think we’re good at prioritising what is needed for the population.
P14
TABLE 14 Pressures on commissioners in A1 CCG
Pressures on commissioners identified in A1 CCG
Pressures on commissioners
from Wye et al.48
Public health and local authority partners drive priorities that are public health issues
(e.g. cancer)
Evidence purveyors
National and regional
performance managers
The press
l Providers present (and sometimes debate) clinical evidence (high-quality RCT-type
evidence in general). This also influences service design that is expected to be easier
to implement
l Working with public health (locally and nationally) in part out of necessity. It
described developing policies that fit what others want/do/prioritise rather than
systematically exploring the evidence. Change4Life was an example given
l Foundation trusts are identified as drivers of priorities such as palliative care and
mental health
Health-care providers
No significant pressures in terms of local priorities but perspectives are sought in the
commissioning processes described by participants (e.g. self-care services)
The public
Service users
Views are actively sought as part of an ‘innovative’ approach to commissioning. Expertise
about what might work is used to design a new service. For example with self-care
consultation events
Clinicians
In some cases, regardless of the evidence base, decision-making is influenced by what
stakeholders/clinicians prefer – if they disagree with the evidence, it will be too
challenging to implement effectively
Internal colleagues
RCT, randomised controlled trial.
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There was an apparent connection between the notion of innovation and evidence in which the concept
of ‘ideas’ was employed in lieu of research evidence:
We’re very good at coming up with ideas in the CCG using evidence and that evidence based
approach . . . but I would say that it is not always our first port of call, we tend to use a lot of
feedback and you know, just experience of the clinicians on the ground around how either current
contracts are working or current services are working or people that are coming forward with more
innovative ways of doing stuff because they’ve experienced that in other areas as it were.
P14
Service development based on stakeholder consultation was another example of an innovative approach
to policy-making. Although decision-makers requested an evidence briefing on self-care, it was unclear
how they intended to use the evidence in the service design. When no research evidence was found, the
commissioners formally consulted with stakeholders to design an innovative service. The primary source of
consultation to collect stakeholder views and experiences to inform the service took the form of a 1-day
workshop event led by the clinical lead on long-term conditions. Rather than feeding into an options
appraisal, this information is used to design a service or to express preferences for different services.
The development of a stakeholder-led service design was guided by knowledge of what works locally and
regionally but, as participant 17 makes explicit, is ‘perhaps not necessarily driven by the best evidence’
(P17). However, national documents from societies (e.g. the Palliative Care Society) are also fed into
the process. These are acquired by the CSU because it works with more than one CCG and can share
knowledge between these groups. This ‘evidence’ is described as forming the basis for an ‘options paper’
to be reviewed by the executive team, but practical constraints mean that the detail of risk included in this
is not in depth.
Participants describe this type of service design as taking small risks to provide services that are innovative
but this has its own challenges. For example, some of the development of integrated teams was to an
extent influenced by providers (P14). Although this was considered a risky strategy, it was perceived to
have paid off (P14). It was also acknowledged that ‘nine out of ten times’ the service is not actually
innovation as it is likely to have been done elsewhere in the country (P14) and even with ‘traditional’
(P14) ways of commissioning, stakeholders would be involved in the mapping of the current service before
drawing on evidence.
I think we, yeah, but I suppose getting underneath the decision making process every, we’ve got quite
a plethora both of experience and personalities around the board table and I think that’s a good
thing. I think there’s always healthy discussion around, you know, innovative bids, I think from a board
perspective they are quite up for innovation, you know, listening to, maybe doing something a little bit
different and I think Integrated Care Team is a prime example of that because that was quite a risky
strategy to adopt.
P14
Competing pressures
The adoption of alternative decision-making processes was justified by the competing pressures
on commissioners:
Balance what’s desirable and what would be, you know, the gold standard way of doing things with
actually what’s practicable and practical given the, you know, we’ve got a very tight running cost
budget that we must adhere to, we can’t go on spending lots of money on running and making these
decisions, so actually, often the decisions that we’ve got to make, the CCG has got to be a pragmatic,
make the decision best we can with the information we’ve got available to us rather than higher into
the [–]nth degree.
P17
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The challenges of a perceived lack of evidence, and limited capacity to evaluate evidence, may prevent
the CCG from making evidence-based commissioning decisions in every case. The response has three
dimensions: seeking an alternative evidence base, focusing on innovation and incorporating organisational
values into decision-making in addition to evidence.
Absorptive capacity
Some of the challenges to the practice of evidence-based policy-making relate to the organisation’s
capacity to acquire, assess, adapt and apply research evidence.
Capacity to acquire research evidence
Acquisition limitations are both skills and resource based. As decision-makers have only limited capacity
to evaluate and process information, the gold standard of evaluating risks and benefits through options
papers is balanced with the feasibility based on costs and resources. Participant 14 explicitly states that
there are limited costs to making decisions (outside of the costs of the subsequent intervention):
The CCG has got to be pragmatic . . . because what we don’t have is a plethora of time to go away
and do the evidence review and equally we don’t, like I’ve alluded to before, have the skills or
knowledge or expertise around that, that’s a very specialist service, in order to do a good lit[erature]
review of a particular area or do you know what I mean?
P14
Having the means to access evidence is not considered a particular challenge (P18); rather, the CCG is
not in the habit of requesting evidence and, when it does, the type of evidence may not be strong
enough as it often seeks case studies. There is some capacity within the CCG to acquire research evidence,
but its relatively small size limits its internal capacity. It draws on external resources, the key one being
the CSU:
CSU would do that on our behalf [draw on academic evidence] to be honest and that comes through
in some of the background work up of the business cases and the papers that come to the exec[utive],
that’s always part of a standard part of the reporting . . .
P14
Although the CSU provides evidence in the reports and business cases, there is no guidance regarding
where this evidence should be drawn from and it does not provide an evidence appraisal service due
to a perceived lack of appraisal and adaptation skills within the CSU [‘they haven’t got the in-house
expertise to do it’ (P18)]. However, it was recognised that the CSU facilitates knowledge-sharing across
the region:
A critique of CSU would be that they don’t have a central . . . and I think what we need to be better
at is having a library of evidence because individual Clinical Directors I know, you know, keep to up to
date with clinical protocols and guidelines and everything like that.
P14
The local public health team assists in acquiring some evidence but this takes different forms:
. . . they go off and they come back and sometimes they just give an e-mail or verbal report and say,
‘Yeah, you’re on the right track here’, or, ‘You’re not on the right track’, or sometimes we ask them
to put something more in writing and write something similar to an evidence briefing.
P18
Other means of acquiring evidence include library services but these are an evidence-collating service and
do not provide any degree of analysis or assimilation of the evidence found (P18 and P17).
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Commissioners do seek evidence themselves, however, and descriptions indicate collective confirmation
bias in which individuals prefer pieces of information that support the preferred alternative64 as they
sometimes seek information from sources that they know share the CCG values:
I think there’s probably a degree of bias in terms of the health foundation stuff, very passionate about
person-centred care, and there’s probably some reporting bias on their behalf to reinforce their
message, but because it seems to be the right thing to do and we’re excited by that we probably look
there and don’t look for evidence to contradict our views.
P18
We look for affirmation I think that we’re doing the right thing, as opposed perhaps don’t always look
for, actively seek out evidence that would contradict what we’re doing. And if we do, if I’m being
honest, I think when we do find it we say, ‘Well yeah but we’re doing something slightly different’.
P18
Some evidence-seeking behaviour is ‘informal’ horizon scanning of what goes on elsewhere (P18 and
also P14). This can generate sources of evidence [e.g. about the ways in which the Health Board in New
Zealand has reduced the burden on hospital care (P18)], but this process is not structured and identifying
these sources is attributed to luck to a certain degree (P18).
Quality assessment of research evidence
Although there are formal processes for evaluating the quality of the evidence used, the example given
above demonstrates that some executive members may lack the skills to do this adequately, for example a
focus on quantity of evidence in a report rather than quality.
Participants observed that the nature of CCGs means that the executive and governing body teams have
diverse levels of experience and degrees of clinical training, so have different training needs. Across the
organisation, training needs also vary in terms of using, seeking, disseminating and understanding
evidence. However, the presence of GP clinical commissioners and their background in evidence-based
medicine means that it is likely that there are those with the appropriate skills to do this: ‘You tend to find
that the clinicians are stronger at using evidence because they have to as part of their current role and
almost their CPD [continuing professional development] to keep up to speed with their particular clinical
interests in clinical areas’ (P14). These clinical skills are perceived as advantageous as they strengthen
critiques of research that is brought to support decisions (P17).
Feasibility and cost were not explored as extensively – one participant suggests that the CCG does not
explicitly attempt to estimate potential cost savings (P18). Appraisal of sources from other places does take
place, although it is recognised that much of this is dependent on trust:
. . . we take a lot of . . . I suppose we do take a lot on trust, I mean they presented some fairly robust
stats showing, you know, over a timescale of about 10 years what was happening in terms of where
patients were accessing health and what was happening to their health outcomes, and that looked
fairly robust.
P18
Public health doctors are better at considering the research basis. Some participants with a clinical
background do demonstrate an understanding of robust high-quality research evidence: ‘Oh, like a
systematic review of several areas which have actually been under trial conditions’ (P18); this is set against
a description of ‘flimsy’ evidence: ‘like a case study, we’ve heard that some, they’re doing something like this
so we think we should do the same, because they’ve seen some benefits in the short-term’ (P18). Participants
described high-quality evidence as including randomised controlled trials (RCTs) and peer-reviewed studies.
However, there was little explanation of why these sources are deemed to be of higher quality than others
and these descriptions appear to reflect teaching in evidence-based health care.
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Although there is potential to develop the organisation’s capacity, one participant argues (P14) that this
should not be via training specifically. Previous attempts to review critical appraisal skills training have
indicated some benefit, but based on poor-quality evidence.
Capacity to adapt research evidence
National recommendations for priorities are judged by commissioners in terms of their applicability locally
given the nature of the local organisations involved: ‘it’s not that we’re just . . . ignor[ing] them, but we
discuss which ones are more likely to be palatable and which ones are more likely to be successful locally’
(P18). The adaptation of knowledge to the participant’s local context appears to be done at the group or
clinical lead level rather than the board level, but this is unclear. The term ‘options’ is used on several
occasions during interviews, with the board making a final evidence-based decision on the back of these
and requesting further information.
Capacity to apply research evidence
As shown above, some participants assume that the CCG is good at applying evidence. However, there
are few examples that demonstrate this and there are mixed views on the CCG’s capacity to use evidence:
‘I don’t feel as a CCG we are great at using evidence’ (P14). ‘And at the moment there isn’t a sort of
formal process or a cultural process within the organisation to do that (to integrate evidence in processes)?’
(P14). Although there is an intention to apply evidence to decision-making, ‘the application of evidence is
not perceived as the main “warrant” for claims of knowledge, in part due to lack of skills in appraising
evidence amongst non-clinical members’ (P14).
There is an informal process of looking at ‘data’ (as evidence) to identify local need (P14) and evidence is
perceived as being used as a kind of retrospective sense-checking (P14), sometimes resulting in biased
evidence-seeking behaviour: ‘[we] don’t look for evidence to contradict our views’ (P14).
Linkage and exchange
The relationship between commissioners, the public health team and the evidence briefing service does
appear to be one of linkage and exchange in this case study. Some evidence transfer already takes place
through the strong existing public health links between individuals in the CCG, and there are some cases
of seeking evidence internally and via providers and stakeholders who have an interest in a particular field.
Participants describe a relationship between commissioners and external organisations such as the CSU
and the public health team that enables the transfer of evidence to support decision-making. This is driven
in part by priority-setting processes and focuses on the relationship with the local public health team.
However, the CSU is not perceived as facilitating knowledge sharing across the regions:
One of the frustrations we experience from a commissioning perspective is the fact that [the CSU]
sometimes don’t share with us across the 13 CCGs, the differences or the learning that they’re getting
around maybe a particular clinical project . . .
P14
There is perhaps a need for a ‘push’ of research evidence from research providers into CCGs, as described
by one participant (P17), especially when it relates to possible changes that the CCG could implement
but have not yet identified as a need (or solution). This, and observations of decision-making meetings,
suggest that the presence of a researcher or public health clinical advisor in policy-development contexts
could potentially help to identify points where evidence may assist decision-making; the so-called ‘blind
spots’. The evidence briefing service facilitated a pull of information into the organisation by prompting
and facilitating the executive team to seek evidence (P17). However, organisational culture may prevent
the integration of knowledge into decision-making once it is acquired. The notion of ‘normalisation’, in
which practices become routinely embedded into the organisational context, requires participants to have
a shared understanding of the purpose and value of the information acquired.65
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There is a preference for a source of evidence to be situated within the decision-making system (i.e. in
meetings) because the involvement at an early stage of people with access to evidence could benefit
decision-making:
Our exec[utive], DPH [Director of Public Health] comes along, but maybe the consultants of public
health who are much closer to the evidence would be better at the exec[utive], or somewhere else in
the system, to challenge every decision we make.
P18
Locating representatives of the research community in decision-making situations may in part act as a reminder
to decision-makers of the value of research. There is also value in members of the research community being
embedded in the local context as this provides an understanding of the local challenges to decision-making:
I think the advantage of public health doing that is they are physically in the borough, they understand
the systems that we have, they understand the population that we have, and all through the year
they’re getting drifted what our issues are, so they come to it, you know, a bit of a running start . . .
whereas using someone like Paul’s team every 3 months you see, ‘Oh we’ve got this new brainwave,
can you help us answer some research questions’, he perhaps doesn’t really know what’s gone on,
you know, what departments in the hospital are struggling and which parts of our population don’t
seem to access health care . . .
P18
There is a perceived need for time to develop relationships with public health consultants before being
able to use them to their full effect. The relationship between the evidence briefing team and participants
illustrates this point, with increased discussion of questions once a rapport was established. The way
in which questions are generated and negotiated with researchers is important because asking the
‘wrong’ questions, whether in internal evidence seeking or in discussions with external evidence providers,
may result in no evidence being identified. The limited amount of research evidence used in CCG
decision-making may in part be a product of commissioners asking the wrong questions, which may
in turn generate recognition of need or demand for inappropriate or unavailable evidence.
Evidence briefing service
There has been a high degree of contact between individuals in the organisation and the evidence
briefing service:
I’ve probably contacted them 6–12 times specifically to ask for help for something, I suspect that if you
add up everybody else’s requests they come to a similar answer, but I’m not sure about that.
P18
On the whole, participants valued the evidence briefing service:
It’s all high quality, the language was good, they really were brief, they came with some conclusions,
but the conclusions were often this is an area that’s not been robustly looked at, or we can’t really
advise . . . you can’t really use the evidence to advise you to do this or not to do this.
P18
However, they addressed the challenges related to the types of questions being asked rather than the
quality of the service itself:
Sometimes it was useful and other times it was less useful and as I say I guess it’s less useful in that
the questions we were asking were hard questions and were often answered with we don’t know the
answer, there needs to be more work.
P18
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One participant expressed a need for evidence that can directly inform decision-making and that can
support risk/cost/benefit analysis, but acknowledges that this information is not available:
Yes, I suppose the sort of things that don’t get answered very easily are things like numbers needed to
treat, impact in terms of if you do this in your population you’ll save 100 lives, or you’ll reduce your
admissions by such and such, and this’ll be the cost, or this’ll be the savings, and but that’s probably
because we won’t ask those questions, so we may just not have got into the habit of asking really
good questions. So then we get an answer that still doesn’t help the people at the exec[utive] make a
good decision.
P18
Some value lies in the nature of the evidence provided by the service:
And actually, you know, we’ve been a little bit assured in the fact that we haven’t found any
absolutely double gangers of things that we potentially should have done in a certain way that we
haven’t but I do think there’s always areas to improve, do you know what I mean?
P14
Perceived impact
Part of the perceived value of the evidence briefing service was not related to use of evidence itself,
but rather the light in which it showed the CCG:
I think it was useful in the fact that it gave us reassurance that, you know, I mean we checked back,
we’d said ‘Well is anyone doing that?’, and actually it also gave us the impetus to say ‘Well no one
else is doing it’ and we’re leading the way and doing something different around diabetes . . .
P14
Another benefit was the impact on awareness and evidence-seeking behaviour in the organisation:
I personally may have learnt to be a little bit more specific with my questioning, thinking back to early
questions which were just tell us about the evidence for telehealth which is a bit vague . . . it’s raised
awareness of . . . I think in people’s minds of our decision-making processes, and how we make good
decisions . . . there’s probably been a trend to reference more evidence in papers that come to the
exec[utive] over the year or 18 months.
P18
One of the outcomes of engagement with the evidence briefing service appears to be a growing
recognition of the lack of appropriate evidence available to support decision-making in the CCG. In one
example (P18), the briefing did support the decision to not engage heavily with an existing service due to a
lack of supporting evidence. However, in another case, the evidence provided by a briefing was ignored
partly because the course of action was supported by the people involved. This suggests that evidence is
just one element of decision-making processes that are also influenced by individual preferences and drive
because ‘it’s assumed [to be] the right thing to do’ (P18).
Participants suggested a better structure for interaction with the evidence service to support members to
understand and use evidence:
We almost needed a bit more like a structure to hang around it like a bit of a training programme or
an awareness programme around, you know, some sort of putting some practical things like if I,
you know, and asking everyone like what does using good evidence look like?
P14
This service was offered as part of the evidence briefing service, but was not taken up by the CCG.
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There is a perceived need for change in the organisation’s culture so that use of evidence becomes an
organisational norm. This should not be addressed through training as this would reduce it to a tick-box
exercise. Participant 17 described a need to change the culture towards evidence so that its use becomes
normalised. This will require skills development and to ensure the absorptive capacity of the organisation,
evidence needs to become part of all conversations. Normalisation Process Theory suggests 16 criteria to
assess the likelihood of activity becoming assimilated into an organisation.66 These include the extent to
which individuals perceive difference in ways of working, agreement with the purpose of an intervention,
individual buy-in and organisational support for the intervention.67 Evidence needs to become part of the
whole organisational way of working:
From my perspective it would just, it’s like making it accessible to everyone, you know, it’s almost like
the girls in the admin[istration] office and it’s not just certain types of people or certain levels of
people within the organisation who should be doing it, it’s almost everyone should have that sort of
minimum education about why it’s good to use evidence, where you can access it, what do we mean
by evidence and things like that.
P14
There is potential value in developing a service that works with all organisations in the region because
much of the work involves partnership working and integration:
Like we talked about relationships with public health and things like that and we are looking more,
that integration is absolutely massive so why would we just look for that for help, it would be good to
integrate that evidence service almost across health and social care as well.
P14
In this case study, the organisational intention is to acquire, assess, adapt and apply evidence in
decision-making taking a logical approach. However, limitations in their capacity to acquire evidence
affects its ability to consistently achieve their ideal processes of commissioning and leads to an emphasis
on alternative sources of evidence and other problems in the treatment of evidence, such as
confirmation bias.
Summary
The CCG aspires to adopt a rational approach to decision-making in which options are identified and
high-quality evidence is used to select the most appropriate option. Despite real-world limitations, this is
achieved in some commissioning cases.
Commissioners value formal research evidence (such as RCTs, peer-reviewed science and clinical guidelines)
and are able to incorporate these into clinical decision-making. However, because high-quality and relevant
evidence may be unavailable, more diverse sources of evidence are used, such as ‘stakeholder views’ and
local patient data. Decision-making processes are therefore more innovative, exploring new options
developed by stakeholders, but without data on effectiveness.
There are two different decision-making processes in the CCG: the first applies an (intended) ‘evidence
cycle’, in which evidence is sought and integrated into decisions and impact is then evaluated. The second
relies on the generation of new service delivery ideas from stakeholders.
The CCG does have some capacity to acquire, assess, adapt and apply research evidence, but this is varied
and limited by resources. It does draw on external resources such as the CSU and public health to do this.
Linkage and exchange takes place between the CCG and public health consultants and with the evidence
briefing service, in particular, to address problems with identifying and answering appropriate and
useful questions.
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Exploring uptake and use of evidence in decision-making in
Clinical Commissioning Group A2
Decision-making processes
The main catalyst for the use of evidence in this case study was the financial constraints specific to this
CCG. As in CCG A1, there is a distinction between the way that commissioners here aspire to make
decisions and the reality of decision-making processes. NICE guidance was used in part because of the
cost-effectiveness element, but also as a bargaining or influential tool when working with providers.
Participant 16 gives the example of the medicines team that considers cost-effectiveness evidence to
facilitate negotiation between consultants and the CCG. Other drivers include the availability of resources
and the influence of factors other than research-based evidence on decision-making processes.
The intended model is evidence-based logical analysis of options:
We don’t debate stuff without knowledge, we say bring it back next time, and we ask public health to
go away and do a, you know, really good piece of work on that really and, and come back again
making recommendations based on clinical evidence and cost-effectiveness; and cost-effectiveness
exercises have usually been done by other people, for example NICE, and if it hasn’t then we’ve got the
local thing called [local treatment advisory group] which is like a mini NICE really, which takes on things
that NICE haven’t done. They have a waiting list of stuff to be considered, but what we can do is defer
or decline particular requests until [local treatment advisory group] have done a bit of work on it.
P02
This perspective was reflected by P03; yet she also suggested that evidence is ‘not bandied around the
CCG much’.
Decisions such as those about priority setting are supported by benchmarking processes, although this is
recognised as ‘not quite evidence-based’ (P03). Other decisions combine evidence [e.g. the Joint Strategic
Needs Assessment (JSNA) is used for priority setting (P16)] with local need but also with local ‘appetite
for change’ (P12). This ‘appetite for change’ highlights the influence that the likelihood for successful
implementation (and the role of GPs in this) has on decision-making.
Challenges to the use of evidence in decision-making
There was little discussion of the practicalities of decision-making and, although descriptions are not consistent,
participants identify two key challenges to the application of this evidence-based policy-making model.
Absence of evidence: some participants perceived that evidence or national policy on a topic does not
always exist even where it has been sought. To fill this gap [‘what do we do then?’ (P12)], commissioners
seek alternative and non-research-based information. This is a particular challenge for commissioning in
relatively new fields such as social prescribing, where research-based evidence is not yet available (as
demonstrated by the briefing provided by the evidence briefing service). The fluidity of research evidence as
well as their own priorities can make it difficult to apply appropriate and timely evidence to current priorities.
Financial constraints: given the financial context of this case, the limited evidence-based decision-making
that is reported may be a reflection of the need to respond rapidly to financial pressures. Establishing ‘risks
and cost–benefit analysis’ is in the interests of patient safety (P03) but the CCG’s strong performance also
affects it because:
I think for us, the priorities are, probably thankful in some respects that they’re money, and I say that,
you know, much as it’s a massive headache, it is because we’re not so worried about quality or
performance, we’ve got really good-quality performance metrics.
P09
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Participants recognise the benefits of using research to make better decisions in the long run:
Decisions are made on financial pressures to give short-term reward, where if you delayed it slightly
you’d probably get a bigger reward in the long run if it was evidence based than if it was, I just, but
that’s hard when you’re in that situation.
P03
There is a lack of skills and resources within the CCG to make evidence-based decisions, although one
participant recognised that if there was less need for a short-term response, ‘better’ decisions may be
made, as those decisions could be informed by evidence (P03).
Absorptive capacity
Other challenges to the use of evidence in decision-making relate to the organisation’s capacity to acquire,
assess, adapt and apply research evidence.
Capacity to acquire evidence
There is no formal process for the acquisition of knowledge in the CCG and there are more benchmarking
exercises described than evidence-seeking exercises (P09). However, there are two clear processes captured
in our data: (1) informal scoping by members of the CCG of information from other CCGs; and (2) pulling
in research evidence via external agencies.
1. Informal scoping: informally scoping the activity of other CCGs, one participant referred to this as
‘plagiarising’ via ‘low-tech’ scanning of the activity of others with similar objectives (P12). This involves an
initial internet search [Google (Google Inc., Mountain View, CA, USA; www.google.com) was specifically
cited as the search engine used], followed by a ‘review [of] the evidence’ (P02). The details of this
process are unspecified but participants describe reading policies and information from ‘evidence bodies’
such as The King’s Fund and other CCGs, and using it to create local policy guidance. If multiple CCGs
have similar policies, this mass is perceived to contribute to the ‘robustness’ of the evidence. The
emphasis given in this case-study CCG to practice from elsewhere is highlighted by descriptions of a
failure to look at what has worked elsewhere leading to a weaker service development.
2. Drawing on external services: individuals do not necessarily seek out evidence directly, rather they
commission it via external sources deemed ‘reputable’, indicating recognition of the need for robust
information (P03). For example, commissioners may request that public health clinical advisors do a
review of evidence including cost-effectiveness. Attitudes towards the regional public health team are
positive but this appears to be based on individual personality in the team. Commissioners also draw
on local treatment advisory group services to review evidence. In contrast, although it is used, support
from the local CSU is referred to as ‘a tick-box exercise’ due to the delays in receiving a response to
questions. Drawing on the public health team expertise is the usual means of acquiring evidence to
support low-value interventions (P02), although the evidence briefing service provided some new and
some updated evidence on MSK procedures.
One of the challenges to acquiring evidence is the lack of skills in the organisation. Skills in considering
evidence in the organisation are perceived to be limited, beyond GP commissioners’ own clinical skills
(P03). Unlike other CCGs in the region, there is an epidemiologist available internally who leads on JSNA
data analysis to identify priorities and need and to plan services. However, it is acknowledged that this is
not based on research evidence as such, but on ‘key information’ (P09) and is likely to be primarily a
benchmarking process given the emphasis on JSNA data.
Capacity to assess research evidence
There is a distinction between participants’ descriptions of evidence-seeking activity (such as internet searches
for other policies) and their understanding of evidence quality that indicates some capacity to appraise the
quality of evidence. Clinical participants do demonstrate some ability to appraise evidence, for example, the
understanding that RCTs are ‘high-quality evidence’, that evidence should be from reputable journals and that
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they should include cost-effectiveness in their evaluations. One non-clinical participant described the
process of seeking quality evidence as being related to ‘not looking at Wikipedia [Wikimedia Foundation,
San Francisco, CA, USA; www.wikipedia.org]’, but instead seeking to quote evidence from ‘reputable’
organisations (P03). Good sources include NICE and the Royal College of Surgeons and these appear to play
an evidence transfer role: one participant collects peer-reviewed research only if it has been included in the
reviewing done by an external organisation such as NICE or the Royal College of Surgeons, rather than
sourcing it himself. However, even clinical members have a mixed capacity to appraise ‘evidence’, as one
described evidence as:
. . . basically any piece of information at all that can have relevance on what you’re, you’re looking to
answer; suppose you’ve got a question to answer, you look at, you look at anything at all that can
help answer that question, then you look at it irrespective of that evidence, I suppose, and gives it
more robustness
P03
while also emphasising the importance of ‘respected journals’ in backing up decisions.
Capacity to adapt research evidence
Participants do not address the replicability of peer-reviewed trials of interventions, but there is an attempt
to adapt evidence from other CCG policies: ‘no point in reinventing the wheel’ (P02). They describe an
approach of selecting elements of another policy that they deem feasible in their own context.
Clinical Commissioning Groups with similar objectives are perceived as ‘independent advisors’ (P12) to help
the CCG go through the process, with no recognition of its potential biases. One participant recognised
the tendency for a CCG to promote its own activity even in the absence of empirical evidence (e.g. in the
area of social prescribing) and these qualitatively ‘compelling’ cases for its own activity make it appealing
to commissioners elsewhere (P16). For example, when the CCG team visited another CCG to explore its
model of service delivery, it discovered that the impact had been overstated: ‘our teams went down to
have a look at it and the difference between [the CCG] plus the control is not that big, it’s so it’s kind of
how you present it’ (P12). This led to the case study B CCG not pursuing that model of care despite its
initial appeal. On the whole, participants did not describe engagement with the evidence used to inform
other CCGs’ policies: one participant stated that he only collates information and selects the best bits
without assessing the quality of the evidence that might have been referenced: ‘I am assuming other areas
have used it [evidence], it’s been factual’ (P13). Another perceived limitation of this type of evidence is the
challenge of replicating locally. In social prescribing the impact demonstrated in other CCGs may not be
replicated locally due to different populations (P13). Although this is also a challenge for implementation
of evidence from clinical trials,68 it is less acknowledged in narrative-based evidence.
In contrast, one of the perceived strengths of other models of care is the influence of ‘soft and passionate’
narrative-based evidence in the form of opinions and anecdotal evidence about the model [e.g. social
prescribing (P16)]. This was the driving force behind seeking evidence about social prescribing from the
evidence briefing service. This suggests that commissioners are influenced by narratives to develop services;
in some cases this may prompt evidence-seeking behaviour, but this may not always be the case.69 There
was also a tension between a desire to learn from the perceived success of others (P12) and a reluctance to
abandon a model of care (such as social prescribing) despite the lack of robust evidence for these services:
[The CCG] was saying that they’d saved money but again you can’t actually say it’s social prescribing,
it could be just looking at new ways of looking at unplanned care, you know, putting it out there.
So it’s a mixture and there’s no way to actually definitely say, but it’s still a benefit.
P13
In turn, the limited engagement with the research evidence that had informed policy development in other
CCGs, the challenges to replicating policy locally and the lack of robust evaluations, appear to affect how
CASE STUDIES EXPLORING UPTAKE AND USE OF EVIDENCE IN CCGS’ DECISION-MAKING
NIHR Journals Library www.journalslibrary.nihr.ac.uk
66
the commissioners use this type of evidence: ‘. . . using those ones that are thought would fit in best
with what we were looking at’ (P13, see also P12). To address this, some members of the CCG take a
‘pick-and-mix’ approach to policies from elsewhere, adopting parts of another CCG’s model but not others
which they ‘couldn’t or wouldn’t necessarily want to reproduce’ (P16).
Capacity to apply research evidence
Evidence, in its various forms, is applied to support decision-making in the CCG but research-based
evidence is not always used instrumentally to directly influence decisions. CCG policies are applied to
create new local guidance, for example around low-value interventions (P03), and non-empirical
information gained from interactions with other CCGs is sometimes applied to the local context,
for example in terms of ways of partnership working:
That’s [model from X CCG] really influenced my thinking when it comes to commissioning . . .
so although that visit to X wasn’t applicable for what we went for . . . actually came away with a
sea change in how we talked to our local providers about things.
P16
Although this demonstrates learning from activity elsewhere, it relates more to learning about the
processes of commissioning rather than the interventions or services themselves. There is also some use of
evidence as a confirmatory tool, for example a preference for research evidence that supports what
commissioners ‘have been asked to do’ (P16).
In comparison with other A1 and B1 CCGs, there is less indication that the A2 CCG seeks ‘stakeholder’ and
patient preferences to inform its decision-making in line with key sources identified by other studies.48 In its
place, there is a greater emphasis on the models of service delivery taking place in other organisations and
on cost-effectiveness information. Stakeholder preferences are collected, patients are represented on
guidelines groups and the CCG also consults more formally with HealthWatch (HealthWatch England,
Newcastle upon Tyne, UK; www.healthwatch.co.uk). However, there is a perception that patients tend to
agree with the messages given by existing research into patient preferences (P16), suggesting that some
commissioners feel that there may be less point in consulting locally if there is research into it.
Table 15 compares the pressures on commissioners identified in the CCG with those documented by
Wye et al.48
TABLE 15 Pressures on commissioners in A2 CCG
Pressures on commissioners identified in case study B Pressures on commissioners from Wye et al.48
Evidence briefing service Evidence purveyors
National and regional performance managers
With regard to low-value interventions The press
Yes, pressures (often evidence based) from consultants in
secondary care to commission specific services or interventions
Health-care providers
Yes, to a limited extent The public
Yes, to a limited extent Service users
Yes: secondary care providers Clinicians
Yes Internal colleagues
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Linkage and exchange
Our data suggest that there is linkage and exchange between the CCG and external research-related
organisations, including the evidence briefing service. This is predominantly the transfer of evidence
reviews from research organisations into the CCG. Although the independence of research reviews is
deemed important, their source is unimportant – public health or the evidence briefing service are equally
respected sources as long as they are ‘stand-alone’ [by which we understood to mean ‘independent’
(P02)]. Descriptions of the working relationship between evidence providers and commissioners were
positive and the CCG draws on and has relationships with several sources of evidence:
Commissioning Support Unit: barriers to the relationship with the CSU included administrative demands
imposed (P02) and the long turnaround that these provide (P03). Services bought from the CSU are perceived
as a transactional ‘tick-box exercise’ that enables the CCG to meet statutory requirements around research,
but without engagement with researchers or a commitment to include evidence in policy-making (P03).
Public health: public health had a key involvement in decision-making around low-value interventions and
the IFR panels (P02 and P03) and descriptions of the relationship with the public health clinical advisor
(PHCA) is largely limited to this policy. This is partly because the lead on low-value interventions was keen
for policy revisions to be evidence based but likely also to be due to the presence of public health clinical
advisors at early meetings of the Low Value Interventions Implementation Group (P02).
Local Treatment Advisory Group: this group provides a service around clinical guidance where NICE has
not created guidance. There are some apparent capacity issues [there was a waiting list for work to be
conducted (P02)]. The link between the public health clinical advisor and the Local Treatment Advisory
Group is important, as the PHCA acts as a knowledge broker as he sits on the Low Value Interventions
Group and can channel requests into the Local Treatment Advisory Group.
Some aspects of linkage and exchange were more evident than others.
l Presence: descriptions highlighted the benefits of face-to-face contact between groups as well as the
importance of researchers [from both the evidence briefing service and public health)] being present
in decision-making fora. For example, the evidence briefing service main contact was described as
‘omnipresent’ in the Low Value Interventions Implementation Group but not necessarily in other
policy-making contexts (P02). Being present enabled PW to identify opportunities for evidence use
rather than depending on decision-makers to do so. Reviewers need to be immersed in context in
order to understand evidence requirements (interview with NHS England members). There is a sense of
a need for a service to ‘handhold’ the CCG in the use of evidence, in part due to lack of skills and lack
of knowledge of how evidence can be used (P03).
l Question generation: working with the evidence briefing service appears to have supported the
generation of appropriate research questions via an ‘organic’ process of discussion between the CCG
and PW (P12). Topics were initially generated by the lead evidence briefing service contact based on
work done elsewhere and these were prioritised based on CCG needs and the contact’s suggestions.
Over time, building this relationship has meant that commissioners have learned to present more
tailored questions (P12). The conversation between the CCG and the evidence briefing service is
perceived as positive because it is ‘iterative’ (P12), suggesting that an incremental approach to
policy-making sometimes takes place in this CCG. There is greater recognition of the role of question
generation in identifying evidence to support decision-making and the importance of asking the right
question when seeking evidence (P03).
l Relationship and rapport: participants were positive about the relationship built with the evidence
briefing service (P09): participants recognise the need to invest time and energy into a relationship
rather than it being a passive process (P09). This ensured that the relationship was ‘not just one-way
traffic’ (P09). Participants also suggested that the degree of linkage and exchange could have been
increased with regular face-to-face meetings about recent topics (P09), taking an informal approach
rather than formal presentations, and an opportunity to ask questions (P16). This would aid
consolidation of the information more so than reading a briefing paper.
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l Individual gatekeepers: one individual was deemed responsible for gatekeeping between the CCG and
the evidence briefing service (P12). Briefings were shared with all of the senior teams, ‘the whole of the
CCG’ (P12). It was assumed that distribution of briefings to locality directors, led to dissemination to all
CCG members. Briefings were integrated into CCG activity: ‘Paul or one of his team shared with us
papers on falls . . . either pressure ulcers or HCAIs [health-care-associated infections] or something, and
those papers what I did with them, I was director sort of covering all the quality at the time as well, was
send them to all of our providers and commissioners and then took it to our Quality Review Groups with
them, and asked them to outline to us where they were delivering against the evidence bases’ (P12).
l Time frames: time is critical to CCGs pulling evidence: the need to turn things around quickly means
that it does not draw on evidence services (P16).
l Shared understandings of objectives and values: shared understandings were perceived to be a positive
aspect of working with PW. Similarly, the longevity of the CCG’s (and previously PCT members’)
working relationship with individuals in public health is deemed beneficial to knowledge transfer (P02).
High regard for some members of the public health team is derived in part from shared values
(specifically that there is only one pot of money to be shared around and therefore services should be
evidence based) as well as the PHCA’s skills.
The dominant direction of information transfer in this CCG was a push of evidence from PW on relevant
topics. The one instance of a pull from the CCG for evidence on social prescribing was on financial
grounds: seeking justification for greater spending in the area (P16). This CCG was the only case in which
a participant raised the transfer from the CCG towards the research organisation: as a vanguard, it was
able to inform the evidence briefing service contact and the service about their needs so that the service
can better deliver to other vanguards (P12).
Evidence briefing service
The evidence briefing service offer appears to have come at a critical time for the CCG, as it was
experiencing significant financial constraints. It was therefore perceived as a means of meeting strategic
objectives while remaining within financial balance (P02).
Positive feedback
Interview participants gave limited but positive feedback on the evidence briefing service. The service was
perceived to have had a positive impact on the CCG’s approach to using evidence where it previously
lacked consistency, ‘[the evidence briefing service] helped us at least have a level of discipline about some
sources that might then prompt, a lot of them prompt further questions, there’s no doubt about it, but at
least we’ve got that level of discipline across us . . .’ (P12), and was perceived to have affected their way of
thinking (P12). The service was also seen in part as a useful ‘critical eye’ (e.g. in the low-value interventions
work) that was valued because it justified their current decision-making. Time constraints are cited as a
factor in the type of evidence seeking that is done and one benefit of the service was time saved for
CCG members.
Knowing a face (PW) was perceived as beneficial (P16). The service was perceived as a trusted and credible
source of evidence (P12) that is ‘robust’ (P09).
Although the briefings were useful, given the absence of available evidence for some topics (P12), it would
be useful to have a summary of studies that are ongoing.
Summary
Research is used instrumentally to inform specific decisions when it is available (e.g. the low-value
interventions policy is clinically focused and NICE guidance is available to inform this) and when the topic
aligns with CCG priorities (the CCG is operating under financial constraints).
Although the CCG aims to use research-based evidence, it draws heavily on the adaptation of policies and
practices from other CCGs. Challenges to this process, such as replicability and a lack of empirical evidence
of effectiveness, are also recognised.
DOI: 10.3310/hsdr05050 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 5
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
69
The CCG’s engagement with the evidence briefing service was strong and there was also engagement
with a larger number of individuals within the organisation than in A1 CCG.
Exploring uptake and use of evidence in decision-making in the
B1 Clinical Commissioning Group
Decision-making processes
Evidence-informed decision-making is valued in this CCG and there is an expectation that evidence will
be included in business cases. However, there appears to be no formal process for doing this and some
participants suggested that evidence ‘gets a bit forgotten’ within the organisation (P10). There is a
perceived need to get research worked into decision-making throughout the process:
I think that if I’m honest it would be finding a way to get a bit closer to that or working on how we
were thinking about evidence at the beginning and throughout the work we do, ‘cos I think it does
get, it does get conveniently, you know, just one more factor to play in, you know, so I don’t know
why that happens but, you know, it’s probably not given enough prominence, so from an organisation
point of view it’s probably to give some more prominence and thought to that.
P10
However, there is currently little clarity of understanding about how the organisation wants to use
evidence, in particular, making evidence part of a whole way of thinking rather than simply one factor.
There is no one model of decision-making captured by the study data. Some participants recognise the
need for a rationale for commissioning decision-making:
We’ve matched our perceptions of what we need to do against the clinical evidence and make sure
what patients are asking for was clinically sound as well and then they will be able to form an opinion
around how the services might look going forward with a good sound rationale and be able to go
back to the people who have been involved in that listening exercise and consultation to say why
decisions were made.
P19
However, a process of formal options appraisal in which the evidence for alternative services is considered
is not applied to all commissioning decisions. Because there is no formal appraisal and comparison of
research-based evidence, decision-makers do not assume that the selected option will maximise costs or
benefits, although there is some checking of patient safety. In contrast, there is a process of negotiation to
find common ground in terms of local preferences and to develop services to fit this.
Drivers
One challenge to a formal process of options appraisal is the multiple pressures on commissioners.
Participants emphasised the many sources of knowledge that impinge on policy-making and this highlights
the many pressures on decision-making.
l Enthusiasm: prioritisation is driven partly by individual enthusiasm (e.g. one participant described being
inspired to address certain commissioning areas by her mentor), although this enthusiasm is not always
borne out in implementation.
l National direction of travel: there was a clear national lead on priority-setting, the commissioning of
social prescribing and the Year of Care programme, possibly because of the nature of the funding in
these areas.
l Individual perspectives and experiences: ‘fears and concerns’ (P05). These can be prejudices or
experiential, not necessarily based on evidence.
l Common sense: some decisions are made because they have face validity [‘barn-door obvious’ (P05)],
even if they are not supported by evidence.
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l Structural factors: the separation of public health and CCGs was considered problematic and the
nature of this CCG as formed from multiple organisations meant that decision-making is still done in
separate organisations, particularly for implementation and pathway design.
l Organisational values: organisational core values are important to decision-making (P06). CCG
members share the same concepts and approaches around holistic care, social justice and inequality
(these are shared organisational values that reflect the notion of safeguarding the ‘common good’.
‘Imposing values’ (P05) may result in some bias.
Pressures on commissioners
Compared with Wye et al.,48 evidence purveyors, national and regional performance managers and the
press were not identified in this CCG; however, health-care providers, the public, service users, clinicians
and internal colleagues were identified.
Use of evidence in decision-making
The catalyst for acquiring and applying evidence in decision-making in this CCG is unclear, although,
as in cases A and B, the evidence-seeking process is led by the need to develop a service that meets
performance targets rather than resulting from the emergence of research findings. However, different
types of evidence are used differently in decision-making.
Evidence is, at times, used instrumentally in terms of ‘a little bit of evidence’ being used to raise interest in
an area, but then there is recognition that this should be tested in a systematic way (P08).
National ‘travel’
Alongside evidence from patients and the public, guidance from NICE guidance and other bodies
influences the commissioning intentions (P06).
Public and patient preferences: stakeholder involvement is especially key during the early stages of
commissioning to shape the service (P06). The influence of patient and public preferences on commissioning
processes is formalised by a consultation process [e.g. the reprocurement of community services (P06)].
This engagement includes a patient questionnaire to inform the development of urgent care, a patient forum
for mental health services and interviews with patients and carers to inform the new service specification for
community services (Governing Body meeting minutes September 2014). Documentary analysis illustrated
the formal emphasis on data generated from public consultation with little mention of research or evidence
in governing body documentation. Documentation associated with all governing body meeting minutes
contains few references to research evidence and a significant focus on patient engagement and
consultation. The service specification for MSK services was partially informed by engagement with 50 MSK
patients (June 2014). Patient and public evidence is also used as a testing ground for commissioning plans.
Providers
Some service design takes place during the procurement phase and is influenced by providers and
potential new providers. There is a market involvement aspect to commissioning as providers are asked to
give their perspective on the design of services (P06). In a ‘market engagement event’, ‘coproduction’ is
used to develop a high-level framework of potential services. This framework and a set of options are then
presented at a stakeholder event to identify potential interest from providers. Because providers often
collect patient and public feedback data, including patient satisfaction surveys, and have an influence over
service specifications, patient and staff satisfaction is also built into the services at this stage: ‘so there was
direct patient involvement, and so the strategy’s been, you know, it’s final draft basically and the views of
patients are in that, so you know, we think we’ve represented patient views in that’ (P10).
However, participants maintain that national evidence has greater weight than surgeon or provider preferences:
‘I would say the main influence is national, or the national evidence says, I think quite low down would be
local surgical preference . . .’ (P10). The description of decision-making processes provided by P19 suggests a
process of integrating stakeholder perceptions but via a safety-checking mechanism that prioritises clinical
evidence over patient perspectives. Part of the rationale for this is to ensure that decisions can be justified.
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. . . We’ve had a significant period of time listening to service users and carers, we’ve matched
comments from them against NICE guidelines and policies and things that come from NHS England,
Department of Health around mental health service provision targets and all those . . . and I’ve been
very clear I think with public and service users around the process we’re going through that yes, we
listen to what you say, it may be that’s what you think you need or you’re asking for, it’s not deemed
to be clinically sound if there’s no evidence base to say it’s what we should be doing. So it’s balancing
the views, the evidence, the impact of cost, quality . . .
P19
However, there is no indication of how this information is used in decision-making. Feedback reports from
stakeholders were produced, but it was unclear whether or not these are used to inform service design
(in contrast with the A1 CCG, where this was a clear intention). Therefore, the process of integrating
public and patient information may be limited to a representation of perspectives:
. . . so they have [a] regular sort of committee group meeting, which is a steering group with, you
know, key people from the patient and voluntary sector playing into that. And then any bits of work
that are going on, or emerging, play into that, so it’s a way of sort of bringing it together in some
kind of co-ordinated way and that, and that allowing to be reported into the senior management
team, the executive, so that we can understand the messages that are coming out.
P10
Working together
Ways to Wellness (www.waystowellness.org.uk) is an example of how the CSU, data analysts and the local
council work together to identify what is the best value for money in service delivery. Evidence (from the
CSU and regional Quality Observatory document) is used as a tool to convince members of a direction of
travel. The regional Quality Observatory, commissioned to look at the evidence around the Ways to
Wellness pathway, amalgamated more robust evidence from RCTs with less research-informed local
information to work out what impact the pathway may have.
‘What works elsewhere’
All participants discussed drawing on other CCGs’ policies and exploring how these could be adapted to
fit local need. However, commissioners aimed to identify the evidence of outcomes that other CCGs have
considered: ‘so I think when it got to pathway level we’d be looking for some sort of local piloting with
some sort of national or local evidence to back it up’ (P06). Commissioners would combine local evidence
from pilots with asking other CCGs what national evidence supports it. Descriptions of collecting data
from other CCGs were not as extensive as those in case study B. This was perhaps due to the nature of
the example topics in each case study: social prescribing (case study B) is a relatively new intervention
and it was recognised that this means there is little robust evidence. In contrast, the reprocurement of
community services (case study C) may have encouraged the use of public consultation.
Face validity
The face validity of evidence was important to decision-makers. In instances when gut instinct suggests that
a service option is wrong, hard research evidence may be sought to support this feeling (P06). In contrast, if
the option has face validity, no evidence is sought. Clinical leads would look at clinical evidence if there was
a move towards changing specific drugs for something ‘you would expect some sort of evidence base for
that . . . and cost analysis’. A distinction lies between micro-level decisions about changing a drug and
macro-level service design because (P06) people struggle to think about the evidence base around service
redesign and micro-level interventions have population-defined intervention evaluations available.
Innovation
Although there is less emphasis on innovation than in the A1 CCG, an innovative approach to
decision-making is adopted to fill the void where there is no research evidence available to inform
commissioning. The perceived advantage of taking an innovative approach is that it enables greater
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flexibility: ‘I think [we] are going into unchartered waters. We do have to be innovative as organisations
and we do have to therefore probably think about creating strategies that probably have very little
evidence because it’s not yet been created’ (P08).
Challenges to the use of evidence in decision-making
Although there is a general principle of evidence-based decision-making, the reality of policy-making takes
a more pragmatic approach to the use of evidence.
Difficulties with evidence: there are a number of perceived problems with evidence. These include a lack of
evidence available to inform decision-making (P05); conflicts between local data and national evidence
possibly owing to national evidence not being generalisable to local context, and queries around the
robustness of local policy. Other problems are with evidence conflicting with other pressures such as the
cost limitations and numbers of patients: ‘evidential problems get, to me, a level of friction’ (P05), and
ambiguity of evidence: ‘there is very often not a clear-cut yes or no that comes out of the evidence’ (P08).
If they are unsure about the evidence, they seek assistance from public health.
Attitudes towards evidence
Disagreement with evidence affects it use and enthusiasm for it because individuals have preferences
for certain evidence depending on whether or not they agree with it (P05). When research evidence is
provided (e.g. a regional Quality Observatory document supporting Ways to Wellness) ideally it will confirm
the CCG’s existing values.
Structural challenges
These include the recognition that decision-making and evidence are complex and the human dimension
has to be taken into account. Decisions need to be implemented and real people and patients deviate
from the evidence in practice/implementation so the evidence may not always stack up locally (P08).
The newness and nature of CCGs means that it is structured and operating differently and there is little
evidence available to support this.
Absorptive capacity
Capacity to acquire research evidence
There is a key gap in the acquisition and review of evidence in-house and ways to ‘translate this into practice’.
As in the A1 CCG, there is no formal process for acquiring research evidence to inform commissioning. This
may in part be because the question about research evidence is not always asked by the executive team and
because commissioning can be done without evidence (P10). The response to the lack of available evidence,
for example, around social prescribing, is to seek to generate evidence in order to see what works: ‘what’s
the evidence from our point of view’, rather than a formal seeking of ‘evidence’.
There are three avenues through which ‘evidence’ is sought: from national bodies by commissioners and
managers themselves; via the CSU, public health teams and other bodies (including the evidence briefing
service); and through the coproduction of evidence through consultation.
l National bodies: although information is sought from think tanks and national bodies – ‘I think there is a
reasonable stab at that’ (P10), this is not necessarily a formal process (P10). Literature searches are
conducted by commissioning managers [e.g. on general community service provision (P06)] and may
draw on evidence from The King’s Fund and the national 5-year forward view and other national papers
such as the ‘Future Hospital Commission Paper’ that are influential as the ‘national direction of travel’.
l External bodies: there is some provision via the CSU to review and assess evidence (participant 06 sent
questions to this service recently around frailty). However, the CSU is more used to looking at data
from a provider-monitoring point of view. As in the A2 CCG, there is therefore some dissatisfaction
with the service provided by the CSU but it is the CCG’s formal means of acquiring evidence. In one
example, the CCG sought evidence via the evidence briefing service (low-value interventions policy).
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l Coproduction of ‘evidence’: for example, stakeholder engagement events were held to collect
information on public preferences to inform new service developments – public preferences are for
health and social care to be integrated again.
One of the challenges to acquiring evidence is a lack of skills and knowledge or resources to seek
information, as well as a lack of understanding about the processes of doing so:
. . . sometimes I say, I need a bit of information on this and someone can go there and do that but at
the beginning of a project sometimes you don’t know where to start and where to start defining
them, the questions for this. So I think it’s expertise and having possibly the right people in-house
where, when the (ideas) come you can start asking the questions.
P06
Acquiring evidence is also challenging because commissioners do not ask questions that are specific enough:
‘we are not very good at trying to define the questions that we might want to do our searching on’ (P06).
It is also because the population might be wider and more complex and the interventions are multiple and
complex. ‘It is like putting the pieces of a jigsaw together with evidence and that is difficult’ (P06).
Capacity to assess research evidence
The CCG’s capacity to assess and appraise research evidence internally is limited, but it does draw on the
skills in local organisations. One participant (P06) demonstrates an understanding of what constitutes
high-quality evidence but this is led by his clinical perspective. Others mention ‘Level 1 A evidence’ and
RCTs so there is recognition of different types of evidence (P05). There is a degree of appraisal of external
CCG policies via judgements about what is good practice – ‘people who’ve won awards’ and ‘understanding
the person’s credibility on the subject area, look at the methodology they’ve used, look at the sample
size . . .’ (P19). Decision-makers have responsibility for appraising evidence and, although the capacity of
individual members to appraise evidence is diverse, they may lack the skills to do this and the process is
informal (P06). Clinical members have experience of critical appraisal in their training but non-clinical
members do not necessarily have this experience (P06).
There is some discord between individual participants’ recognition of what constitutes high-quality
evidence and the practice of employing information to inform commissioning. However, P06 suggests that
evidence is unlikely to ‘fundamentally change the pathway’. For example, one clinical member includes
‘professional articles in journals’ about other CCGs’ policies and activity, as well as talking to other CCGs
about what it has done as ‘evidence’ (P19).
The ‘value’ placed on different sources of evidence is mixed: although participant 06 places sources such
as the Nuffield Trust at the top of the hierarchy, he also states that local piloting and data analysis done on
the ground with feedback from patients would be ‘hugely influential’ on decision-making despite not
being high-level evidence. What works elsewhere has a key role, despite the recognition that this is ‘not
pure research . . . [and] not necessarily had been through a rigorous research process’ (P19).
Adapting research evidence
Although the organisation has some capacity to acquire evidence that includes research evidence, through
their own searching and by employing external organisations, the way in which patient and public preference
is incorporated into decision-making is unclear, as is the extent to which it is only a consultation process.
Replication of other policies and practice in the local context is recognised as a challenge. One participant
discusses the need to adapt lessons learned elsewhere (from other CCGs): ‘never think that you can just
lift and shift something that works in one city to another . . .’ (P19). In bringing together what works
elsewhere with stakeholder information and demographics, there is a process of amalgamating different
sources of ‘evidence’ (local information, stakeholder preferences and what works) in order to design a
service. The important aspect is making sure that what works elsewhere also meets the needs of local
people (preferences as well as demographic data).
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Capacity to apply research evidence
Evidence is only ever one factor that plays into decision-making and this needs to change and the
organisation needs to put thought into how it might do that (P10): ‘you know I think there’s a reasonable
chance we’ve got a blind spot on how we, you know, fully bring evidence into our commissioning’ (P10).
When multiple evidence sources are amalgamated by delivery groups an attempt is made to integrate
evidence of varying quality: ‘getting a balance right between the academic evidence and what I call the
softer evidence’ (P19). At pathway level, evidence is more likely to be needed and applied (P06), owing to
the need for evidence around clinical intervention options rather than the design of a whole service. There
is also a strategic deployment of evidence to gain influence (Nutley et al.11), used as a persuasive tool that
supports behaviour change among providers (P05) and as a defence for non-payment for evidence-free
interventions to providers:
. . . now NICE guidance is to move away from the sort of invasive ligation and stripping and go
towards, to go minimally invasive sclerotherapy and oblation, but we know that there’s massive
disparity in trusts in, just in the [this region] where some are doing lots of the minimally invasive and
some are doing the sort of more, you know, the old-fashioned stuff, so it’s about taking that
information, having a clinical discussion with the trust, if necessary backed up with a contracting, . . .
putting a target in if that’s what’s needed to say ‘you know, we’re looking for you in the next year to
reduce that to 50% and the year after that to 25%’, whatever that might be.
P19
Linkage and exchange
There is evidence of a model of linkage and exchange between this CCG and local research bodies.
In some cases, there are links with research institutions such as universities, but, for the most part, the
research community is represented by the public health team, the CSU, the regional Quality Observatory
and, during the last stages of the project, the evidence briefing service. Some indications of linkage and
exchange are more evident:
Synthesis of local data with general knowledge: the synthesis of local data with wider evidence was done
by the CCG itself rather than via knowledge brokers. Public health specialists appear to have provided this
service for the community services reprocurement process.
Trust: trust between the CCG and ‘researchers’, in this case the organisations providing access to evidence,
is important to maintain the relationship. There is existing support from public health embedded in the
CCG, the regional Quality Observatory and the CSU, which are perceived as suppliers of information in the
form of business intelligence. Some elements of this are positive and the long-term relationships with
individuals in public health have resulted in trust in their work. Evidence transfer and information-seeking
behaviour (pull of evidence into the CCG) is assisted by the close relationship between members of the
CCG and the public health team. The latter is considered a robust source of evidence that provides a
reliable quality of work.
The CSU contractually provides support to the CCG for decision-making, including providing evidence;
however, the adequacy of the current service is questioned by some commissioners. Although one
participant described a good linkage between the CSU and the CCG in terms of questions asked and
evidence provided (P19), apparent difficulties in this relationship are based on a perceived disconnect
between the question asked and the answer provided:
It’s a bit like going to a garage and saying, you know, I’ve got this real dreadful noise in my car from
that wheel and I think there’s a wheel bearing gone, and they look at it and say, possibly, but we
think the paint needs to be changed.
P05
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The result is a lack of fit in the data to the question and a lack of clarity about what information
(interpretation of data or non-analytical production of data) is being provided by the CSU. There was
disagreement regarding where this service would be best located, as one participant believed that such a
service would be better located within the CCG (P05).
The region’s Quality Observatory appears to replace a skills deficit in the organisation by providing a service
that supports interpretation of routine data (P05). The success of this relationship is attributed to the
transactional nature of the relationship ‘because we are paying them directly’. A second element may be
the personal relationships between individuals in each organisation and a memory. Strong links between
researchers (or in this case professional bodies) are important in changing practice: ‘I feel very strongly that
you go back to the people that come up with the goods’ (P05). A similar picture is built around public
health where the history of individuals from public health working with the CCG is strong due to the
quality of previous work.
Question generation: one of the challenges with seeking evidence relates to defining questions. This is
especially problematic for services that address the needs of complex populations, for example, community
services. This complexity was referred to as a ‘jigsaw’ with multiple pieces to put together (P06). The
interaction with the evidence briefing service (PW) in this arm of the service did not fully address this
problem during the intervention period:
. . . we came up with a list of areas that we thought might be useful to have a bit of evidence base to,
and had that conversation with Paul and then sent an e-mail. He, I think prior to that he sent me
information about areas that he’d, other areas he’d been doing work for and what might be useful to
reinventing the wheel and things.
P06
However, because the service was also working with local CCGs, some of the topics were similar and
meant that the same questions could be asked: ‘the list that he came back with what the work he’d
been doing on wasn’t a million miles away from what people asked internally to what they’d like some
information on’ (P06). The availability of the service did enable individual clinical leads to present questions
that would be useful to current commissioning topics. The process of comparing the CCG’s list of questions
with those being prepared by the evidence briefing service seems to have been useful in part because PW
had an understanding of the work going on across the region. Furthermore, early negotiation of questions
with PW was useful:
I think it was a little bit puzzled about how high level the search was going to be, i.e. urgent care versus
75-year-old antibiotics at home, that; so I was, so I was a little bit unsure about the scope of the sort of
evidence coming back and things. I mean ‘cos [sic] if we went off and went as a search on urgent care or
that sort of stuff versus give me a search on telephone triage in general practice, I think that; so I didn’t
really know where to start on that point, I knew; and when I was chatting with Paul he was like, ‘Well
really there’s some areas that are quite broad, some areas that can be quite specific, and if you’ve got any
key questions just get people to ask the key questions, or if there’s big areas you want to focus on like
frailty, things like that, put them down as well’. So that was a bit of a mixture I think that we put down.
P06
Other aspects of linkage and exchange presented greater challenges for this
Clinical Commissioning Group
Dissemination of briefings
This appears to have been a relatively weak area in the CCG compared with the A1 CCG. Dissemination of
briefings took place in meetings and via e-mail, but there is no evidence of if or how this information was
integrated into decision-making. This was in part attributed to busy workloads (P06). The CCG did send
the briefings to interested people externally, such as providers (P06).
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Forging new connections
Apart from the evidence briefing service and other than named individuals in public health, there is a lack
of knowledge about who commissioners should contact to provide research evidence to answer questions:
‘I struggle a bit with knowing who to contact’ (P06).
One-to-one encounter
One participant would have preferred more one-to-one or teleconference contact with the service in order
to improve the transfer of knowledge:
I think when you start with the high-level list, and sometimes you want to drill down a little bit into
more specific questions, I think that probably came out of one of these; you might say, well that’s an
area but actually I’d like to do a bit of a wider search on that specifically. So that would have been
useful to do, and I could have done that through e-mail and things, but sometimes if you have more
set meetings knowing that you’re probably more that your ad hoc asking a question to someone and
you, but you know that you could ask a question and this is the way we do it and, on a monthly basis/
6-weekly basis, and I think we probably would have getting more out of it . . . I always knew I could
probably ask further questions and things but very, but very loosely; I think it was just, just there
wasn’t any sort of real structure around it so time just passed.
P06
Development of positive relations
There is further work to be done to develop the relationship between the CCG and CSU as a source of
research information.
Regional network
An ideal ‘business intelligence’ service would be a collaborative service that cuts across multiple
organisations in the region such as the local authority.
There is slightly more evidence of a ‘user pull’ movement to draw research into the organisation rather
than a response to a ‘push’ from outside the organisation. However, the degree to which research-
obtained evidence is drawn into the CCG is limited.
Pull
The executive team seeks information from public health colleagues when they feel there is evidence
lacking. This suggests a pull of research knowledge from decision-makers; however, this process appears
to be aided by working closely together. In some cases the catalyst for this evidence briefing service is the
need to answer a specific research question (as in the case of evidence around orthopaedic interventions
during the review of the low-value interventions policy). In other cases, when the policy question is more
generalised (such as reconfiguration of GP services), information is sought differently.
Push
There is a push of evidence from national bodies such as the Commissioning for Value packs; however, there
is a perceived need for this to be more relevant for commissioners as they currently lack meaningful data.
Evidence briefing service
Given the ambiguity of evidence described above, some participants sought a service that could categorise
interventions in a simple format:
. . . what I’d love to be able to do, ‘cos there’s no point in anybody’s time being wasted reinventing
the wheel, I’d like people to come up and say, you know, this is a list of things; there’s three
categories in this list, those for which there’s absolutely no input, no benefit, and probably some
harm, those where it’s dubious and those where it’s even more, it’s less dubious but if you’re going to
have to put; it’s informed data.
P05
DOI: 10.3310/hsdr05050 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 5
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
77
This reflects the process applied to the low-value interventions briefings work that applied a red–amber–green
system to the selected clinical interventions (see Uptake and use of evidence in meso-level commissioning).
Participants also described a need for time in which to engage with the service in order to generate
appropriate questions and to understand what is needed in order for them to be answered. However,
there remains a transactional dimension to the relationship:
Subcontracting is better, ‘cos [sic] (a) it makes me smarter about the questions I want to ask, ‘cos [sic]
it’s going to cost me as soon as I walk into a room with somebody; it’s like being, it’s like going and
having a discussion with a lawyer, you don’t go in and have a nice chat, you go in with a list of things
that you’ve thought out in advance. So yes, it makes me smarter (b) it’s a better use of public purse,
and (c) because of my background, or, or whoever’s going to this conversation isn’t necessarily going
to be the same as the other person, the sparking between, in, in the discussion is actually going to
generate so that the sum is more than the, sorry, the product is more than the sum . . .
P05
Feedback
Although awareness of the service and the briefings was mixed, reflecting the degree of dialogue between
individuals and PW, the Medical Director did recognise briefings when prompted.
Participants provided positive feedback on the format and brevity. The format was considered helpful even
to those with research skills (P06) and, as a snapshot of the evidence on an area, the briefings are good
and reader-friendly and there was an assumption that the work has been thorough. The briefings were
considered useful despite indicating a lack of evidence as they enable decision-makers to identify other
criteria on which to base their decision:
We commissioned and received some briefings and I think they were, you know, they were high
quality and the GP in A&E [(accident and emergency)] one because it’s so complicated I don’t think it
unlocked the decision for us but it informed our thinking so I would struggle to say that I saw a
briefing that disappointed me.
P08
Even the absence of available evidence identified in briefings informed decision-making because the CCG
was forced to seek other types of information:
Well it helped us know that whatever decision we made was unlikely to be universally supported by
the evidence and therefore we had to use other criteria really in making decisions whether or not we
would invest in that as a model. Although there is an absence of evidence – in cases like social
prescribing they talk about ‘generating evidence’ and seeing what works.
P08
Evidence from the briefing service was used in the commissioning of low-value interventions to confirm
CCG intentions but there was no discussion of how it would have proceeded if the evidence contradicted
its preferences.
The evidence briefing service may fill a gap that the CSU and other regional sources cannot meet (P10).
A positive effect was also perceived on individuals’ use of evidence: working with the service helped one
participant (P10) to see the value in presenting evidence to the board. The evidence briefing service has
helped to make evidence a part of culture but it can be difficult to keep it in mind during decision-making.
In part, it was the relationship between individuals that supported this as the two-way dialogue between
PW and the service helped to identify what information would be of most value. It appears that briefings
generated some dialogue between key contacts but it was unclear if they have been more widely read and
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there was little discussion about content (P06). Low-value intervention commissioning was clearly cited as
the case in which the briefings have fed into decision-making:
The use of evidence is definitely higher profile . . . much more inclined to test out our assumptions and
our things that we want to do based on evidence that might be out there.
P19
Participants also expressed some negative feedback. There was a perceived lack of visibility of the service:
I thought it would be more visible. So I’ll not, you know, I’ll tell you that my guess is that we’re not
the high intervention is my guess because it was not something that came across my radar very much.
P08
At the highest level of the organisation there was an expectation of more from the service:
Well I imagine there might be some very direct work with us as a CCG in terms of perhaps, you know,
a governing body development session on the nature of evidence or how to use evidence or, you
know, some kind of developmental type seminar which maybe it was never ever going to be set up
to be.
P08
However, other participants had a clearer understanding of the objectives of the service: ‘I think it’s been
very, it was clear what you were able to give us’ (P10).
The ambiguity of research evidence was one challenge to its use and one participant described a service
that categorised interventions according to harms and benefits (P06). This approach suggests a desire for a
logical analysis of risks and benefits which is not currently present in the CCG’s decision-making models.
Summary
There is an intention to use evidence in decision-making and recognition that all decision-making should
be supported by a clear rationale.
However, in this CCG the many and varied pressures that influence decision-making were especially evident.
Stakeholder involvement is viewed as key during the early stages of commissioning, and consultation to
gather preferences from patients and the public was a formal part of service development. Providers also
played a role in the development of new service models.
Compared with other case sites, engagement with the evidence briefing service was low but there was an
increase in contact following the delivery of the post-intervention questionnaire.
Uptake and use of evidence in meso-level commissioning
This case study is of the development of a collaborative process involving all CCGs in the region to review
and consider the inclusion of a wider range of procedures on a regional VBCP list of low-value interventions.
The review cuts across all the study CCGs so the case study captures processes of joint policy-making and
the unique challenges that arise from this.70
Decision-making processes
The VBCP Implementation Group was developed via monthly meetings. The implementation working
group that designed and updated the policy includes representatives from all CCGs in the region but is
explicitly not a decision-making group. The policy is reviewed annually but is also viewed as a working
document that may require more regular sign-off from individual CCG boards. The distinction concerns the
nature of the changes proposed by PHCA and the Implementation Group: significant changes to criteria or
DOI: 10.3310/hsdr05050 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 5
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
79
additional interventions require ratification by CCG boards annually, whereas minor changes can be
approved by the Implementation Group. Board-level ratification is driven partly by the potentially
controversial nature of some decisions in the public eye.
This policy differs from others in our case studies because it is driven by current practice informing policy
wording and content: ‘moving policy in line with clinical practice’ (policy document) and ‘bringing wording
in line with decision precedents’ (policy document). In practice, there are a number of other influences.
Drivers
Drivers for low-value interventions policy development appeared more numerous and interlinked than for
other topics. Perhaps unsurprisingly, financial constraints were an important driver. This is apparent in
discussions in Implementation Group meetings (e.g. there is a focus on ‘big-ticket’ items that have the
potential to maximise cost savings) and the policy document. The joint decision-making context highlighted
the diversity of financial contexts of each CCG, for example, reducing spend was a particular driver for
Case Study B, which was demonstrated by the internal document produced to outline impending changes
to the policy in that CCG with cost as the context for the changes. This pressure also means that the
Implementation Group was keen that providers are not able to strongly influence decision-making as this
tends to increase CCG costs (9 July 2014 observations).
Second, meeting observations indicate a need for legal defensibility owing to the potential for judicial
review. This was openly stated by the PHCA but also indicated by members’ stressing the need for an audit
trail of their decisions, especially for those not signed off by individual CCG boards. In one board meeting
(at the A1 CCG) there was concern about public response to the policy and anxiety that decisions be
‘defensible’ and future proofed: for example, for an intervention such as in vitro fertilisation, economic
impact was considered but discussion focused on the legal and public implications of the decision. This
may explain why commissioners draw heavily on policies from other CCGs, because these provide the
strength in numbers that may make decisions robust (P03) and validate local activity. Internet searches
were used to identify IFR policies in other CCGs to see what interventions had been included by other
organisations before looking at the evidence for each intervention.
There is also a concern about implications for patient safety that drives a focus on evidence to support
policy-making. Although this has the potential to conflict with the drive to reduce costs, it is also used in
tandem with this; for example, in one board meeting the PHCA reiterated the focus on patient safety and
the release of money from areas of limited clinical benefit for use elsewhere.
In contrast with local commissioning on other topics, research evidence and NICE guidance were key drivers
in low-value commissioning both in the language used and the discussions in implementation and board
meetings (e.g. in the A1 CCG the rationale presented by the PHCA was evidence based and questions
presented by board members in the A2 CCG emphasised the evidence base). This is seemingly facilitated by
the clinical nature of the decisions being made and the greater availability of evidence in these areas. It is
also likely to be more important due to the potential legal implications highlighted elsewhere and helps to
protect against challenges from providers. Sources of evidence for legal justification are primarily existing
guidance: NICE was commonly referenced by board members. Although seemingly straightforward, this
driver is complex. For CCGs where the financial motivation for inclusion of an intervention in the policy is
especially strong, there was relief when, having retrospectively sought evidence, it found that it supported
their decisions. Observations of meetings suggested that the PHCA did recognise conflict between NHS
England (national evidence) and the CCG (local evidence). Evidence is welcomed if it matches the objectives
of the policy; for example, there was relief that the evidence briefing service review supported the decisions
that had already been made by the working group (P02).
At board level, evidence sometimes comes into conflict with values; in the A1 CCG there was much
discussion around the rationale for surgery being offered (quality of life vs. health reasons). Despite,
or perhaps because of, the local financial constraints, organisational values do play a part in the
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decision-making: with the low-value interventions policy the new interventions are seen as ‘the right thing
to do’ (P02). Some policy decisions, such as surrogacy, appear to be made on ‘moral’ grounds (PHCA). The
board in the A1 CCG was interested in the role of the CCG’s values – for example, patient quality of life
was raised several times. The PHCA made it clear that the policy should reflect the CCG’s values as it is an
expression of the CCG’s values.
Public health role in decision-making
The PHCA draws on information from clinical experts locally (including providers) and from clinical
networks nationally. The local treatment advisory group also provided some support but primarily around
low-number/high-cost treatments. The CSU provides administrative support but does not have the capacity
to provide analytical support.
Challenges of multiorganisational policy-making
Financial drivers, although influential in terms of policy-making, also demonstrate one of the challenges
of cross-organisational policy-making. It highlights the importance of local/organisational context on
decision-making as those CCGs with more acute financial constraints were more enthusiastic about the
inclusion of additional interventions in the policy, whereas those CCGs with fewer financial constraints
demonstrated less enthusiasm. Although this gave rise to some heated discussion, there was an understanding
that there needed to be a joint policy. As a result, the ‘better-off’ CCG members were less enthusiastic about
their implementation of the policy.
Regional commissioning involves navigating through multiple agendas, including those of different CCGs
(P02). This may mean that there is potential for conflict between organisational values. Joint decision-making
also presents the challenges of ensuring that the policy does not include a pathway that contradicts another
in the region, all the more so when there are multiple organisations to consider. The consensus in the board
meeting in the A1 CCG appeared to be that the public should be involved in decision-making on this topic
in the future and that decisions needed to be made jointly with other CCGs in order to cover themselves.
The policy is also perceived as creating a ‘technical solution to a cultural problem’ (P18), which is
problematic because this may be neglecting the real issues. That is, GPs already know the evidence about
the decisions; it is just not the culture to refer in this way.
The benefits of shared policy-making are the shared governance and safety nets that this provides
(9 September 2014 observations). National and regional commonality is a protection against legal
proceedings, as individual CCGs were reluctant to progress in isolation from other CCGs in the region.
On a practical level, multiorganisational working provides opportunities to test parts of policies within one
CCG before being rolled out elsewhere.
Summary
That the low-value interventions policy focuses on interventions rather than wider services leads to a
greater drive to seek evidence than for other policies. This is potentially strengthened by the need to
publicly justify reductions in referrals. The process of PW offering to critique interventions focused on push
rather than pull ‘without being asked’ (P02). However, in the absence of the evidence briefing service,
some commissioners suggested that they would have drawn on public health services (P02). Existing
relations between the PHCA and commissioners meant that there was an intention to seek evidence to
support low-value interventions decision-making and public health presence on the working group;
however, the evidence briefing service provided an additional push of evidence.
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Chapter 6 Discussion and conclusions
The Health and Social Care Act 20123 has mandated research use as a core consideration in healthservice commissioning arrangements. NHS commissioners are expected to use research to inform
commissioning and decommissioning of services, and there is a substantive evidence base on which they
can draw. Building on development work undertaken as part of the NIHR CLAHRC for Leeds, York and
Bradford and under the auspices of the CRD core contract with the NIHR, we sought to establish whether
or not having access to a responsive evidence briefing service would improve the uptake and use of
research evidence by NHS commissioners, compared with less intensive and less targeted alternatives.
We did this by undertaking a controlled comparative evaluation with CCGs in one defined geographical
area of North England.
Statement of principal findings
Over the course of the study the evidence briefing service addressed 24 topics raised by participating CCGs
(see Chapter 3). Requests for evidence briefings served different purposes. The majority of requests were
focused on options for the delivery and organisation of a range of services and possible interventions to
support the self-management of long-term conditions. Most of the requests could be categorised as
conceptual, not directly linked to discrete decisions or actions but often intended to gain knowledge and
awareness of possible options for future actions. Symbolic drivers of use of research (i.e. to justify or support
pre-existing intentions or actions) were less frequent and included a pre-existing decision to close a walk-in
centre and to lend weight to a major initiative to promote self-care already under way. Instrumental use was
linked to explicit disinvestment processes. There were no instances in which requests for evidence could be
viewed as representing an imposed use of research.
Our primary research question asked whether or not access to a demand-led evidence briefing service
would improve the uptake and use of research evidence by NHS commissioners, compared with less
intensive and less targeted alternatives. In terms of the primary outcome measure, the evidence briefing
service was not associated with increases in CCG capacity to acquire, assess, adapt and apply research
evidence to support decision-making.
Regardless of the intervention received, at baseline participating CCGs indicated that they lacked a
consistent approach to their research-seeking behaviours and their capacity to acquire research remained
the same at follow-up. At baseline, CCGs were non-committal (neither agreeing nor disagreeing) about
whether or not they had the capacity to assess the quality, reliability and applicability of research for use in
decision-making. This perception remained unchanged at follow-up. There was also no change between
baseline and follow-up on perceptions of CCGs’ capacity to adapt and summarise research results for use
in decision-making; there was neither agreement nor disagreement that CCGs had the capacity to do so.
Finally, individuals’ perceptions that their CCG did not have systems and processes in place to apply
research routinely also remained unchanged.
A secondary research question sought to establish whether or not contact between researchers and NHS
commissioners would increase use of research evidence. Exposure to the evidence briefing service did not
increase perceptions of the quality or quantity of contact between CCGs and researchers, nor did it
lead to perceived improvements in institutional (CCG) support for contact between commissioners and
researchers. Exposure did not increase perceptions that communication between CCGs and researchers
helped commissioners to achieve professional goals, nor did it increase what were already positive
perceptions of researchers in general.
Exposure to the evidence briefing service did not appear to have any impact on individuals’ intentions to
use research evidence in decision-making or their perceptions of a shift in collective CCG norms towards
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the use of research for decision-making. Regardless of intervention received, these measures were
positively orientated at baseline and were sustained at follow-up.
Our final secondary research question asked whether or not evidence briefings tailored to specific local
contexts could inform decision-making in other CCGs. Our ability to answer this question was undermined
by a lack of recorded documentary evidence of research use (a finding in itself) across participating sites.
With a few exceptions, most discussions between commissioners and the evidence briefing team were
informal and rarely involved minuted meetings or formal gatherings of CCG staff. This lack of a visible
audit trail or indeed for the onward distribution and cascade of generated outputs makes us dependent on
self-report and/or observed use for impact. Therefore, it is difficult to determine the extent to which the
evidence briefings produced had wider value across participating CCGs and in those outside the study.
Strengths and limitations
This quantitative component of the evaluation was in many ways the most challenging aspect of the study.
We were reliant on the quality of the sampling frames provided by (1) CCG cases themselves and
(2) nationally, in the form of contact data for each CCG. We found that information provided by CCGs,
and especially that sourced for the national benchmarking component of the study, was sometimes
inaccurate (spelling mistakes in e-mail addresses and surnames), incomplete (absent e-mail addresses or
contact numbers) or included individuals who no longer worked at a CCG. As such, each CCG had to be
contacted to obtain, check and recheck the contact details of staff provided. In a related limitation, we asked
individuals to complete the national survey on behalf of their CCG and in consultation with colleagues, but, in
a rapidly changing landscape, we cannot rule out the possibility that different individuals completed the survey
at baseline and follow-up.
The respective baseline and follow-up response rates of 68% and 44% are not unreasonable given the
number of competing requests for information CCGs are routinely faced with. For example, our response
rates compare favourably with annual surveys conducted by the Health Foundation and The King’s Fund
over the same time period,71,72 and with a contemporaneous Canadian randomised evaluation of the
effects of an evidence service on policy-makers’ use of research evidence that failed to recruit.37,73 However,
we acknowledge that we experienced considerable attrition in the percentage of participants in our study
who completed both baseline and follow-up surveys. In the study case sites the percentage of individuals
completing both surveys ranged from ≈60% for those receiving intervention A to ≈30% in the CCGs who
were allocated to receive intervention C, the non-responsive version of the service. As the turnover of staff
employed at participating CCGs was relatively stable over the course of the study, there may be a degree of
selection bias apparent in our study.
We utilised an 87-item questionnaire to collect data relevant to the primary outcome and, although all
responses were on short scales (none required any written responses), piloting estimated that it would
take participants up to 45 minutes to complete. We employed a range of factors to increase the odds
of response including pre-notification, follow-up contact, online and postal formats, reminder copies,
mention of an obligation to respond and university sponsorship.74 However, we are aware that both
shorter questionnaires and financial incentives are also associated with increased response rates.74 In this
instance, it may be that the perceived return for time invested of access to a funded evidence briefing
service either immediately or after the intervention phase was complete (the offer made to participants in
the ‘control’ standard service intervention C) was deemed inadequate compensation by some participants.
The CCGs allocated to intervention C had expressed initial enthusiasm for participation. However, the lack
of any immediate return from, or a sufficient relationship with, the evidence briefing service over the
course of the study may go some way to explaining why CCGs allocated to the ‘control’ intervention C
had the lowest response rate.
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Survey length may also have contributed to the lack of completeness in the data collected. This lack of
completeness necessitated the use of multiple imputation to strengthen analysis.45,46 In line with best
practice in multiple imputation, comparison with the non-imputed data revealed similar means
and distributions.
Taken together, these limitations mean that we have been cautious in our interpretation of any apparent
impact of the evidence briefing service on the primary outcome measures. Indeed, we have been careful to
avoid the pitfalls of p-values in assessing whether this study provides evidence ‘for’ or ‘against’ rejection
of the null hypothesis.62 Although the statistical tests applied have generated some apparent statistical
differences, beyond those that we would have expected to see by chance, our approach to interpretation
has, we think, injected appropriate caution in interpreting the real-world significance of what was
observed. Although not explicitly stated in the original protocol, it would be reasonable to consider a shift
of at least one point on any Likert scale as indicative of impact. So although, for example, we observed a
statistically significant decline in attitudes towards research use at follow-up, the magnitude of this shift
(no shift on the scale) is unlikely to be behaviourally significant. The benchmark of a national sample of
non-intervention CCGs also helps assess the theoretical significance of what was observed. The fact that
CCGs receiving the ‘control’ standard service intervention C and the national benchmarking sample have
all ‘improved’ (capacity) suggests a degree of maturation and perhaps something of a ‘rising tide’75
phenomenon at play. In other words, a CCG may be making negligible gains in capacity as it becomes
more established over time.
An original aim was to employ documentary analysis to identify and understand the ways in which
briefings generated by the service were taken up and considered in the decision-making processes of each
participating CCG. Our development work undertaken as part of the NIHR CLAHRC for Leeds, York and
Bradford (admittedly with PCTs) had suggested that this would be a feasible approach to take. However,
early analysis undertaken to trace evidence briefings generated in the intervention phase revealed, with
few exceptions, a lack of recorded evidence of use. Most discussions between contacts in CCGs and the
evidence briefing team were informal and rarely involved minuted meetings or formal gatherings of CCG
staff. Indeed, we were often responding to requests from one, two or three named individuals who
would be leading a piece of work or clinical area on behalf of the CCG as a whole. As such, analysis of
records supporting the more formal executive and governing body meetings provided little information
about sources used or about the decision-making process itself. The ‘unseen and informal spaces’76 of
decision-making processes, the small numbers of staff involved and the reality that no audit trail existed
for sources used during these processes meant that there was little or no ‘traceability’77 of use of evidence
briefings at an organisational level. A similar lack of traceability exists for the dissemination of evidence
briefings to other participating CCGs. We know when and to whom content was distributed, but are
reliant on self-report and so we know little of what happened or how content was used (if at all) thereafter.
Our experience aligns well with others who have faced similar challenges in identifying whether or not
systematic reviews are used and the extent to which they add value to decision-making processes in
public health.77
Delivery of the evidence briefing service
In this study, we sought to make best use of outputs from the NIHR Systematic Reviews Programme and
specifically those in relation to the CRD’s core work programme. The CRD core funding supported the
provision of the DARE, NHS EED, and HTA and PROSPERO databases. As mentioned in Chapter 3, NIHR
funding for the CRD’s core work programme ceased during the course of the study and with it so did the
availability of a continuously updated single source for systematic reviews and economic evaluations. The
ability to acquire and assess research-based knowledge of this type can be a significant undertaking and
although systematic reviews continue to be indexed on a variety of database platforms, no such resource
now exists for economic evaluations. Although the evidence briefing team were able to utilise existing CRD
search and retrieval capacity to ensure the delivery of study commitments, the lack of a continuously
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updated single resource to draw on does have funding implications for future service provision of this type.
It is worth noting that not all questions could be addressed through existing systematic reviews. A feature
of many of the outputs produced was an absence of synthesised evidence; this was particularly the case
for those that focused on summarising evidence for proposed new models of care. As such, search and
retrieval activity was actually greater for topics where we sought to establish ‘known unknowns’ than for
those topics with a larger and already synthesised evidence base.
When we conceived the evidence briefing service, the evidence-informed rationale was that addressing
real decisions or problems in collaboration with those directly affected should mean that research evidence
was more likely to be used and inform decision-making. Then, in the NIHR CLAHRC for Leeds, York and
Bradford, the service was an adjunct to a larger implementation programme of research. In this study, the
evidence briefing service as constituted represented a resource-intensive intervention. From the outset, we
sought to add insight as to how much added value the service would offer over alternative or more basic
approaches. Although no costs associated with searching, information support and document retrieval or
with publication and dissemination of the evidence briefings were included in the study application,
1.5 full-time equivalent experienced researchers and a significant proportion of the principal investigator’s
time were committed to its delivery. There was sustained engagement with the service by individuals in the
CCGs receiving intervention A and because we employed a degree of flexibility in the service delivered
(employing a combination of full evidence briefings and shorter more exploratory evidence notes in
response to questions raised) we were able to deliver a number of outputs beyond the estimate made in
our original application. However, the nature of requests we received were largely conceptual and the
impact of evidence briefings on more explicit instrumental decision-making processes was limited.
Although we recognise that conceptual use of research is an entirely appropriate and necessary goal in
itself, we question whether or not supporting conceptual use represents a sufficient level of impact to
justify a resource-intensive intervention of this type.
Reflections on delivery
It has long been understood that real-world decision-making reflects a complex interaction between
economic, political and social factors, different sources of knowledge (of which research evidence is one)
and the beliefs and ideologies of those making the decisions.10,11,78 This study has provided further insight
as to how and where services packaging evidence derived from systematic reviews may most efficiently be
deployed to impact on decision-making processes in a commissioning context.
Work undertaken to support decisions around the inclusion of 14 MSK procedures designated as low value
into a regional list of interventions that CCGs will not normally fund had the most traceable impact on
decision-making. Participating CCGs appeared to value the transparency that the evidence briefing service
brought to the process. The existing regional value-based policy list predated the creation of CCGs but the
process for assessing the evidence for new policies did not appear to have been transferred into the new
system. Indeed, the proposed MSK polices had been compiled by one CCG using a ‘copy, paste and
adapt’48 approach from existing policies identified at other CCGs across the country. This led other group
members to question their provenance. The offer to undertake an independent and systematic appraisal
of the evidence assisted the collective deliberation process, not least by providing reassurance to the
representatives of the other CCGs.
Although our intention was that the evidence briefing activity was demand led, there is a consistent
message from CCG informants that they would have valued more of the systematic and transparent push
approach employed in the low-value work to identify interventions and ways of working that should be
funded or not funded. However, we also need to recognise that the nature of decision-making and the
processes employed in the context of these low-value policies was very different to those experienced
elsewhere in the study. The low-value policy work represented a meso (regional)-level process with CCGs
coming together to make decisions collectively. This process had a clear objective, namely to establish clear
DISCUSSION AND CONCLUSIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
86
region-wide policies across CCGs relating to interventions of no or low clinical benefit; a process that
needed to be both transparent and defendable. Further clarification on how best to identify and support
this type of meso-level commissioning activity may be warranted.
Most other requests from CCGs could be categorised as conceptual, that is, not directly linked to discrete
decisions or actions, but intended to provide knowledge and awareness of possible options. The issues
raised were iterative and evolving in nature without obvious end points or decisions,79 and our role provided
knowledge and awareness of possible options for future actions. This is perhaps best exemplified by the
work undertaken around interventions to support the implementation of self-management. Our experience
mirrored earlier accounts describing commissioning services for people with long-term conditions as a long
drawn-out process.80 The process of producing the series of related briefings involved a range of discussions
and activities with a range of individuals and stakeholders both within and outside the CCG. The time and
effort involved appeared to be disproportionate to the likely impact on the local commissioning decisions
we sought to support. Even after the intervention phase was complete, deliberations on how best to act
were still ongoing and needed additional input from a trusted local source (a senior member of the local
public health team) to summarise and contextualise the already summarised information. It is likely that
many of the self-management issues that we were asked to address would have been salient and relevant
to CCGs in other settings across the country. And it could be argued that this would apply to most of the
briefings produced as part of this study. Passive dissemination of the social prescribing briefing has generated
considerable interest from CCGs and Health and Wellbeing Boards outside the study. Given the absence of
evidence of effect, further advice on how to evaluate has been sought from those either currently providing
or considering introducing social prescribing programmes.
Given the large resource requirement and the particularity of process and unpredictable timing of
decision-making in individual commissioning organisations, it may be better to invest far more in identifying
commissioning priorities and uncertainties from key informants with local credibility. These could then be
serviced by a centralised evidence synthesis service and less costly targeted dissemination strategies could
be used to raise awareness among what appear to be receptive commissioning audiences’ options or
actions in key audiences. The cases examined here suggest that this would include those members of local
public health teams supporting CCGs. Targeted dissemination (similar to the approaches the CRD previously
employed with the Effective Health Care and Effectiveness Matters series of bulletins) could deliver similar
impacts.15,81 Indeed, passive dissemination of the social prescribing briefing has generated considerable
interest from CCGs and Health and Wellbeing Boards outside the study and the evidence briefing team
have been asked for further advice on a number of these decision-making processes. Taken together, this
may suggest that resource-intensive approaches to providing evidence are best employed to support
instrumental decisions occurring at a meso level where impact is likely to be proportionately greater. This
would also be consistent with informants’ requests for more ‘supply-side’ push (researcher-led distribution
of research) alongside the demand-led (pull) access they received. The potential for impact from the
targeting of tailored messages and topics at specific audiences may be of interest to the NIHR Dissemination
Centre and merits further investigation.
Implications for research use
If meso-level activity may represent the best focus for resource-intensive services, we still need to consider
how to systematise research use among individual CCGs. The Supporting Policy In health with Research:
an Intervention Trial (SPIRIT) Action Framework (published after the intervention phase of this study was
completed) hypothesises that a catalyst is required for the use of research, the response to which is
determined by the capacity of the organisation to engage with available research.82 Where there is
sufficient capacity (the value placed on research, the tools and systems the organisation has to support
research engagement; and the skills and knowledge of staff), a series of research engagement actions
might occur that facilitate research use. The SPIRIT Action Framework82 predicts that the greater the
organisational capacity, the more research engagement actions (accessing and appraising research,
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generating new research and interacting with researchers) will occur, which will in turn result in a greater
use of research evidence.
Using the SPIRIT Action Framework to reflect on this study, we had catalysts and engagement opportunities
(around the questions raised and the briefings produced), but the service as constituted did little to enhance
the capacity of the organisation to use research routinely. Both baseline and follow-up data suggest that
commissioners are well intentioned ad hoc users of research evidence and that they work in a setting where
there is a lack of systems and processes to do this routinely. CCG informants also indicated the potential
for confirmation bias in their evidence-seeking behaviours and the challenges of being confronted with an
absence of reliable evidence for policies or options that they were pursuing. This suggests a knowledge and
skills gap that this study has not addressed. The evidence briefing team offered training on how to acquire,
assess, adapt and apply evidence to CCGs receiving intervention A or intervention B (which could have
addressed these knowledge and skills gaps), but this offer was not taken up. Rather than making training
a demand-led ‘offer’ it may have been better to identify the capacity for research use of each CCG at the
outset, and develop a corresponding offer to each organisation that included training relevant to their current
state. At the very least, this study has highlighted the importance of building organisational capacity as a
component of evidence use, an area that appears to be under-researched.83 SPIRIT is informing an ongoing
evaluation of a multifaceted programme to build organisational capacity for the use of research evidence in
policy and programme development in Australia.84 Findings from this will help shed light on the value of the
Framework to develop and test other interventions to build organisational capacity to use research.
Public health specialists have traditionally supported and facilitated the use of research evidence in a
commissioning context.19,20,48 Throughout this study we observed that despite its relocation, the public
health specialist remained accessed and engaged with by CCGs despite being no longer central to
decision-making processes. Some senior staff in participating CCGs had much prior experience of support
from public health teams under previous commissioning arrangements. As the interventions followed soon
after the preceding arrangements had ceased, it is perhaps no surprise that the CCG commissioning staff
made use of the service offered by the CRD. Nevertheless, all the CCGs continued to place value on the
knowledge and expertise of trusted ‘critical friends’85 in the shape of public health consultants. They
provided a bridge between the old and new commissioning arrangements and brought valuable insights
and networks from beyond the boundaries of the CCG. Although we often observed commissioners
looking out and undertaking fact-finding trips to see what other CCGs around the country were doing,
the same individuals were often unaware that colleagues in adjacent areas were undertaking similar work
or grappling with similar questions. Public health specialists were the individuals viewed as most likely to fill
this local knowledge gap and to mitigate against a general dissatisfaction with the knowledge-sharing
capabilities of the formal commissioning support arrangements. Whether fair or otherwise, there was a
general perception among CCG informants that the CSU lacked the necessary infrastructure and/or
expertise to efficiently acquire, assess and adapt research for use in decision-making. The one-to-one
transactional arrangements the CSU had with CCGs were themselves viewed as a barrier to wider
knowledge sharing across the region. This danger of ‘network closure’ undermining local knowledge
sharing and historically trusted relationships has been anticipated previously.86
Wye et al.48 have argued that researchers need to build relationships and engage with commissioners
locally using commissioners’ preferred methods of conversations and stories, to find out what is wanted
and how best to deliver it. In this study we had fewer face-to-face engagement opportunities than
originally anticipated; this was despite case informants indicating that they would have liked more. We
consistently offered to discuss priority areas and the key messages and implications arising from evidence
briefings face to face, but in many instances participants found it easier to have a quick telephone or
e-mail discussion with the CRD team. Our geographical distance from the intervention sites may have
influenced the mode of interaction and communication, and in turn reduced the type of contact perhaps
necessary to facilitate an increased use of research evidence on the part of commissioners. Although we
do not discourage the cultivation of face-to-face relationships, the reality of the decision-making process is
that any engagement is resource intensive and so researchers need to carefully consider how best to target
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those interactions that will deliver the best return. Even with proximity, somebody needs to be around or
‘in the room’ when ideas first germinate, to spot the potential catalysts to research use and to question
what is the evidence for this? Why do we want to pursue this course of action? Given this, Wye et al.’s48
suggestion that researchers cultivate relationships with local public health teams could represent the
intermediary channel through which use of research by individual CCGs can be influenced. Public health
staff are more likely to be ‘in the room’ and have the necessary skills and local networks to facilitate
knowledge sharing within and across the commissioning landscape. The current emphasis on innovation
and the development of new models of health and social care is favouring coproduction approaches to the
design, commissioning and delivery of services. This shift may strengthen the intermediary role of public
health. But, if this intermediary role is to be sustained, public health specialists will need to be supported
and resourced to return to playing a more central role in commissioning.
Alongside capacity building and engagement, macro-level intervention is also needed to enhance research
use at the level of the individual CCG. The Health and Social Care Act3 mandates CCGs in the exercise of
their functions, to promote innovation in the provision of health services, promote integration and to make
use (in the health service) of evidence obtained from research. Infrastructure to support the statutory duty
to drive innovation at scale is under way. Fifty ‘vanguard’ sites are supported by a £200M transformation
fund from NHS England. A similar commitment of significant resources has also been made via the
Better Care Fund and the Prime Minister’s Challenge Fund; providing further impetus to innovation
and integration between health and social care. However, whereas the current policy climate explicitly
incentivises innovation and integration, there is no equivalent incentive for finding and applying research
to support the many decisions required to turn this vision into a reality. The CCG Assurance Framework87
focuses on leadership, financial and performance management, planning and delegated functions, but
contains no specific metrics on whether or not CCGs are fulfilling their statutory duties in respect of use of
evidence obtained from research.
During the course of this study we were given the opportunity to suggest wording to sharpen that existing
in the CCG Assurance Framework87 on the use of evidence derived from research. We suggested the
wording ‘each CCG must, in the exercise of its functions, demonstrate the ability to acquire, assess,
adapt and apply evidence obtained from research in health-service decision-making.’ This has now been
incorporated into appendix 2 of the Assurance Framework operating manual.87 However, whereas it is
stipulated that CCGs must have a plan in place to address their duties in relation to promoting and
supporting the conduct of research, there are no similar explicit requirements relating to the use of
evidence obtained from research. If we are serious about shifting CCGs from being well intentioned but
inconsistent users of research evidence, then a more explicit set of requirements may be necessary. Ideally,
the incentive structure that exists for health-service innovation and integration may need to be replicated
to support CCGs’ fulfilment of their statutory duties in respect of use of research under the Health and
Social Care Act 2012.3 Without this, the current ad hoc engagement with research is likely to remain.
In the current financial climate, disinvestment decisions relating to interventions of no or low clinical value
are likely to remain high on the commissioning agenda. In this study, we witnessed the development of
collaborative processes for considering disinvestment at the local level. A lack of organisational memory
about the processes previously in place with earlier commissioning arrangements was also apparent.
Despite this, practical challenges in identifying and contextualising research evidence to inform these
processes remain.55 Unlike the rigorous processes in place to inform the NICE guidance on the use of new
and existing medicines, no similarly resourced infrastructure exists to support disinvestment decisions.7
Although NICE makes ‘do not do’ recommendations publicly available, we found low awareness of these
among commissioners and a notable lack of skills to systematically and transparently identify other relevant
evidence that could inform disinvestment decisions. The NIHR already funds infrastructure with the skills
necessary to support disinvestment activity at a local level. This includes the NIHR CLAHRCs, rapid evidence
centres and HTA groups. More proactive and targeted dissemination of low-value recommendations
combined where necessary with synthesis using standardised methods could enhance the ability of local
commissioners to identify and then generate local policies on interventions of no or low clinical benefit.
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Recommendations for research
We are conscious that our findings relate to a specific decision-making context and setting and have been
generated at a time when the commissioning arrangements are rapidly evolving. Given this, further
comparative evaluation and clarification of the role and value of similar demand-led evidence briefing
services in other contexts and settings may be warranted. The SPIRIT Action Framework may provide a
guide on which the evaluation of any future services seeking to increase the use of research in policy can
be based.
Our study has revealed commissioners to be well intentioned but lacking the necessary skills and
infrastructure to make use of research evidence routinely. Further research is required on the effects of
interventions and strategies to build individual and organisational capacity to use research. Exploration and
clarification of the potential for macro-level intervention to incentivise research use is also warranted.
Disinvestment decisions relating to interventions of no or low clinical value remain high on the
commissioning agenda. No established process appears to be in place for assessing research evidence to
inform the generation of local policies. Rather than have local settings developing their own distinct
approaches it would seem sensible if a country-wide approach was taken to identify and then summarise
the evidence for interventions of no or low clinical value. Methodological research is therefore required to
establish an optimal, transparent and standardised approach that identifies and contextualises research
evidence that can then be used to inform local decision-making processes.
Our study suggests that resource-intensive approaches to providing evidence may best be employed to
support instrumental decision-making at a meso level. Otherwise, less resource-intensive approaches to
delivering optimally packaged systematic review-derived findings should be pursued. We know that passive
dissemination can represent better value in some contexts and settings, particularly when there is a single
clear message and/or when the topic is known to align with known commissioning priorities and or
uncertainties. Many research agencies fund or undertake engagement activities and have invested in a
range of communication channels. How best to harness ‘supply-side’ infrastructure to deliver effective
targeted communications remains unclear. As such, there is considerable scope for comparative evaluation
of the impact of different active and targeted dissemination strategies on the uptake and use of research
by commissioners and other key stakeholders.
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Appendix 1 Survey instrument for Clinical
Commissioning Group case sites
Clinical Commissioning Groups’ use of 
Research Evidence 
 
We are exploring the use of research evidence by Clinical Commissioning Groups.   
You are being asked to participate because you are a member of a Clinical 
Commissioning Group that has agreed to be part of this research study.  We want 
your perspective on your organisation’s decision-making processes. 
 
We appreciate that you have many demands on your time but it is important that as 
many CCG members as possible complete and return the questionnaire.   There are 
four sections in this questionnaire.  Each section does not need to be completed 
in one sitting so please feel free to complete each section individually at your 
convenience.  However, it is important that all four sections are completed in full in 
order for your data to be useful.  All responses are on short scales, none require any 
written responses.  
 
If you are ready to go, read and (if you agree), tick the two consent boxes below.  
Return the questionnaire to the research team at the University of York using the pre-
paid envelope provided.    
 
 
 
I have read and understood the information sheet provided 
 
 
 
I understand that by completing and returning this questionnaire I 
am giving my permission for the data I provide to be analysed and 
reported by the research team at the University of York 
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Section 1 Organisational Capacity for Using Research Evidence  
This first section is interested in the way in which you think your Clinical 
Commissioning Group uses research evidence.  Please respond to each question by 
circling the single number that most closely fits your view.   Please note the scales 
differ between each set of questions.   
Questions 1-5 
 
 Strongl
y 
disagre
e 
Disagre
e 
Neither 
agree 
nor 
disagre
e 
Agree Strongl
y agree  
We have skilled research staff.  1 2 3 4 5 
We have arrangements with external 
experts who search for research, monitor 
research, or do research for us.  
1 2 3 4 5 
Our staff have...      
...enough time for research. 1 2 3 4 5 
... the incentive to do research (it is used in 
our              decision-making). 
1 2 3 4 5 
... the resources to do research. 1 2 3 4 5 
      
 
6-8   We look for research in... 
 
 
Don’t do 
Do 
poorly 
Do 
inconsisten
tly 
Do with 
some 
consisten
cy 
Do well 
...journals (that is by subscription, 
internet, or library access). 
1 2 3 4 5 
...non-journal reports by library, 
internet access, or direct mailing from 
organisations such as the Department of 
Health or King’s Fund. 
1 2 3 4 5 
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... databases by subscription or Internet 
access, such as the Cochrane 
Collaboration, DARE, and citation 
indices (PUBMED). 
1 2 3 4 5 
 
9-12 
 
 
Don’t do 
Do 
poorly 
Do 
inconsistentl
y 
Do with 
some 
consisten
cy 
Do well 
We look for information on web sites 
(that collate and/or evaluate sources) 
such as Clinical Evidence.  
1 2 3 4 5 
We work with researchers through 
formal and informal networking 
meetings with our staff. 
1 2 3 4 5 
We get involved with researchers as 
a host, decision-maker partner, or 
sponsor. 
1 2 3 4 5 
We learn from peers through informal 
and formal networks to exchange 
ideas, experiences, and best practices.  
1 2 3 4 5 
 
13-15    Our staff... 
 
 Strongly 
disagree 
Disagre
e 
Neither 
agree 
nor 
disagre
e 
Agree Strongly 
agree  
... have critical appraisal skills and tools 
for evaluating the quality of methodology 
used in research. 
1 2 3 4 5 
... have the critical appraisal skills to 
evaluate the reliability of specific research 
by identifying related evidence and 
1 2 3 4 5 
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comparing methods and results. 
... can relate research to our organisation 
and point out similarities and differences. 
1 2 3 4 5 
 
16-17 Our CCG has arrangements with external experts... 
 Strongly 
disagree 
Disagre
e 
Neither 
agree 
nor 
disagre
e 
Agree Strongly 
agree  
... who use critical appraisal skills and 
tools to assess methodology and evidence 
reliability, and to compare methods and 
results. 
1 2 3 4 5 
... to identify the relevant similarities and 
differences between what we do and what 
the research says. 
1 2 3 4 5 
 
18-21   Our CCG has enough skilled staff with time, incentives, and resources 
who use research communication skills to... 
 Strongly 
disagree 
Disagre
e 
Neither 
agree 
nor 
disagre
e 
Agree Strongly 
agree  
... present research results concisely and 
in accessible language. 
1 2 3 4 5 
... synthesize all relevant research, along 
with information and analysis from other 
sources. 
1 2 3 4 5 
... link research results to key issues 
facing our decision makers. 
1 2 3 4 5 
... provide recommended actions to our 
decision makers.  
1 2 3 4 5 
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22-25 Our CCG has arrangements with external experts who use research 
communication skills to... 
 Strongly 
disagree 
Disagre
e 
Neither 
agree 
nor 
disagre
e 
Agree Strongly 
agree  
... present research results concisely and 
in accessible language. 
1 2 3 4 5 
... synthesize all relevant research, along 
with information and analyses from other 
sources. 
1 2 3 4 5 
... link research results to key issues 
facing our decision makers. 
1 2 3 4 5 
...provide recommended actions to our 
decision makers. 
1 2 3 4 5 
 
26-32 
 Strongl
y 
disagr
ee 
Disagree 
 
Neither 
agree 
nor 
disagr
ee 
Agre
e 
Strongl
y agree  
 
Using research is a priority in our CCG. 
1 2 3 4 5 
Our CCG has committed resources to ensure 
research is accessed, adapted, and applied in 
making decisions. 
1 2 3 4 5 
Our CCG ensures staff are involved in 
discussions on how research evidence relates to 
our main goals. 
1 2 3 4 5 
The management of our CCG has clearly 
communicated our strategy and priorities so that 
those creating or monitoring research know what is 
needed in support of our goals. 
1 2 3 4 5 
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We communicate internally in a way that ensures 
there is information exchanged across the entire 
organisation.  
1 2 3 4 5 
Our corporate culture values and rewards 
flexibility, change, and continuous quality 
improvement with resources to support these 
values.  
1 2 3 4 5 
When we make major decisions, we usually allow 
enough time to identify researchable questions and 
create/obtain, analyse, and consider research 
results and other evidence.  
1 2 3 4 5 
 
Questions 33-40 
 
 Strongl
y 
disagr
ee 
Disagree 
Neither 
agree 
nor 
disagr
ee 
Agre
e 
Strongl
y agree 
The CCG management team evaluates the 
feasibility of each option, including potential impact 
across the organisation as well as on clients, 
partners and other stakeholders.  
1 2 3 4 5 
Decision-makers in the CCG give formal 
consideration to any recommendations from staff 
who have developed or identified high-quality and 
relevant research. 
1 2 3 4 5 
Staff who have provided evidence and analysis 
usually participate in decision-making 
discussions. 
1 2 3 4 5 
Relevant on-staff researchers are made part of 
decision-making discussions. 
1 2 3 4 5 
 
Staff and appropriate stakeholders... 
     
... know when and how major decisions will be 
made.  
1 2 3 4 5 
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... contribute evidence and know how that 
information will be used.  
1 2 3 4 5 
... receive feedback on decisions, with a rationale 
for the decision. 
1 2 3 4 5 
... are informed of how available evidence 
influenced the choices that were made in our CCG   
1 2 3 4 5 
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Section 2 You and Research Evidence 
 
This section focuses on your own, personal, use of research evidence.  For each 
statement, please tick the one box that mirrors your view. Please be as honest as 
possible. 
  
Questions 41-43 Strongly 
disagree 
Disagre
e 
Somewha
t 
disagree 
Neither 
agree 
nor 
disagree 
Somewha
t 
agree 
Agree Strongl
y agree 
 
I expect to use research evidence to help 
think through what I will say or contribute 
to a CCG policy meeting. 
       
I want to use research evidence to help 
think through what I will say or contribute 
to a CCG policy meeting. 
       
I intend to use research evidence to help 
think through what I will say or contribute 
to a CCG policy meeting. 
       
 
44-47   Using research evidence to help think through what I will say or contribute to 
a CCG policy meeting is... 
 
Very 
harmful 
Moderately 
harmful 
Slightly 
harmful 
Neutral Slightly 
beneficial 
Moderately 
beneficial 
Very 
beneficial 
       
Very bad Moderately 
bad 
Slightly 
bad 
Neutral Slightly 
good 
Moderately 
good 
Very 
good 
       
Very 
unpleasant 
(for me) 
Moderately 
unpleasant 
(for me) 
Slightly 
unpleasant 
(for me) 
Neutral Slightly 
pleasant 
(for me) 
Moderately 
pleasant 
(for me) 
Very 
pleasant 
(for me) 
       
Very 
unhelpful 
Moderately 
unhelpful 
Slightly 
unhelpful 
Neutral Slightly 
helpful 
Moderately 
helpful 
Very 
helpful 
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48 Most people who are important to me in my professional life think that  
 
I should 
definitely  
not 
I should 
almost 
certainly 
not 
I should 
probably 
not 
Neutral I should 
probably 
I should 
almost 
certainly 
I should 
definitely  
       
 
 use research evidence to help think through what I will say or 
contribute to a CCG policy meeting. 
  
 
 
 
Questions 49-52 Strongly 
disagree 
Disagre
e 
Somewha
t 
disagree 
Neither 
agree 
nor 
disagree 
Somewh
at 
agree 
Agre
e 
Strongl
y agree 
Those I work with expect me to use 
research to help think through what I will 
say or contribute in a CCG policy 
meeting. 
       
I feel under social pressure to use 
research evidence to help think through 
what I will say or contribute in a CCG 
policy meeting. 
       
People who are important to me in my 
professional life want me to use 
research evidence to help think through 
what I will say or contribute in a CCG 
policy meeting. 
       
I am confident that I could use 
research evidence to help think through 
what I will say or contribute in a CCG 
policy meeting. 
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Question 53-55 Very 
difficult 
Moderatel
y difficult 
Slightl
y 
difficul
t 
Neutral Slightl
y easy 
Moderatel
y easy 
Very 
easy 
For me to use research evidence 
to help think through what I will say 
or contribute in a CCG policy 
meeting would be  
       
The decision to use research 
evidence to help think through 
what I will say or contribute in a 
CCG policy meeting is beyond my 
control. 
 
       
Whether or not I use research 
evidence to help think through 
what I will say or contribute in a 
CCG policy meeting is entirely up 
to me. 
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Section 3 Your Relationship with Researchers 
 
This section is interested in the relationships that you currently have with researchers 
in general.  Circle the single number that represents your view. 
Question 56-57 
 
 
Never 
A few 
times 
a 
year 
Once 
a 
month 
Once 
a 
week 
Every 
couple 
of 
days 
Daily 
How often do you meet face-to-
face with researchers in the 
course of your job? 
1 2 3 4 5 6 
How often do you communicate 
via email, Skype, or telephone 
with researchers in the course 
of your job? 
1 2 3 4 5 6 
 
Question 58-62 In general, when you communicate (e.g., face to face or via 
email, phone, or Skype) with researchers, how do you find the 
contact?  Please respond on each of the following scales.  For 
example, on the first scale, if you find the contact very friendly, please 
circle number 7, or if you find the contact moderately unfriendly, you 
might circle 3.  
 
Not at all friendly 1 2 3 4 5 6 7 Very friendly 
Not at all 
pleasant 
1 2 3 4 5 6 7 Very pleasant 
Not at all helpful 1 2 3 4 5 6 7 Very helpful 
Not at all 
cooperative 
1 2 3 4 5 6 7 
Very 
cooperative 
Very negative 1 2 3 4 5 6 7 Very positive 
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Question 63-65 When you communicate with researchers, do you feel that this 
communication: 
 
Helps me to achieve my goals? Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
Helps researchers to achieve their 
goals? 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
Helps researchers and me to 
achieve goals that benefit us both? 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
 
Question 66-71 To what extent do you agree with each of the following 
statements?   
 
“In general, CCGs are very 
supportive of CCG leaders and 
researchers working closely 
together” 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
“In general, the NHS is very 
supportive of CCG leaders and 
researchers working closely 
together” 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
“CCG leaders and researchers 
recognise the expertise of each 
others’ group” 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
“CCG leaders have a higher status 
than researchers in the NHS” 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
“CCG leaders feel like part of one 
overarching team committed to 
achieving the same goals” 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
“CCG leaders and researchers feel 
like members of two separate 
groups with different goals” 
Not at 
all 
1 2 3 4 5 6 7 
Very 
much 
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Question 72-75 Next, we’d like to ask you about your position as a CCG 
leader.  
 
“I identify strongly as a CCG 
leader” 
 
Not at 
all 
1 2 3 4 5 6 7 Very much 
“Being a CCG leader is an 
important part of who I am” 
Not at 
all 
1 2 3 4 5 6 7 Very much 
“I feel strong ties with other CCG 
leaders” 
Not at 
all 
1 2 3 4 5 6 7 Very much 
“I feel a sense of solidarity with 
other CCG leaders” 
 
Not at 
all 
1 2 3 4 5 6 7 Very much 
 
We would now like to ask you some questions about your general perceptions of 
researchers.  Please answer as honestly as you can. Your responses are 
anonymous. 
 
Questions 76-81 Based on your experience please rate the extent to which you 
have each of the following feelings about researchers in 
general. (Please circle one number on each scale). 
 
Do you feel ... 
 
Warm 1 2 3 4 5 6 7 Cold 
Negative 1 2 3 4 5 6 7 Positive 
Friendly 1 2 3 4 5 6 7 Hostile 
Suspicious 1 2 3 4 5 6 7 Trusting 
Respect 1 2 3 4 5 6 7 Contempt 
Admiration 1 2 3 4 5 6 7 Disgust 
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Question  Please use the scale to indicate your overall attitude towards 
researchers by circling the bar on the scale that is closest to 
your feelings.  
    
Very 
negative  
Very 
positive 
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Section 4 About You 
 
Finally, we have a few questions about you.  These are important as they will help us 
to understand different perspectives within clinical commissioning groups.   
 
Question 83 In your current role with the CCG, do you have any formal 
responsibility for doing or managing research?   
Yes - doing  Yes - managing  
Neither  Yes - both  
 
Question 84 What is your highest educational attainment? 
School level (NVQ, GCSE, A Level or 
equivalent) 
 Masters degree  
Undergraduate degree  Higher degree (PhD)  
 
Question 85  Do you have any medical qualifications?  If yes, please state. 
No   Yes  
.. 
.. 
 
Question 86 Do you have any previous experience of doing research?   Tick as 
many as apply.  
I have worked 
as a 
researcher in 
an academic 
context 
I have 
commissioned 
research  
I have been a 
co-applicant or 
advisor on a 
research 
project 
I have been 
employed 
within a 
healthcare 
organisation as 
a researcher 
Other – 
please give 
details below 
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.................................................. .............................................. 
............................................ .................. 
 
Question 87 When something new comes along I usually... 
Like to be the 
first to take 
part and jump 
in with both 
feet  
Start to take 
part fairly early 
on 
Wait until 
some people 
have started 
doing it before 
I do 
Start once the 
majority of 
other people 
are doing it 
Wait until 
everyone else 
is doing it 
before having a 
go 
     
 
Question 87 Are you... 
 
 
 
Thank you for completing this questionnaire.  If you have any comments you would 
like to make on the topic of this survey, please use the box below.  
 
 
Male  
Female  
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Appendix 2 Example data extraction form for
systematic reviews
Author (year): 
Full reference:  
 
Population: 
Intervention(s): 
Comparison(s): 
Outcomes: 
Number of included studies: 
Relevant characteristics of included studies: 
Main Results: 
Authors Conclusions: 
 
 
DARE quality criteria 
Was the search adequate?      Y/N/Unclear 
Comments (make a note of dates and databases searched): 
Were inclusion/exclusion criteria reported?   
 Y/N/Unclear 
Comments: 
Were the data synthesised?     
 Y/N/Unclear 
Comments (make a note of methods): 
Were sufficient study details reported?    
 Y/N/Unclear  
Comments: 
Was study quality assessed?      
 Y/N/Unclear  
Comments (make a note of how assessed):  
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Appendix 3 Vignettes of evidence briefings
Enhancing access in primary care settings flow chart
Records identified through
database searching
(n = 307)
Additional records identified
through searching relevant
organisational websites
(n = 4)
Records after duplicates removed
(n = 298)
Full-text articles 
assessed for eligibility
(n = 28)
Studies included in
evidence briefing
(n = 8)
Full-text articles 
excluded, not in scope
(n = 20)
Records excluded on
title and abstract
(n = 270)
Topic Enhancing access in primary care settings
CCG A2
Role Commissioning director and chief officer
Date of contact 15 June 2015
Type of contact E-mail
Reason for contact Emerged from previous evidence note on accountable care organisations and other integrated
models of care: a scope, circulated 26 May 2015
Question to be
addressed
Focus on access: an individual service component, part of the development of the Accountable
Care organisation
Sources searched CRD Databases; NHS Evidence (systematic review filter); The King’s Fund; Health Foundation;
Nuffield Trust; Nesta; RCGP; NIHR Journals Library and NIHR ongoing projects
Search terms used Access, GP, primary care, out of hours, waiting times (in various combinations)
Our response GP surgeries across the country are implementing new strategies such as extended hours, telephone
consultation and role substitution to meet rising demands. Evaluation of extended hours shows uptake
varies depending on locality and that uptake on Sundays is lower than on extended weekdays and
Saturdays. Overall there is limited impact on Emergency Department activity. Telephone consultation
shifts the workload from face-to-face to telephone contact and increases the number of primary care
contacts within 28 days of the initial consultation. Role substitution is being widely promoted but the
extent to which this will reduce GP workload is unclear. The whole-system implications of extended
hours, telephone consultation and role substitution need to be considered. Each strategy has the
potential to reveal unmet need and displace activity rather than reduce workload. The lack of good-
quality evidence around these approaches highlights the need for evaluation alongside implementation
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs. Available at:
www.york.ac.uk/media/crd/Ev%20briefing_Enhancing%20access%20in%20primary%20care.pdf
Date sent 14 July 2015
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Additional work l A1 CCG contacted to query a presentation by Dr James Kingsland on the direct correlation
between GP access and A&E attendance
l Our response was that there have been large cross-sectional-based surveys where patients seen
in A&E reported that the reason for their visit was the inability to see a GP88 and that levels of
access to general practice is associated with use of urgent care services.89 So it is fair to say that
there is consistent evidence that a significant number of A&E attendances are likely to be
related to access. However, association does not equal causation as it does not necessarily
follow that extending hours/increasing access does in fact reduce A&E attendance. Evidence on
the effects of interventions designed to improve access is lacking
l In the extended hours section of our briefing we mention the Flores review which is a review of
UK and international primary care interventions. There is evidence presented here that
increasing access does reduce attendances but it is either creating a primary care centre where
there was not one or increasing access for Medicaid or uninsured patients. The UK evidence in
the review focused on the positive impact of colocated walk-in centres or primary care-led front
ends to A&E
l The team offered to summarise this additional information if that would be helpful. We also
offered to look at any supporting evidence Dr Kingsland used to make his case to the CCG
A&E, accident and emergency; RCGP, Royal College of General Practitioners.
Social prescribing flow chart
Records identified through
database searching
(n = 45)
Additional records identified
through searching relevant
organisational websites
(n = 14)
Records after duplicates removed
(n = 47)
Full-text articles 
assessed for eligibility
(n = 27)
Studies included in
evidence briefing
(n = 7)
Full-text articles 
excluded, not in scope
(n = 20)
Records excluded on
title and abstract
(n = 20)
Topic Evidence to inform the commissioning of social prescribing
CCG A2
Role Commissioning managers
Date of initial contact 20 October 2014
Type of contact E-mail
Reason for contact Evidence-based steer on what sorts of self-management programmes or structures could be
commissioned as part of the Pioneer programme
Question to be
addressed
l The topic of social prescribing was proposed as part of a series of briefings on self-management
themes identified in an initial scoping of the evidence. Other topics were: education, support, care
planning, mobile telephone applications (evidence note), shared decision-making (evidence note)
l What is the effectiveness and cost-effectiveness of social prescribing programmes?
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Sources searched DARE, CDSR and NHS EED
As few relevant reviews were identified, we conducted quick searches of MEDLINE, ASSIA, Social
Policy and Practice, NICE, SCIE and NHS Evidence to locate details of any relevant guidance or
service evaluations
We also searched the websites of The King’s Fund, Health Foundation, Nuffield Trust and Nesta to
locate any reports of relevant evaluations in UK settings
Search terms used Social AND prescribing; Community AND referral; Exercise AND prescription OR referral; Art AND
therapy OR prescription; Behaviour change interventions; Social AND interventions
Our response l There is little good-quality evidence to inform the commissioning of a social prescribing
programme. There are pockets of activity across the UK, mostly pilots with a small-scale evaluation
l If existing knowledge is to be improved, evaluation of new schemes should be comparative by
design and address what, when, for whom and how well does it work? What effects does it
have? What does it cost?
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs. Available at:
www.york.ac.uk/media/crd/Ev%20briefing_social_prescribing.pdf
Date sent 12 April 2015
Additional work l Once publicly available, the evidence briefing generated significant interest from CCGs and
Health and Wellbeing Boards located elsewhere in England and Scotland. All of the enquiries
focused on how the effects of social prescribing schemes should be evaluated
l Given the interest the team have opted to convert this work into a systematic review, which
has now been registered with PROSPERO (CRD42015023501)
Care-planning flow chart
Records identified through
database searching
DARE, NHS EED
(n = 153)
Additional records identified
through searching relevant
organisational websites
(n = 5)
Records after duplicates removed
(n = 151)
Full-text articles 
assessed for eligibility
(n = 10)
Studies included in
evidence briefing
(n = 6)
Full-text articles 
excluded, out of scope
(n = 4)
Records excluded on
title and abstract
(n = 141)
Topic Promoting patient-centred care planning consultations
CCG A1
Role Clinical director and Director of Public Health
Date of initial contact 13 November 2014
Type of contact E-mail
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Reason for contact Evidence-based steer on what sorts of self-management programmes or structures could be
commissioned as part of the Pioneer programme
Question to be
addressed
l The topic of patient-centred consultations was proposed as part of a series of briefings on
self-management themes identified in an initial scoping of the evidence. Other topics were
education, support, social prescribing, mobile telephone apps (evidence note) and shared
decision-making (evidence note)
l What is the effectiveness of interventions to promote patient-centred consultations?
Sources searched DARE, NHS EED, CDSR, NHS Evidence and NHS England
Search terms used Care, planning, consultation, primary care, general practice (in various combinations)
Our response Personalised care planning can improve some measures of physical health in people with long-term
conditions such as diabetes and asthma; lack of time in consultations is perceived as a barrier to
care planning by professionals and patients; interventions aimed at improving consultation skills for
both professionals and patients could improve outcomes; encouraging professionals to initiate
care-planning discussions and reassuring patients that social and emotional issues are legitimate
discussion topics could be helpful
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs. Available at:
www.york.ac.uk/media/crd/Ev%20briefing_care%20planning.pdf
Date sent 2 March 2015
Supporting self-management flow chart
Records identified through
database searching
(n = 851 general 
self-management search)
Additional records identified
(n = 23)
Records, specific to question,
 after duplicates removed
(n = 61)
Full-text articles 
assessed for eligibility
(n = 15)
Studies included in
evidence briefing
(n = 7)
Full-text articles 
excluded, not in scope
(n = 8)
Records excluded
(n = 46)
Topic Supporting self-management: helping people manage long-term conditions
CCG A1
Role Clinical director
Date of initial contact 13 November 2014
Type of contact E-mail
Face-to-face (Project Oversight Group development session 30 January 2015 where PW presented
self-management overview slides)
Reason for contact Evidence-based steer on what sorts of self-management programmes or structures could be
commissioned as part of the Pioneer programme
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Question to be
addressed
The topic of self-management support was proposed as part of a series of briefings on
self-management themes identified in an initial scoping of the evidence. Other topics were
education, social prescribing, care planning, mobile telephone apps (evidence note) and shared
decision-making (evidence note)
What is the evidence of effectiveness for self-management support?
Sources searched The series of self-management related briefings and notes shared a common large search with updating
searches using specific terms as necessary plus interrogation of reference lists and citation tracking
Sources included DARE, NHS EED, CDSR, NHS Evidence, Health Systems Evidence, The King’s Fund,
Nesta, Health Foundation and the Nuffield Trust
Search terms Common terms: self management, self care, long term condition, chronic condition, patient
centred (in various combinations)
Specific terms: support
Our response Successful self-management interventions are multicomponent and tailored to individuals’ needs.
Key components include education, action planning and practical, psychological and social
support. Condition-specific self-management reduces overall hospital use and improves quality of
life in the short term – effects on costs are mixed. Key considerations for implementation include
strong clinical leadership, training and resources, and regular evaluation
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs
Available at: www.york.ac.uk/media/crd/Ev%20briefing_supporting%20self-management.pdf
Date sent 16 February 2015
Unplanned admissions from care homes flow chart
Records identified through
database searching
(n = 23)
Additional records identified
(n = 9)
Records after duplicates removed
(n = 27)
Full-text articles 
assessed for eligibility
(n = 27)
Studies included in
evidence briefing
(n = 10)
Full-text articles 
excluded
(n = 17)
Records excluded on
title and abstract
(n = 0)
Topic Interventions to reduce unplanned admissions from care homes
CCG A2
Role Commissioning director and commissioning manager
Date of initial contact 27 October 2014
Type of contact E-mail
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Reason for contact Under the Better Care Fund, CCG have a key project related to reducing inappropriate admissions
and deaths in hospital of patients from care homes
Question to be
addressed
What is the evidence, if any, around this? For example, is there evidence that a single GP covering
a whole care home reduces admissions to hospital (rather than a few seeing only their own
patients)? What improves clinical care in care homes?
Sources searched DARE, NHS EED, CDSR, The King’s Fund, Age UK and NHS Evidence
Search terms Unplanned admissions, care home, elderly, geriatric services
Our response Much of the evidence for integration and community geriatric services comes from case studies
which are not always well reported. Closer working between health-care and care home staff
(through dedicated GP or community geriatric services), protected training for care home staff,
and implementing processes for stated end-of-life care preferences all appear promising. NICE
recommends implementation of multifaceted interventions to prevent delirium in long-term care
settings. The lack of good-quality evidence highlights the need to monitor the impact of changes
made to services particularly in relation to resource use and patient experience
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs
Available at: www.york.ac.uk/media/crd/Ev%20Briefing_unplanned%20admissions%20from%
20care%20homes.pdf
Date sent 3 December 2014
Lay-led self-care education flow chart
Records identified through
database searching
(n = 851 general 
self-management search)
Additional records identified
(n = 15)
Records, specific to question,
 after duplicates removed
(n = 150)
Full-text articles 
assessed for eligibility
(n = 11)
Studies included in
evidence briefing
(n = 7)
Full-text articles 
excluded
(n = 4)
Records excluded
(n = 139)
Topic Effects of lay-led self-care education programmes
CCG A1
Role Clinical director and clinical lead
Date of initial contact 13 November 2014
Type of contact E-mail
Reason for contact Evidence-based steer on what sorts of self-management programmes or structures could be
commissioned as part of the Pioneer programme
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Question to be
addressed
The topic of self-care education was proposed as part of a series of briefings on self-management
themes identified in an initial scoping of the evidence. Other topics were self-management
support, social prescribing, care planning, mobile telephone apps (evidence note) and shared
decision-making (evidence note)
What is the evidence for the effects of lay-led self-care education programmes or interventions
that it might commission to help people manage their own care
Sources searched The series of self-management related briefings and notes shared a common broad search with updating
searches using specific terms as necessary plus interrogation of reference lists and citation tracking
Sources included DARE, NHS EED, CDSR, NHS Evidence, Health Systems Evidence, The King’s Fund,
Nesta, Health Foundation, Nuffield Trust
Search terms Common terms: Self management, self care, long term condition, chronic condition, patient
centred (in various combinations)
Specific terms: Lay, patient, peer, education, knowledge
Our response Evidence suggests programmes produce small, short-term improvements in self-efficacy, self-rated
health and levels of exercise. The Expert Patient Programme resulted in small improvements in
self-efficacy and quality of life and was likely to be cost-effective. There was no evidence for the
outcome of unplanned health-service use
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs
Available at: www.york.ac.uk/media/crd/Ev%20briefing_Lay-led%20self-care%20education.pdf
Date sent 11 December 2014
Topic Value-based commissioning of MSK procedures: an appraisal of evidence for the proposed policies
CCG All
Role N/A
Organisation Regional group but work originally instigated by A2 CCG. Invitation to support group originally
came from B3 CCG
Date of initial contact June 2014
Type of contact Regular monthly meetings and some e-mail contact
Reason for contact A2 CCG presented the MSK resource pack to the VBCP Implementation Group. A coterminous
CCG that also shared the policy indicated that, if agreed by other CCGs, these procedures would
be incorporated into the regional Value Based Commissioning policy. We were asked to undertake
an independent appraisal of the evidence underpinning the proposed policies for MSK procedures
Question to be
addressed
Evidence for the following procedures was reviewed: autologous cartilage transplantation,
autologous blood injection for tendinopathy, bunions, carpal tunnel syndrome, discectomy for
lumbar disc prolapse, Dupuytren’s contracture, epidural injections for lumbar back pain, exogen
ultrasound bone healing, facet joint injections for back pain, ganglia, hip resurfacing, knee
arthroscopy and irrigation, non-specific low back pain and trigger finger
Sources searched Staged searches for each topic*: 1. NICE guidance 2. websites of relevant Royal Colleges for
guidance 3. CDSR 4. DARE and NHS EED
*The production of this report involved a modified version of the process used for evidence
briefings (see Chapter 3); we have not produced a flow diagram documenting the number of
records identified due to the stepped approach to searching for each individual procedure
Search terms Condition-specific terms
Our response Summaries for each procedure outlined whether or not proposed policy was in line with current evidence
Final output 32-page report, including a summary table and flow chart describing the approach to using
evidence in commissioning decisions
Available at: www.york.ac.uk/media/crd/Evidence%20review%20MSK%20VBC%20Interactive.pdf
Date sent Summary findings presented at October 2014 meeting. Full report circulated January 2015
Additional work 17 June 2015: contacted by manufacturer of one of the technologies included in the briefing –
confirmed our conclusion was in line with NICE guidance on the topic (insufficient evidence to
support routine use in clinical practice)
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Self-care for chronic obstructive pulmonary disease flow chart
Records identified through
database searching
(n = 851)
Additional records identified
(n = 18)
Records, specific to question,
 after duplicates removed
(n = 62)
Full-text articles 
assessed for eligibility
(n = 38)
Studies included in
evidence briefing
(n = 20)
Full-text articles 
excluded, not in scope
(n = 18)
Records excluded on
title and abstract
(n = 24)
Topic Self-care for COPD
CCG A1
Role GP vice chairperson, Planned Care Lead
Date of initial contact 28 April 2014
Type of contact Face to face
Reason for contact Emerging from general discussions and following on from the earlier Evidence Note (Self Care,
circulated 1 July 2014), a more specified briefing focused on COPD was requested
Question to be
addressed
l Self-care support for people with COPD and looks at the following interventions compared
with usual care: multicomponent self-care interventions (including elements such as
education, telephone support and action plans); pulmonary rehabilitation
l Outcomes of interest include unplanned hospital admissions, length of hospital stay, quality of
life and any associated costs
Sources searched The series of self-management related briefings and notes shared a common broad search with
updating searches using specific terms as necessary, plus interrogation of reference lists and
citation tracking
Sources included DARE, NHS EED, CDSR, NHS Evidence, Health Systems Evidence, The King’s
Fund, Nesta, Health Foundation, Nuffield Trust
Search terms Common terms: Self management, self care, long term condition, chronic condition, patient
centred (in various combinations)
Specific terms: chronic obstructive pulmonary disease, COPD
Our response There is consistent evidence that multicomponent interventions reduce respiratory-related hospital
admissions and improve quality of life for people with COPD. Multicomponent interventions that
include action plans, exercise, education and smoking cessation are likely to be beneficial
Hospital- and community-based pulmonary rehabilitation has some short-term impact on
health-related quality of life and hospital admissions, but the effects of home-based rehabilitation
are unclear
Final output Evidence briefing format was altered to include a one-page evidence summary table following
feedback from the CCG. The briefing was sent via e-mail to named contacts in all participating CCGs
Available at: www.york.ac.uk/media/crd/COPD%20self%20care.pdf
Date sent 1 July 2014
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Loneliness and social isolation flow chart
Records identified through
database searching
(n = 49)
Additional records identified
(n = 6)
Records after duplicates removed
(n = 40)
Full-text articles 
assessed for eligibility
(n = 15)
Studies included in
evidence briefing
(n = 10)
Full-text articles 
excluded
(n = 5)
Records excluded
(n = 25)
Topic Interventions for loneliness and social isolation
CCG A1
Role GP vice chairperson, Planned Care Lead
Date of initial contact 28 April 2014
Type of contact Face to face
Reason for contact Emerging from general discussions about priorities
Question to be
addressed
Evidence for interventions aimed at reducing loneliness and social isolation, particularly in elderly
people
Sources searched DARE, NHS EED, and CDSR for relevant systematic reviews and economic evaluations. SCIE, Age
UK, Health Foundation, The King’s Fund and Nesta were also searched for relevant reviews and
policy reports
Search terms Social isolation, loneliness, contact, support, befriending
Our response GPs may be well placed to identify people who suffer from, or who are at risk of, loneliness and
social isolation
Overall, evidence of effective interventions is limited, but group-based activities and support that
provide opportunities for social interaction appear to show some promise in addressing isolation
and loneliness
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs
Available at: www.york.ac.uk/media/crd/Loneliness%20and%20social%20isolation.pdf
Date sent 1 July 2014
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Evidence to inform urgent and emergency care systems flow chart
Records identified through
database searching
(n = 133)
Additional records identified
 through related evidence 
briefings and evidence notes
(n = 36)
Records after duplicates removed
(n = 111)
Full-text articles 
assessed for eligibility
(n = 27)
Studies included in
evidence briefing
(n = 22)
Full-text articles 
excluded, not in scope
(n = 5)
Records excluded
(n = 84)
Topic Evidence to inform urgent and emergency care systems
CCG Emerging from general discussions with CCGs about initial priorities
Role N/A
Organisation N/A
Date of initial contact N/A
Type of contact Initial face-to-face discussions with CCGs about priorities
Reason for contact Emerging from general discussions with CCGs about initial priorities – opportunity to consolidate
previous work for Vale of York and Bristol CCGs
Question to be
addressed
Review evidence on a number of topics relating to urgent and emergency care services
Sources searched DARE, HTA, Health Systems Evidence, NHS EED, and CDSR for relevant systematic reviews and
economic evaluations
Search terms used Accident AND emergency AND admissions
Out of hours
Service AND delivery and urgent
Triage AND emergency OR accident
Urgent AND triage
Our response A primary care front end to the emergency department involving GPs could be used to assess and
treat patients presenting with less urgent problems. Other workforce models with promise include
ECPs and nurse practitioners. ECPs can reduce patient transport to emergency departments,
although this appears to be dependent on the setting
Overall, the evidence for many interventions is limited and a lack of cost-effectiveness data
reinforces the need for rigorous evaluation of service change
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Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs
Available at: www.york.ac.uk/media/crd/Evidence%20to%20inform%20urgent%20and%
20emergency%20care%20systems.pdf
Date sent 24 March 2014
ECP, emergency care practitioner.
Consolidating urgent care services flow chart
Records identified through
database searching
(n = 111)
Additional records identified
(n = 3)
Records after duplicates removed
(n = 94)
Full-text articles 
assessed for eligibility
(n = 21)
Studies included in
evidence briefing
(n = 11)
Full-text articles 
excluded
(n = 10)
Records excluded
(n = 73)
Topic Consolidating urgent care services
CCG A1
Role Clinical lead
Date of initial contact 15 October 2013
Type of contact E-mail
Reason for contact CCG were considering implementing an ‘urgent care hub’, locating out-of-hours provision on a
single site adjacent to an accident and emergency department
Question to be
addressed
What evidence is there for such a model of delivery, impact on A&E volume, who should triage?
Sources searched DARE, NHS EED, HTA Database, CDSR, Health Systems Evidence. Also The King’s Fund, Nuffield
Trust, RCGP and the BMA
Search terms Accident AND emergency AND admissions
Out of hours
Service AND delivery and urgent
Triage AND emergency OR accident
Urgent AND triage
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Our response l We did not find any systematic reviews assessing the effectiveness of a single site ‘urgent care
hub’. Reviews assessing strategies for triage and treating non-emergency cases presenting to
emergency departments may inform elements of a single site hub. We found evidence that
suggests triage liaison physicians, working in a team or alone, and fast-tracking patients with
less serious symptoms both reduce emergency department waiting times and length of stay
l Evidence from a small number of poor-quality studies suggests that rapid assessment zones
and employing GPs and nurse practitioners in emergency departments may improve the
flow of non-emergency cases through the department. The evidence about the safety and
cost-effectiveness of any of these strategies is lacking
Final output Evidence briefing was sent via e-mail to named contacts in all participating CCGs
Available at: www.york.ac.uk/media/crd/Consolidating%20urgent%20care.pdf
Date sent 20 November 2013
BMA, British Medical Association; RCGP, Royal College of General Practitioners.
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Appendix 4 Vignettes of evidence notes
Topic Self-care overview
CCG A1
Role GP vice chairperson, Planned Care Lead
Date of initial contact 17 January 2014
Type of contact E-mail with follow-up discussion by telephone
Reason for contact As a result of a successful Pioneer bid for integrated care and its aim to build capability for
self-care, asked for a ‘quick and dirty’ appraisal of the evidence relating to this?
Question to be
addressed
CCG requested a rapid summary of the evidence relating to increasing self-efficacy with patients
and in the general public to build capability for self-management
Sources searched DARE, NHS EED, and CDSR for relevant systematic reviews and economic evaluations. Health
Foundation, The King’s Fund and Nesta for relevant reviews and policy reports
Our response l There is a very large evidence base (albeit of varying quality) that can inform the CCG’s plans
to increase the capacity for self-care. Rather than adopting a whole-systems approach from
the outset, it may be more beneficial to identify and then target the populations and
conditions driving unplanned health- and social-care service use
l Priority should be then be given to identifying the self-care interventions most likely to be
effective in these groups and to considering ways of overcoming barriers to implementation
Final output Evidence note sent via e-mail
Date sent 30 January 2014
Additional work Following this initial overview of the evidence base, we developed a series of full evidence
briefings and notes on self-management themes: education, support, social prescribing, care
planning, mobile telephone apps (evidence note), shared decision-making (evidence note)
Topic Models of psychiatric liaison implemented in general hospital settings
CCG A2
Role Commissioning director
Date of initial contact 30 July 2014
Type of contact Face-to-face meeting
Reason for contact Arising from general discussion about priorities. Team had just been approached by Vale of York
CCG about the same topic
Question to be
addressed
Summary of the evidence about the components, benefits and associated costs of different
psychiatric liaison models that have been implemented in general hospital settings
Sources searched DARE, NHS EED, and CDSR for relevant systematic reviews and economic evaluations. Health
Foundation, The King’s Fund and NHS Evidence for relevant reviews
Our response Due to differences in liaison psychiatry services and outcomes reported and the methodological
quality of studies identified, it is not clear which model of service or, service components, are
most effective. Questions also remain around cost-effectiveness; the cost ‘savings’ attributed to
the RAID model are overstated. This underlines the importance of evaluating any implementation
of a liaison psychiatry service and to give careful consideration to outcome measurement
Final output Evidence note sent via e-mail
Date sent 3 September 2014
RAID, Rapid Assessment, Interface and Discharge.
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Topic Evidence to inform a review of a pharmacy minor ailments scheme
CCG A1
Role Senior officer, Planning and Service Reform – Commissioning Support on behalf of A1 CCG
Date of initial contact 22 July 2014
Type of contact E-mail with follow-up face-to-face meeting (on 30 July 2014)
Reason for contact CSU conducting a review of the minor ailments service and CCG suggested that they seek
assistance from us to identify evidence
Question to be
addressed
General summary of the evidence about the effects of pharmacy-based minor ailments schemes
to support a review of current and future provision of such schemes in their locality
Sources searched DARE, NHS EED, and CDSR for relevant systematic reviews and economic evaluations. NHS
Evidence, Health Foundation, The King’s Fund, Nuffield Trust and Royal Pharmaceutical Society for
relevant policy reports and service evaluations
Our response We were able to identify a highly relevant systematic review not included in the draft review
by Commissioning Support. The limited evidence suggested schemes do appear to offer an
alternative to GP consultation. Two unanswered questions remain: we do not know how much
demand would be shifted away from GPs if a scheme was introduced; we do not have a
complete picture on the cost of providing such a scheme
Final output Evidence note sent via e-mail
Date sent 9 September 2014
Topic ‘One-stop shop’ screening model for diabetes
CCG A1
Role Commissioning manager
Date of initial contact 3 September 2014
Type of contact E-mail with follow-up telephone conversation
Reason for contact Manager mentioned to KF face to face that they were looking for assistance on this topic. Team
followed up
Question to be
addressed
Would implementing a comprehensive one-stop shop annual review and screening model for
diabetes have an adverse impact on either the quality or uptake of screening (feet and eyes)?
Sources searched DARE, NHS EED, and CDSR for relevant systematic reviews and economic evaluations. NHS
Evidence, Diabetes UK, Health Foundation, The King’s Fund, NETSCC, NICE and Nuffield Trust for
relevant policy reports and service evaluations
Our response We were unable to identify any evaluations of models similar to that being proposed or indeed
any evaluation that showed a negative link between a comprehensive annual review and
screening uptake
Final output Evidence note sent via e-mail to the project group
Date sent 19 September 2014
NETSCC, NIHR Evaluation, Trials and Studies Coordinating Centre.
Topic Evidence to inform the development of integrated community teams
CCG A1
Role Manager, Service Planning and Reform – Commissioning Support on behalf of A1 CCG
Date of initial
contact
7 August 2014
Type of contact E-mail with follow-up telephone conversation
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Reason for contact Initial stages of developing integrated community teams in A1 CCG. In particular keen to hear
about any other areas, nationally and internationally who have implemented a similar integrated
team, what the key outputs were (reduction in secondary care attendances/admissions, etc.) and if
there is any commonality in terms of best practice from areas where the service has worked
particularly well. Provided details of a model in the Netherlands which they were planning to visit
Question to be
addressed
Summary of the evidence for effects of integrated community teams including any examples of best
practice
Sources searched DARE, NHS EED, and CDSR for relevant systematic reviews and economic evaluations. The King’s
Fund, Health Foundation, Nuffield Trust, NETSCC, NHS Evidence and RAND Europe for relevant
reviews, case studies
Our response l Overall, the available literature appears dominated by case studies and descriptions of service
models and there is a lack of reliable evidence of effectiveness and cost effectiveness. The lack
of evidence in this area emphasises the importance of evaluating the impact of new services as
these are introduced. There may be lessons and approaches from ongoing evaluations that the
CCG can use to inform their own service planning
l RAND Europe has highlighted that integrating care is not just a matter of implementing
pre-defined steps of a particular service model. As such, it has developed a series of structured
questions for decision-makers to use when planning service redesign
Final output Evidence note sent via e-mail
Date sent 29 September 2014
NETSCC, NIHR Evaluation, Trials and Studies Coordinating Centre.
Topic What validated tools are there for frailty risk profiling in an A&E context?
CCG A2
Role Commissioning director and chief officer
Date of initial contact 20 October 2014
Type of contact Telephone and e-mail
Reason for contact Chief officer conversations with A&E consultants who, along with all the dramatic stuff they do,
feel they are increasingly filters/triage for frail older people with complex needs – if there was a
risk profile of either low or high risk that they could use, it would have a lot of traction. Suspect
part medical history, part medication and part based on investigation results. This is different from
anticipatory care planning as they have crossed the hospital threshold
Question to be
addressed
Initial confusion over the question. We thought that we were being asked to assess risk
stratification tools, but the chief officer clarified that they meant predictors in the A&E department
which may be more biomedical than the predictors of frailty. So rather than predictive modelling,
the CCG are more interested in predicting risk of adverse outcomes in frail individuals presenting
in the acute setting (planned or unplanned)
Sources searched DARE, NHS EED, and CDSR for relevant systematic reviews and economic evaluations. Also,
consulted with National Clinical Director and consultant Andrew Clegg and asked them what they
would suggest for risk profiling in an A&E context
Our response l Although evidence on its diagnostic accuracy is lacking (no studies yet conducted), they said
current BGS consensus is that the Edmonton Frail Scale may be a useful tool to identify frailty,
especially when considering a surgical intervention, as it might help with care co-ordination
l A copy of the scale is included on p.15 of NHS England’s guidance on care pathways for frail
older people – scores at either end of the scale could identify those at high and low risk –
see: www.england.nhs.uk/wp-content/uploads/2014/02/safe-comp-care.pdf
l There is no single tool that can be used alone and so it’s used in combination with medical
history, medication review, etc. Also the common clinical presentations of frailty (e.g. falls,
delirium and sudden immobility) can alert clinicians to the possible presence of frailty as they
can mask serious underlying illness
l Mentioned team are producing an Effectiveness Matters bulletin on recognising and managing
frailty in the community and that would be circulated at the end of the month/beginning December
Final output E-mail followed by Effectiveness Matters bulletin
Date sent 3 November 2014
A&E, accident and emergency; BGS, British Geriatrics Society.
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Topic Mobile telephone apps
CCG A1
Role Clinical director and Director of Public Health
Date of initial contact 1 November 2014
Type of contact E-mail
Reason for contact Evidence-based steer on what sorts of self-management programmes or structures could be
commissioned as part of the Pioneer programme
Question to be
addressed
l Following initial sift of evidence base, we proposed a series of briefings on self-management
themes: education, support, social prescribing, care planning, mobile telephone apps
(evidence note), shared decision-making (evidence note)
l What is the effectiveness of mobile telephone apps in supporting self-management?
Sources searched DARE, NHS EED and CDSR
Our response l We identified three potentially relevant reviews and a rapid scope of the literature
l Despite growing popularity and availability, there is a lack of reliable evidence to guide
decision-making on the effects of mobile telephone apps on health-related outcomes.
Much of the available evidence is small scale and focuses on development, user testing and
feasibility rather than on establishing effectiveness and cost effectiveness
Final output Evidence note sent via e-mail
Date sent 24 November 14
Topic Interventions to promote shared decision-making
CCG A1
Role Clinical director and clinical lead and Director of Public Health
Date of initial contact 13 November 2014
Type of contact E-mail
Reason for contact Evidence-based steer on what sorts of self-management programmes or structures could be
commissioned as part of the Pioneer programme
Question to be
addressed
l Following initial sift of evidence base, we proposed a series of briefings on self-management
themes: education, support, social prescribing, care planning, mobile telephone apps
(evidence note), shared decision-making (evidence note)
l What is the effectiveness of interventions to promote shared decision-making?
Sources searched DARE, NHS EED and CDSR
Our response l We identified five relevant systematic reviews and an overview of reviews; all identified
limitations in their findings relating to small sample size and variation in the included studies
l Where shared decision-making is tailored appropriately it can have beneficial effects on
patient-centred outcomes. Patients may be more likely to follow through with treatments and
actions if decisions are mutually agreed. Decision-aids improve patients’ knowledge of the
options and enable more accurate expectations of potential benefits and harms
Final output Evidence note sent via e-mail
Date sent 5 January 2015
Topic Accountable and other integrated models of care: a scope
CCG A2
Role Commissioning director
Date of initial contact 8 May 2015
Type of contact Telephone with e-mail follow-up
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Reason for contact l CCG awarded vanguard funding: this will be supported through the opening of a Specialist
Emergency Care Hospital, an extension of primary care to create ‘hubs’ of primary care
provision across the county seven days a week. This redesign of community and acute services
will ensure patient care is delivered increasingly in community settings, and bring together
commissioning responsibility across the whole health economy
l Following implementation of the new model, patients will be able to access their GP over the
weekend, preventing the need to go to the emergency department when symptoms worsen.
The model cuts across organisational boundaries and includes enhanced access to community
nursing services, fully co-ordinated discharge and shared IT that will support better care in a
number of health settings and in the home
Question to be
addressed
The CCG staff are interested in a scope of different models of accountable care – they are very
early in the development process and will be looking for interventions and ways of working that
they can pilot test before implementing more fully. They are reasonably familiar with US ACOs but
may still be interested in a ‘lessons-learned’ overview. More interested in European models and
mentioned they were interested in the Alzira model in Spain and some Dutch care models that
they had heard about but are lacking information on
Sources searched DARE, NHS EED and CDSR for relevant systematic reviews and economic evaluations. Given the
nature of the topic we carried out a general search for reports on acute care models including
searching the websites of The King’s Fund, NHS Confederation and Monitor
Our response l Brief scope of the literature around ACOs and other integrated models provided. We focused
on programme performance as there is a real lack of informative supporting evidence at
this level
l A variety of care models have been implemented, but evaluation of performance is lacking.
Common components of models include; capitated budgets, shared electronic patient records
and strategies to reduce inappropriate hospital admissions and length of stay – integrated
care pathways, risk stratification and case management
l This is an initial rapid scope of the literature and further exploration of performance can be
undertaken for any models or intervention components of particular interest
Final output Evidence note sent via e-mail
Date sent 26 November 2015
Feedback Developed a related briefing ‘Enhancing access in primary care settings’ to focus on individual
service components as part of the developing ACO
ACO, Accountable Care Organisation; IT, information technology.
Topic Telehealth for COPD
CCG A2
Role Commissioning manager
Date of initial contact 20 July 2015
Type of contact E-mail
Reason for contact Locality are implementing a COPD telehealth pilot and are interested in learning lessons from
evaluations of other implementation projects
Question to be
addressed
Update of Telehealth for patients with long-term conditions (June 2013) produced for Vale of
York CCG, with a focus on COPD and implementation issues
Sources searched DARE, NHS EED, CDSR, NHS Evidence and PubMed for relevant systematic reviews and economic
evaluations published since June 2013
Our response The focus of the evidence note was on telehealth interventions for people with COPD. Although a
number of systematic reviews and economic evaluations have been identified much of the
evidence is weak and reported effects are mixed. Small-scale incremental introduction that
enables adaptation, refinement and greater system integration should remain the preferred
approach. Evaluation at this scale should involve a focus on initial experience, acceptability and
system fit
Final output Evidence note sent via e-mail
Date sent 6 August 2015
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Topic Public engagement in decision-making
CCG A1
Role Chief officer and clinical director
Date of initial contact 12 August 2015
Type of contact E-mail
Reason for contact l We are interested in the concept of participatory democracy. We have a whole system of
patient/public engagement but wondered if it was far reaching enough. How can we truly
engage with residents of the borough in supporting them to help us make good decisions
and take responsibility for making them? The term participatory democracy has been used
l Our questions are: where in the UK/the world has this level of public empowerment been
successful in shaping health-care services? What are the interventions/strategies we need to
adopt to support it? What benefits (or risks) does this kind of approach bring?
Questions to be
addressed
l Who was involved?
l How and why were they invited?
l What was the nature of the type of engagement/participation?
l What was the level of commitment?
l How much did the process cost?
l What decisions were made using these interventions and what benefits/risks were associated?
l Could there be something more specific about evaluation of these approaches, have they
been used only for specific pathways of care or certain decisions or systematically across the
whole commissioning cycle? (‘evidence base for true engagement of local residents in
decision-making processes for the CCG in terms of healthcare’)
Sources searched DARE, NHS EED, CDSR, NHS Evidence, PubMed and Google
Our response The evidence about public participation in health-care policy-making is mainly descriptive and
largely focuses on discrete deliberations or specific service redesigns. We found no evidence
evaluating systematic use across a whole commissioning cycle. There is also a lack of detail about
the overall impact public involvement has on decision-making processes generally. Nevertheless,
early engagement, genuine and open interaction and processes led and supported by health
professionals appear associated with success. The methods used to recruit and engage public
participation should be tailored to the question and the setting
Final output Evidence note sent via e-mail
Date sent 4 September 2015
Topic Independent review of evidence for existing value-based hernia and hysterectomy policies
CCG All
Role N/A
Organisation Regional group
Date of initial contact August 2015
Type of contact Regular monthly meetings and some e-mail contact
Reason for contact Requested by consultant in public health as part of ongoing review of regional policies
Question to be
addressed
Review those topics that have the greatest absolute value opportunity. Hysterectomy and inguinal
hernias are both on the proposed list of policies so it would be useful to have a review
Sources searched l Searched the NICE website for relevant quality standards, guidelines and technical appraisals.
The websites of the relevant professional colleges were also searched for guidelines. (CDSR,
DARE and NHS EED were searched for relevant systematic reviews published since the search
date of any identified guidelines)
l Used the staged process previously outlined for MSK procedures (see Chapter 4)
Search terms Condition-specific terms
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Our response l Essentially both guidelines are under review but recent evidence would suggest that the
current policy is not going to alter very much
l NICE guidance on the diagnosis and management of hernia was planned for 2015 but
development has been suspended in order to prioritise other topics. Updated NICE guidance
on hysterectomy is due for publication in April 2016
Final output Evidence note
Date sent October 2015
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Appendix 5 Guide for commissioners on using
evidence to support decision-making
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